University of Wollongong

Research Online
University of Wollongong Thesis Collection
1954-2016

University of Wollongong Thesis Collections

2016

Investigating the potential of whole grain sorghum as an ingredient in foods
to assist in the prevention of chronic disease
Anita Stefoska-Needham
University of Wollongong
Follow this and additional works at: https://ro.uow.edu.au/theses
University of Wollongong
Copyright Warning
You may print or download ONE copy of this document for the purpose of your own research or study. The University
does not authorise you to copy, communicate or otherwise make available electronically to any other person any
copyright material contained on this site.
You are reminded of the following: This work is copyright. Apart from any use permitted under the Copyright Act
1968, no part of this work may be reproduced by any process, nor may any other exclusive right be exercised,
without the permission of the author. Copyright owners are entitled to take legal action against persons who infringe
their copyright. A reproduction of material that is protected by copyright may be a copyright infringement. A court
may impose penalties and award damages in relation to offences and infringements relating to copyright material.
Higher penalties may apply, and higher damages may be awarded, for offences and infringements involving the
conversion of material into digital or electronic form.
Unless otherwise indicated, the views expressed in this thesis are those of the author and do not necessarily
represent the views of the University of Wollongong.

Recommended Citation
Stefoska-Needham, Anita, Investigating the potential of whole grain sorghum as an ingredient in foods to
assist in the prevention of chronic disease, Doctor of Philosophy thesis, School of Medicine, University of
Wollongong, 2016. https://ro.uow.edu.au/theses/4835

Research Online is the open access institutional repository for the University of Wollongong. For further information
contact the UOW Library: research-pubs@uow.edu.au

Faculty of Science, Medicine and Health
School of Medicine

Investigating the potential of whole grain
sorghum as an ingredient in foods to assist in
the prevention of chronic disease

Anita Stefoska-Needham
Bachelor of Science (Biology and Nutrition) (University of Wollongong)
Master of Science (Nutrition and Dietetics) (University of Wollongong)
Advanced Accredited Practising Dietitian (Dietitians Association of Australia)

This thesis is presented as part of the requirement for the
award of the degree of

DOCTOR OF PHILOSOPHY

University of Wollongong

2016

© Copyright 2016

Anita Stefoska-Needham
All Rights Reserved

ABSTRACT
Background: Whole grain intake is associated with reduced risk of chronic diseases,
such as cardiovascular disease and Type 2 diabetes. Unlike more commonly
recognised whole grains, sorghum is a so-called “ancient”, gluten-free whole grain
food that is gaining attention from food manufacturers, consumers and researchers as
a beneficial ingredient in novel product development. Sorghum is widely cultivated
globally due to its adaptability to semi-arid/arid conditions and high temperatures,
and has significant potential for sustainable grain production in harsh climates. It is a
dietary staple in some communities of Asia, Africa and Central America, however in
countries such as the United States and Australia, sorghum is predominantly used as
an animal feed, with only small quantities utilised for the manufacture of human
foods. If sorghum is to be accepted as a common food, attention to food formulations
and processing methods that produce desirable sorghum-based cereal products,
whilst preserving the grain’s beneficial nutritional and functional attributes, is
required.

Sorghum whole grain has been shown to have lower starch and protein digestibility
in vitro, resulting in reduced metabolisable energy and hence smaller weight gains in
animals, and some cultivars are high in dietary fibre and rich in polyphenolic
compounds. Based on their purported mechanisms, these attributes may contribute to
positive effects on metabolic markers and body weight and therefore may more
broadly influence chronic disease prevention in humans when they consume
sorghum-based foods regularly. However, there is a paucity of human studies to
date.

i

Research Hypothesis and Study Aims: This thesis proposes that sorghum grain
consumption may assist in chronic disease prevention via weight management,
especially in populations where food is ubiquitous and obesity-related chronic
diseases are prevalent. Research examining the effects of sorghum intake on health
outcomes, such as weight loss and disease biomarkers, requires clinical studies.
These studies may also expose potential protective roles of the sorghum grain as part
of a whole diet. The key hypothesis of this thesis is that sorghum is a viable
alternative to more commonly consumed whole grain cereals in the human diet and
may have positive benefits on factors associated with metabolic health including
weight management. A review of the literature described sorghum grain structure
and composition which relate to mechanisms by which sorghum grain components
may influence weight management and chronic disease risk; and summarised the
evidence on effects of sorghum consumption on health outcomes related to chronic
disease prevention. This review provided insights into the knowledge gaps and study
imperatives that informed the experimental components of the thesis.

In order to conduct human trials successfully, particularly with participants who do
not typically consume traditional sorghum foods, suitable ready-to-eat sorghum
grained cereal foods in the form of flaked breakfast cereal biscuits were formulated
and tested prior to intervention trials commencing. A randomised, crossover, feeding
study using the flaked sorghum biscuits was conducted to investigate mechanisms
related to general metabolic markers and antioxidant status, as well as acute satiety.
A randomised controlled trial (RCT) was then conducted with the aim to test the
weight-loss effects of longer-term whole grain sorghum flaked biscuits consumption
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incorporated into an energy-restricted diet plan. This study also examined the effects
on key biomarkers of metabolic health, inflammation and oxidative stress.

Methods:
Gaps in the knowledge of effects of sorghum consumption on indicators of metabolic
disease, including weight, were identified and elements of study designs were
incorporated into the experimental components of the thesis. Whole grain flaked
cereal biscuits were formulated on a pilot line by our industry partner (Sanitarium
Health and Wellness) using a multistep process involving steaming, drying, rolling
and baking. For the acute satiety study, forty subjects (20 males and 20 females)
were tested on four occasions after a 12-hour fast. At baseline, they consumed 50
grams (or 3 biscuits) of one of four treatment meals: white, red or brown whole grain
sorghum flaked biscuits or a whole grain flaked wheat biscuit control. Subjective
satiety was measured at 8 time-points over four hours and food intake at the
subsequent meal and for the rest of the day recorded. In a subset of 20 subjects,
plasma glucose, insulin, and four appetite-related gut peptides (GIP, GLP-1, PYY
and ghrelin) were also measured. In the subsequent RCT investigating chronic
sorghum consumption, sixty subjects (14 males and 46 females) were randomised to
either a sorghum (intervention) or wheat (control) group. Both groups received
advice on an energy-restricted diet from an Accredited Practising Dietitian and were
provided with 45 g of cereal products to include daily in their prescribed diets for 12
weeks. The primary outcome was weight loss. Secondary outcomes included: plasma
glucose, HbA1c, insulin, total cholesterol, HDL-c, LDL-c, TAG, and various
markers of inflammation and oxidative stress (IL1β, IL-6, IL-8, TNFα, hsCRP, HPX
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and TAC), measured at 0 and 12 weeks. Subjective satiety ratings were assessed at 0,
6 and 12 weeks.

Results: A vast array of nutritional and bioactive sorghum grain components, such
as slowly digestible starches, polyphenols including anthocyanins in red sorghum,
unsaturated fatty acids, and dietary fibre (including resistant starch), were identified
in the literature, with potential actions in health protective metabolic processes.
There was a paucity of human studies that are necessary to better understand effects
of sorghum consumption (as a whole food), especially those related to health
outcomes and indicators of disease. These findings justified the human studies
described. During the acute meal test study, subjects reported significantly lower
satiety ratings after consuming wheat compared to sorghum biscuits. Incremental
AUC of postprandial GLP-1, GIP and in males, PYY, were significantly higher
(p=0.018, p=0.031, p=0.036 respectively) for sorghum breakfasts compared to
wheat. Energy intake at a subsequent meal did not differ between treatments, nor did
glucose, ghrelin and TAC responses. The red sorghum biscuit showed the greatest
alteration in appetite hormones, suggesting that the specific combination of its
components (such as unique anthocyanin flavonoids) requires further investigation.
Hence, these results informed the choice of a red sorghum-based biscuit to test in the
subsequent 3 month RCT. This trial did not identify any significant differences in
weight loss or any clinical variables between a sorghum cereal group and a wheat
control in an energy-restricted diet. For both groups, the majority of clinical indices
changed significantly over time (p<0.05) and equivalent amounts of weight were lost
(p=0.369). These results did not concur with the initial acute satiety study and there
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was no translation to differences in weight reduction effects for sorghum and wheat
cereals.

Conclusions: Research presented in this thesis provides human evidence for acute
satiety effects from whole grain sorghum ingestion in the form of flaked cereal
biscuits. However, it could not be concluded that whole grain sorghum assists
specifically with weight management, or is superior to wheat (another whole grain
product). Further clinical trials are necessary to establish an evidence base for weight
loss effects from chronic sorghum consumption. In the longer term, this research
would help to further evaluate the weight loss potential of sorghum consumption,
especially red sorghum grown in abundance locally in Australia. Weight loss effects
would be considered to assist in the prevention of chronic diseases, particularly those
associated with obesity. Nevertheless, new knowledge was generated from these
studies demonstrating the potential of sorghum consumption to enhance acute
satiety. Sorghum is not only a gluten-free whole grain cereal, but also a promising
ingredient in cereal foods targeting appetite control. Commercially, the results of the
feeding trials may contribute to the development of the sorghum industry globally by
adding to the evidence base on human health effects. This thesis also showcases the
collaboration between food industry and science to progress sorghum, a relatively
unknown human food in Australia, through the food product innovation pipeline with
positive outcomes for all stakeholders including researchers, food manufacturers and
also consumers.
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CHAPTER 1:
Introduction and Thesis Overview

A component of this chapter is the substantive content of the following article:
Stefoska-Needham, A. (2016) Progressing the position of sorghum, a potentially sustainable cereal
crop, through the food product innovation pipeline: an Australian perspective. Agroecology and
Sustainable Food Systems. (Under Review)
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1.1 Introduction
Human health, food and the national economy are interlinked. The current Australian
economy is undergoing change that reflects shifts within primary industries. With the
decline of mining, other sectors such as manufacturing, services, education and
agriculture have become increasingly important in stimulating economic growth. Of
these five economic pillars, agriculture has been a consistent and important
component, despite contributing less than 3% of gross domestic product (GDP) in
2014(1). Australia’s farmers produce enough food to feed 80 million people(2),
providing not only 93% of the domestic food supply(3), but also supporting an export
market valued at more than A$41 billion per annum or more than 13% of export
revenue(1; 2). The major commodities are grains and oilseeds, followed by meat, then
industrial crops (sugar, cotton and wine), wool, dairy and horticulture(1; 2).

In fact, the demand for Australian-produced food is increasing, especially from
Asian markets such as China, driven by their large populations and a growing middle
class. Furthermore, frequent food contamination incidents in Asia have resulted in a
general mistrust of food produced in that area and a growing demand for Australia’s
“green and clean” produce. The problem was seen in China, in 2008, when melamine
(a toxic polymer) was added to infant formulae, resulting in 6 infant deaths and
52,000 hospitalisations(4). As a consequence, the demand for Australian-made infant
formulae, perceived to be safe, surged, stripping local supplies(4). These types of
incidents have reinforced Australia’s reputation as a producer of the highest food
quality, with exceptional food safety and biosecurity standards.
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Australian agriculture faces major challenges in supplying the increasing demand for
food in the local and Asia-Pacific region, one of which is climate change. Climate
change has resulted in increased global temperatures and reduced rainfall, which in
turn have impacted on the usability of land for farming through loss of biodiversity,
dry-land salinity, acid soils, pests and weeds(5). Hence, it has become critical to
engage in sustainable agricultural practices in order to protect farming land whilst
meeting demands for greater food production. In turn, cultivating more
environmentally sustainable crops, suitable to Australia’s often-harsh climate, is
important, especially since grains are the nation’s leading commodity(1).

Sorghum (Sorghum bicolor (L.) Moench) is a good example of a sustainable crop
that requires fewer nutrient inputs and significantly less water than other crops, such
as corn(6). In many countries of Africa, Asia and Central America, sorghum is widely
cultivated due to its adaptability to semi-arid and arid conditions and high
temperatures, and is a major contributor to the staple diets of local populations(7).
Globally it ranks fifth in cereal production and in Australia it ranks third, with the
2014-2015 sorghum harvest producing 2.2 million tonnes of grain across 730,000
hectares of total land area(7; 8). This was a significant increase on previous years,
predominantly in response to above-average rainfalls and a higher demand from
China. In Australia, the primary use of sorghum has been as low-value livestock feed
and more recently in biofuel production(9), while demand for use in human food
manufacturing has been negligible. Sorghum has therefore remained both underutilised and less-recognised compared to other cereal crops, such as wheat.
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The commercialisation of sorghum for human use in Australia has faced significant
challenges, limited mainly by (a) a reluctance from farmers, in the absence of
reliable markets, to invest in crop management necessary to improve the volume and
consistency of production, and (b) the lack of incentives for grain processors to
invest in market development, given the availability of alternative grains with better
profit margins. Despite these limitations, a small number of food products have
emerged on supermarket shelves over recent years that contain sorghum as a key or
component ingredient, suggesting that demand for sorghum in human food
production is increasing. For example, the Sanitarium Health and Wellbeing
Company, a leading cereal food manufacturer with a strong ethos for healthy eating
and wholesome foods, engaged in food innovation and launched a gluten-free
breakfast cereal made exclusively from sorghum in 2014(10). The launch of this
product aligned with the broader expansion of the health food sector seen in
Australia(11), suggesting that the relationship between food and health is having an
increasing impact on food innovations by food producers. These types of food
product developments and investments are what is required to further stimulate
consumer interest in sorghum as a human food ingredient, and encourage growers
and food product manufacturers to participate. Furthermore, the lure of a growing
consumer movement dedicated to "healthy living" and “naturally functional”
foods(11) and the ability of food companies to reformulate rather than to always
innovate, often helps to overcome initial corporate resistance.

To successfully launch new products in the marketplace and promote them to
consumers, marketing and branding become critical components. However, in
Australia, the marketing of novel food products made from ingredients with potential
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benefits for human health, such as sorghum-based foods, must be conducted within a
strict regulatory environment. Moreover, any food companies wishing to make a
health claim must comply with “Standard 1.2.7 - Nutrition, Health and Related
Claims”, regulated by Food Standards Australia New Zealand (FSANZ)(12). This
standard regulates claims appearing on food labels and in advertisements, in the form
of nutrition content claims and health claims. These claims are voluntary statements
made by food companies and may refer to the nutritional content of the food
(nutrition content claims) or they may refer to a relationship between food, or a
property of food, and a health effect (health claims). Health claims are further
categorised as “general level health claims” (GLHC) or “high level health claims”
(HLHC). GLHCs refer to a component or nutrient in a food and how it may affect
health. For example, ‘Fibre helps to keep you regular’(13). These types of claims
cannot be used in association with serious diseases, such as heart disease, or
indicators of disease, such as cholesterol. HLHCs refer to a component or nutrient in
a food and how it may affect a serious disease or biomarker (indicator) of a serious
disease. An example of this type of claim is: ‘This food is low in sodium (salt). A
diet low in sodium may help reduce blood pressure’(13). Overall, health claims must
be based on food-health relationships that have been substantiated according to
Standard 1.2.7 and manufacturers need to provide supporting scientific evidence to
demonstrate that their product contains the described ingredient/s(12). Health claims
related to weight control and satiety effects of foods are currently not permitted.
HLHCs must also meet the Nutrient Profiling Scoring Criterion (NPSC), a point
system broadly ranking the nutritional quality of a food(12). For example, foods high
in saturated fat and sugar are not allowed to carry a health claim, even if low in salt,
because they would not meet the NPSC.
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Scientific evidence therefore underpins the substantiation of health claims for food.
However, not all scientific evidence is equivalent. The National Health and Medical
Research Council (NHMRC) classifies the quality of scientific evidence according to
a hierarchy which assigns “levels of evidence” based on the type of research question
asked and its associated research design (Table 1.1)(14). FSANZ uses these “levels of
evidence” in its validation of health claims for food. Thus, for novel sorghum-based
foods, substantiating potentially beneficial effects on disease risk factors will require
rigorous scientific investigation in human studies. In addition, consistent results from
randomised controlled trial (RCTs) are needed to build the highest level of evidence
for practice. Specifically, investigating the long-term effects of consuming sorghum
as part of a healthy diet is necessary in order to build on the small number of
promising human studies, as well as other encouraging in vitro and animal research.

To this end, the research presented in this thesis is a contribution to the level of
evidence necessary to substantiate potential future health claims related to sorghumbased foods. The results may also guide other researchers, consumers, the food
industry, growers, health professionals, and government-based grain advocacy
organisations on the general benefits of sorghum consumption for humans, and the
process for research to investigate health effects from particular food ingredients.
Findings from the body of work presented in the thesis collectively add to the
knowledge base for sorghum as a promising whole grain cereal with the potential to
assist in the prevention of chronic disease, particularly in developed countries such
as Australia. The relevant thesis components are: (1) a critical review of the existing
literature on sorghum, (2) research underpinning the innovative development of a
sorghum-based food product, (3) a study of the mechanisms of sorghum grain action,
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and (4) a randomised controlled trial testing the effects of chronic consumption of a
novel sorghum based product.

Moreover, this thesis represents more than just a contribution of evidence in support
of a scientific question. It showcases the collaboration between food industry and
science to progress the position of sorghum, a relatively unknown human food in
Australia, through the food product innovation pipeline (Figure 1.1). In doing so, our
knowledge is increased about many facets of sorghum - from plant biology through
to environmental and agronomic considerations necessary for plant growth, to the
nutritional and chemical composition of sorghum grain, and then finally the potential
mechanisms of action that may be behind observed longer-term effects of chronic
sorghum consumption. In addition, by developing a food product suitable for the
modern Australian palate, the impact of grain processing and food format selection
on clinical effects was elucidated.

Figure 1.1 Key factors in the innovation of sorghum-based food products
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(15)

Table 1.1 NHMRC Hierarchy of Evidence
Level

Intervention

I

A systematic review of
level II studies

II

A randomised
controlled trial

III-1

A pseudorandomised
controlled trial (i.e.
alternate allocation or
some other method)

III-2

A comparative study
with concurrent
controls:

Non-randomised
experimental trial

Cohort study

Case-control
study

Interrupted time
series with a
control group
A comparative study
without concurrent
controls:

Historical control
study

Two or more
single arm study

Interrupted time
series without a
parallel control
group
Case series with either
post-test or pretest/post-test outcomes

III-3

IV

Diagnostic
Accuracy
A systematic
review of level II
studies
A study of test
accuracy with an
independent,
blinded
comparison with a
valid reference
standard, among
consecutive
persons with a
defined clinical
presentation
A study of test
accuracy with an
independent,
blinded
comparison with a
valid reference
standard, among
non-consecutive
persons with a
defined clinical
presentation
A comparison with
reference standard
that does not meet
the criteria
required for Level
II and
III-1 evidence

Prognosis

Aetiology

Screening
Intervention
A systematic review of
level II studies

A systematic
review of level II
studies
A prospective
cohort study

A systematic
review of level II
studies
A prospective
cohort study

All or none

All or none

A pseudorandomised
controlled trial (i.e.
alternate allocation or
some other method)

Analysis of
prognostic factors
amongst persons
in a single arm of a
randomised
controlled trial

A retrospective
cohort study

A comparative study
with concurrent
controls:

Non-randomised,
experimental
trial

Cohort study

Case-control
study

Diagnostic casecontrol study

A retrospective
cohort study

A case-control
study

A comparative study
with concurrent
controls:

Historical control
study

Two or more
single arm study

Study of
diagnostic yield
(no reference
standard)

Case series, or
cohort study of
persons at
different stages of
disease

A cross-sectional
study or case
series

Case series

A randomised
controlled trial
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1.2 Thesis Overview and Structure
This thesis begins with a summary of the existing evidence on whether sorghum
consumption assists in the prevention of chronic disease (Chapter 2). Gaps in the
literature were identified, in particular a paucity of reports on research involving
human subjects. These observations were used to guide the development of the
human clinical trials designed for the experimental components of the thesis.

A methodological framework underpinning the research undertaken for the thesis is
presented in Chapter 3. This includes overviews of experimental study designs and a
discussion of the different experimental methods utilised in the clinical trials within
the thesis, giving insights into concepts of validity, strengths and limitations.
Importantly, reviews of specific biomarkers, both as indicators of health status and
appetite regulation, are also provided.

In order to conduct human trials testing sorghum-based foods in the Australian
context, product development is important as such foods are not commonly
available. Chapter 4 describes the overall processing protocols used to formulate a
ready-to-eat sorghum grain breakfast cereal for use as a suitable test food in human
trials. Details are provided on the nutritional, chemical and physicochemical
properties of the end-products to enable more accurate interpretation of clinical
effects observed in the clinical trials conducted.

To examine some of the potential mechanisms of action of sorghum consumption on
health, an acute study was conducted (Chapter 5). This trial investigated not only
subjective satiety, but also alterations to post-prandial responses in glucose, insulin
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and a number of appetite-regulating gut hormones. In addition, antioxidant status
was measured. Results confirmed that sorghum-grained breakfast cereal enhances
acute subjective satiety and increases satiety-enhancing hormone levels acutely after
ingestion. The cereal food made from red sorghum grain, a variety rich in
anthocyanin flavonoids, elicited the greatest overall acute satiety-enhancing
responses.

While these initial acute satiety results indicated that satiety effects might translate to
longer-term effects on food consumption and thereby weight, this required testing on
chronic disease biomarkers or health outcomes from a sorghum-enriched diet
(containing red sorghum flaked biscuits) using a “gold-standard” study design, the
randomised controlled trial. Chapter 6 presents results from this trial, demonstrating
that equivalent amounts of weight were lost in the sorghum intervention group and
the wheat control group, and for both groups the majority of clinical indices showed
significant beneficial changes over time.

Chapter 7 summarises the results and conclusions of the four tenets of this thesis (the
current scientific evidence of effects, the product formulation and the two
experimental studies), and uses these to address the central aim and hypothesis.
Limitations of the study designs are discussed and key recommendations for future
research are provided.
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CHAPTER 2:
Nutritional composition of sorghum and evidence of its
effects on health

A major component of this chapter is the substantive content of the published article:
Stefoska-Needham, A., Beck, E.J., Johnson, S.K., Tapsell, L.C. (2015) Sorghum: An Underutilized
Cereal Whole Grain with the Potential to Assist in the Prevention of Chronic Disease. Food Reviews
International, 31:401-437.
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2.1 Introduction
Cereal whole grains are significant contributors to energy, nutrients and dietary fibre
in the human diet and are important for health. Numerous prospective studies
demonstrate that regular consumption of whole grains lowers the risk of heart disease
and diabetes by 20-30%(16; 17), improves blood glucose regulation(18), achieves better
weight management over time(19; 20), and lowers the risk of certain types of cancer
(21)

. A critical appraisal of the body of evidence is reflected in multiple national

dietary guidelines that inform the community to eat more “grain foods particularly
whole grain cereals” and to reduce consumption of refined grains(17; 22).

Sorghum (Sorghum bicolor (L.) Moench) is a gluten-free whole grain cereal that is
better known to Western societies as an animal feed rather than a human food source.
Sorghum is grown around the world, and ranks fifth in global cereal production after
maize, rice, wheat and barley(7). Sorghum is widely cultivated due to its adaptability
to semi-arid and arid conditions and high temperatures. In these regions it is a major
contributor to the staple diets of local populations(9). In countries such as Australia
and the United States, the primary use of sorghum has been as livestock feed and
more recently in biofuel production(9). Increasingly, the nutritional and agronomic
advantages of sorghum, combined with a growing consumer movement dedicated to
"healthy living"(11), has peaked commercial interests in developed economies on how
to make sorghum-based food products more accessible to consumers who remain
largely unaware of their potential health benefits.

The starting point for exposing health benefits of foods is often their nutritional
properties. In the case of sorghum, as with plant foods generally, the phytochemical
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component is of particular interest and this reflects recent developments in the
nutritional sciences. The type of phytochemicals, namely phenolic acids, flavonoids
and condensed tannins, in some sorghum varieties have been purported to reduce the
risk of certain types of cancer, cardiovascular disease, obesity and diabetes(23).
Sorghum also has decreased starch and protein digestibility in vitro, and is high in
dietary fibre and resistant starch and this array of qualities may play a role in
mechanisms that reduce disease risk (Table 2.1). Not least, is the fact that sorghum is
gluten-free and is suitable for people with coeliac disease and gluten intolerances(24).

Table 2.1 Sorghum’s nutritional and functional attributes associated with metabolic
disease effects
Component/Property

Proposed benefits

Slow starch digestibility(25; 26)

Potential to attenuate blood glucose & insulin

(slowly digestible starches; interactions with

responses & increase satiety through reduction of

endosperm & polyphenolic compounds that

glycaemic index of sorghum-based foods. This

reduce starch hydrolysis)

has relevance in appetite regulation, weight
management & risk reduction of obesity-related
diseases such as diabetes

High antioxidant activity(23)

Potential to reduce oxidative stress that plays an

(phenolic acids, monomeric polyphenolic

important role in the pathogenesis of many

flavonoids, polymeric polyphenolic condensed

chronic diseases such as diabetes, atherosclerosis,

tannins)

some cancers, aging, arthritis & neurological
diseases

High fibre(27)

Offers benefits to gut microbiome, metabolic

(including resistant starch, ranging
(28)

from 2.2 g

(29)

– 6.5 g

disease risk & gastrointestinal health

/ 100 g dry matter)

High unsaturated fatty acid content of
(30; 31)

lipid

Improving dyslipidemia & thus promoting heart
health

(oleic acid, linoleic acid, linolenic acid and
policosanols in wax(18))
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In a traditional nutrition sense, the value of sorghum grain has been considered to be
slightly inferior compared to other cereal grains on the basis of lower protein and
starch digestibility and consequently, reduced metabolisable energy. This
consideration is especially relevant to many of the world’s poorest and most foodinsecure communities where sorghum is a core food. In these cases sorghum is
combined with legumes and other cereals to increase macro- and micro- nutrient
density of sorghum-based foods and diets(32;

33)

, and to this end, bio-fortified

transgenic sorghum lines have been developed(34). Paradoxically, these properties of
lower digestibility and reduced available energy may prove to be better suited in
populations where over-weight and obesity related chronic diseases, such as
metabolic syndrome, diabetes, heart disease and cancer are major public health
issues(35).

Over the past decade, key researchers have exposed the potential role of sorghum in
human health and in disease prevention(23; 36; 37). They have argued for a paradigm
shift from perceiving sorghum as a low-value cereal grain to a health-promoting,
environmentally sustainable food for inclusion in the global human diet. In order to
achieve commercial adoption of this position, food innovation is required that would
extend the range of sorghum-based products available to consumers. At the same
time, quality human clinical trials are required to provide evidence of health effects.

The research needs to be conducted in a food-health paradigm that considers not only
the effects of individual grain constituents and their involvement in physiological
processes, but also the effects of consuming sorghum-based foods within the broader
context of whole diets. Because sorghum has been largely used as an animal feed in
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Western societies, much of the research has been done on livestock, but a wide range
of studies have emerged that provide the basis for moving into human clinical
studies. To guide valid hypotheses for clinical human research, a summary of the
existing evidence and knowledge base is required.

2.2 Literature review method
A comprehensive, narrative literature review was determined most appropriate in
light of the complex amalgamation of research topics considered (plant anatomy,
food chemistry, food processing, nutrition, and evidence for health effects). Search
terms included “sorghum”, “sorghum grain”, “composition”, “nutrient”, “chemical”,
“human”, “health”, “chronic disease”, “diet”, “benefit”, “weight”, “subject”,
“intervention”, “clinical”, “trial”, and combinations thereof.

The following

databases were utilised to identify relevant literature; Cochrane Library, CINAHL,
MEDLINE, PubMed, Science Direct, Scopus and Web of Science.

Aims of the review were to:
1) describe sorghum grain structure and the specific chemical, nutritional and
functional attributes that relate to mechanisms by which sorghum grain components
may influence weight management and chronic disease risk;
2) summarise the evidence reported in the scientific literature on effects of sorghum
consumption on health outcomes related to chronic disease prevention.
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2.3 Results
2.2.1 Structure of the Sorghum Plant
Sorghum is a self-pollinating, summer annual belonging to the grass family of
Poaceae. The sorghum plant resembles a cane-like grass, ranging in height from
60cm to 460cm. It mostly has a single stem and produces a deep taproot under
favourable soil conditions(38). The leaves look similar to maize leaves, varying from
7 to 24 leaves per plant depending on the cultivar (Figure 2.1). The flower head (or
seed head) is usually a compact panicle, of approximately 25-36cm, that sits on top
of the stalk of a mature plant and carries two types of flowers.

Source: iStock by Getty Images (www.istockphoto.com)

Figure 2.1 Field of red sorghum plants depicting maize-like leaves and compact
panicles (grain seed heads)
16
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2.2.2 Sorghum: potential as a environmentally-sustainable, commercial crop for
human food production
Sorghum is a dependable crop that requires fewer nutrient inputs and significantly
less water than other crops(6). Largely due to its remarkable natural diversity,
sorghum can be grown on over 80% of the world’s agricultural land, including
marginal land not suited to cultivation of other crops(39). As global demand increases
for more productivity from low-quality land with fewer resource inputs, sorghum is
positioned well to meet those needs in a sustainable way. However, historically the
utilisation of sorghum for human use in Western societies has been grossly limited
mainly due to its reputation as a livestock feed, the lack of potential markets and the
paucity of human dietary studies, as discussed in Chapter 1. Having said this, during
the course of this thesis, a growing number of food products have emerged on
supermarket shelves that contain sorghum as a component ingredient, suggesting that
demand for sorghum for use in human food production is increasing (Figure 2.2). In
the majority of instances, these food products have been marketed for their glutenfree attribute rather than other potential nutritional attributes of the sorghum grain.

Figure 2.2 Example of different sorghum-containing food products currently on
supermarket shelves (May 2016)
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2.2.3 Nutritional and chemical composition of the sorghum grain
Sorghum grain is similar to maize with respect to chemical composition, with its key
components being: starch, proteins, lipids, non-starch polysaccharides and
phytochemicals such as phenolic compounds, phytosterols and policosanols.
Sorghum grain also contains dietary fibre, including resistant starch, and
micronutrients including vitamins and minerals, oil bodies, waxes and ash.

The grain is spherical with a slightly flattened germ end, reaching approximately
4mm in length(40) (Figure 2.3). Like other cereal grains, the sorghum caryopsis is
divided into three distinct anatomical parts: the pericarp (outer layer or seed coat),
endosperm (storage tissue) and germ (embryo). Genes referred to as the R and Y
genes control pericarp colour. The testa is a sub-coat located between the pericarp
and endosperm, and is also controlled by genes (B1 and B2 genes)(41). When both
genes are dominant, the testa is pigmented. In general, sorghum grains are smaller
than those of maize but have a similar starchy endosperm that is usually white and
floury.

Most sorghum grains are partially covered by husks (glumes) that are

removed from the grain during threshing. Consequently, there is no husk to remove
during milling(42). The pericarp is made of 3 segments - epicarp, mesocarp and
endocarp(43). The epicarp is the outermost layer and is usually covered with a thin
waxy film. It contains most of the sorghum pigments that strongly influence the grain
colour. The mesocarp, the middle structure, contains varying amounts of starch
granules(40), a feature unique to sorghum and pearl millet.

18

CHAPTER 2: Nutritional composition of sorghum and evidence of its effects on health

Figure 2.3 Sorghum Caryopsis
(© Anita Stefoska-Needham adapted from Sautier and O’Deyes(44))

The endosperm is the largest part of the caryopsis, accounting for 82-87% of the
grain weight(43) in the form of mostly starch and protein. It is comprised of the
aleurone layer, peripheral layer, and corneous and floury areas. The aleurone
contains proteins (protein bodies, enzymes), ash (phytin bodies) and oil
(spherosomes). The germ is comprised of the scutellum, the embryonic axis and
embryonic disc. The germ is very rich in lipids and contains a large proportion of
protein. The protein of the germ is mainly albumins and globulins, which are rich in
lysine, tryptophan and other essential amino acids(45).
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The proximate nutritional composition of sorghum whole grain is similar to wheat
whole grain; energy density is 1377 vs 1418 kJ/100 g dry weight, total carbohydrate
74.6 vs 71.1, fat 3.3 vs 2.5 and protein 11.3 vs 13.7 g/100 g dry weight, respectively
(Table 2.2). However, sorghum has lower starch digestibility relative to other grains
such as maize, rice, wheat and barley, although the degree of digestibility depends on
the method of processing(25;

46)

. The nutritional quality of sorghum proteins is

diminished because they are more resistant to digestion(46) and have low levels of
essential amino acids such as lysine, tryptophan and threonine(47). In contrast, there
are high levels of leucine that were previously implicated, but now not accepted, as a
cause of niacin deficiency and consequently endemic pellagra in some sorghumeating populations(48-51).

As with cereals more broadly, sorghum is a source of B-complex vitamins such as
thiamin, riboflavin, vitamin B6, biotin, and niacin, but levels are diminished with
grain refining processes including decortication(52). The mineral composition in
sorghum is similar to millet and is predominantly composed of potassium and
phosphorus, with low levels of calcium(53). Sorghum-based foods are a good source
of both iron and zinc, although anti-nutrients such as phytates may diminish
bioavailability(54; 55). A complete nutrient analysis of sorghum is detailed in Table
2.2.

Sorghum grain is generally rich in health-promoting phytochemicals, especially
polyphenols. Importantly, sorghum varieties are classified largely according to their
total extractable phenols, in combination with grain appearance (Table 2.3). White
sorghums have no detectable tannins or anthocyanins and have very low total
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extractable phenol levels. Red sorghums have no tannins but have a red pericarp with
significant levels of extractable phenols, namely anthocyanins. Brown sorghums
have a pigmented testa and contain significant levels of tannins, with varying degrees
of pericarp pigmentation. Black sorghums are a special variety of red sorghum that
turns black in sunlight during maturation and they contain very high levels of 3deoxyanthocyanidins (3-DAs), which are located in the pericarp(57; 58).

The colour of the sorghum grain, the naturally occurring variations of which are
shown in Figure 2.4, significantly influences the colour of the flour and thus the
appearance of end food products.
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Table 2.2 Nutritional Composition of Sorghum, Wheat and Corn
(per 100g dry weight, edible portion)(40; 56)
Proximates
Energy (kcal / kJ)
Protein (g)
Total lipid (fat) (g)
Carbohydrate, by difference (g)
Fibre (g)

Sorghum,White,Whole
329/1377
10.62
3.46
72.09
6.7#

Wheat, Durum, Whole
339/1418
13.68
2.47
71.13
10.7*

Corn, Yellow
365/1527
9.42
4.74
74.26
7.3

Lipids
Fatty acids, total saturated (g)
Fatty acids, total monounsaturated (g)
Fatty acids, total polyunsaturated (g)
Cholesterol (mg)

0.610
1.131
1.558
0

0.454
0.344
0.978
0

0.667
1.251
2.163
0

Minerals
Calcium, Ca (mg)
Iron, Fe (mg)
Magnesium, Mg (mg)
Phosphorus, P (mg)
Potassium, K (mg)
Sodium, Na (mg)
Zinc, Zn (mg)
Copper, Cu (mg)
Manganese, Mn (mg)
Selenium, Se (mg)

13
3.36
165
289
363
2
1.67
1.080
1.630
12.2

34
3.52
144
508
431
2
4.16
0.553
3.012
89.4

7
2.71
127
210
287
35
2.21
0.314
0.485
15.5

Vitamins
Vitamin C, total ascorbic acid (mg)
Thiamin, B1 (mg)
Riboflavin, B2 (mg)
Niacin, B3 (mg)
Pantothenic acid, B5 (mg)
Vitamin B6 (mg)
Folate, DFE (µg)
Vitamin B-12 (µg)
Vitamin A, RAE (µg)
Vitamin D (IU)
Vitamin E (alpha-tocopherol) (mg)

0
0.332
0.096
3.688
1.250
0.440
20
0
0
0
0.50

0
0.419
0.121
6.738
0.935
0.419
43
0
0
0
0.71*

0
0.385
0.201
3.627
0.424
0.622
19
0
11
0
0.49

Amino Acids
Tryptophan (g)
Threonine (g)
Isoleucine (g)
Leucine (g)
Lysine (g)
Methionine (g)
Cystine (g)
Phenylalanine
Tyrosine (g)
Valine (g)
Arginine (g)
Histidine (g)
Alanine (g)
Aspartic acid (g)
Glutamic acid (g)
Glycine (g)
Proline (g)
Serine (g)

0.124
0.346
0.433
1.491
0.229
0.169
0.127
0.546
0.321
0.561
0.355
0.246
1.033
0.743
2.439
0.346
0.852
0.462

0.176
0.366
0.533
0.934
0.303
0.221
0.286
0.681
0.357
0.594
0.483
0.322
0.427
0.617
4.743
0.495
1.459
0.667

0.067
0.354
0.337
1.155
0.265
0.197
0.170
0.463
0.383
0.477
0.470
0.287
0.705
0.655
1.768
0.386
0.822
0.447

*Whole grain wheat flour

#White sorghum (fibre in other sorghum types ranges between 8.8-11.1g / 100 g).
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Table 2.3 Classification of sorghum according to appearance and extractable phenols
Tannins

Anthocyanins

Pericarp

Testa

White or “Foodtype” Sorghum

Nil

Nil

Not pigmented

Absent

Red
Sorghum

Nil

High

Red

Not pigmented

Black Sorghum

Nil

Very High

Black

Not pigmented

Brown Sorghum

Very high

High

Pigmentation variable

Pigmented

Figure 2.4 Grain colour variation in seed heads of different sorghum cultivars
(Image source: © Anita Stefoska-Needham)
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2.2.4 Processing of sorghum grain to produce foods for human consumption
Cereal-based food products, including those made from sorghum grain, require
processing(59). The aim of processing is to transform raw grains into edible food
products that possess good sensory qualities and retain beneficial nutritional and
functional properties(60). In Western countries, cereal grains are most commonly
utilised in the production of breads, breakfast cereals and cereal-based snack foods.
For breads and other baked goods, grains are generally milled to produce flour,
which in turn is subjected to treatment with water and heat(59). Commercial
breakfast cereals may be extruded, puffed, baked and flaked. Feasibly, sorghum
grain can be treated using the same methods, in addition to being popped, in a
similar manner to corn(60). However, processing affects the chemical composition
and physical properties of foods, either positively or negatively, thereby impacting
on the potential health benefits that can be delivered by the end food product (60). For
example, processing may affect starch gelatinisation and digestibility and therefore
impact on the glycaemic index (GI) of a food(61), with implications for blood
glucose regulation(62). Also, the levels of phytochemicals tend to be lower in
processed sorghum foods than in the native grains, lowering the food’s total
antioxidant capacity and thereby sorghum’s potential to mitigate oxidative stress
processes(60). Overall, research on the effects of different processing methods on
sorghum grain is limited, in particular in relation to the flaking of sorghum grain,
which was the method used to manufacture a food product for testing in the
experimental components of this thesis (full method described in Chapter 4). Only
one study was identified in the literature(345), showing that flaking sorghum
grains reduces soluble, bound and total polyphenol content, however because this
was not a clinical study extrapolation to the human condition is not possible.
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Sorghum constituents isolated from the native grain may have different effects after
processing/treatment compared to those arising from the natural, unprocessed grain.
Moreover, the effects elicited by the whole food may be greater or different from
the corresponding actions of the individual food constituents, through synergistic
interactions between components within the food matrix (described by the concept
of food synergy: Section 2.2.6)(63). Thus, it is essential to examine sorghum as a
whole food, as is, after processing. To assist with our understanding of the whole
food effects, it is important to firstly recognise the array of sorghum components, as
reviewed in the following section.

2.2.5 Sorghum grain components with the potential for functional properties
Starches
Sorghum grain is a good source of starch, containing approximately 71% of dry
whole grain weight(40). The starch is encapsulated in granules that are located
predominantly in the endosperm (storage tissue), though uniquely some are present
in the pericarp (outer layer of grain)(40). Sorghum starch is comprised of both
amylose and amylopectin polysaccharides (branched polymers of glucose) with
very low percentages of amylose present in the starch of waxy sorghum varieties
compared to 24-33% in non-waxy sorghum starch(37). Sorghum starch granules are
densely packed and enclosed by protein bodies embedded in a protein matrix, a
unique structural aspect of sorghum grain(46). Disulphide-bond cross-linking
involving kafarins in the protein matrix forms a protective network around the
starch granules reducing starch digestibility(26).
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The lower starch digestibility reported for sorghum foods is not an intrinsic property
of the sorghum starch granules themselves, but appears mainly to be a consequence
of the interactions of the starch with the endosperm protein matrix, as well as with
cell wall material and polyphenolic compounds, such as condensed tannins and
flavonoids(62;

64-67)

. These interactions impede carbohydrate-hydrolyzing enzymes,

such as α-glucosidase and α-amylase, thereby lowering starch digestibility(68). The
presence of the protein matrix has also been associated with reduced starch
gelatinisation during cooking resulting in partially-gelatinised sorghum starch
granules that may resist enzymatic degradation(46). Sorghum starch has amongst the
highest gelatinisation temperatures, ranging from 66-81 °C, depending upon
cultivars, and is higher than that of maize, wheat and barley(37;

69)

. However, the

extent of gelatinisation of starch granules as a result of processing cannot easily
predict digestibility and physiological effects such as glycaemic responses. Factors
such as the precise ratios of amylose to amylopectin, their arrangement within the
starch granule, further degradation of other polymer molecules and post-processing
conditions also influence the postprandial effects of a starchy food(70).

Recent publications report on the in vitro starch digestibility of different sorghum
foods, including sorghum-refined maize snack-like extrudates(71), whole grain
sorghum-refined wheat flour flat bread(72) and whole grain sorghum-durum semolina
pasta(28). These in vitro studies confirm that sorghum foods can be formulated and
processed to deliver slowly digested starch (SDS), with the potential to assist in
improving blood glucose control, however these predicted positive results require
rigorous testing in humans.
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Resistant Starch and Non-Starch Polysaccharides
Sorghum foods also contain varying amounts of resistant starch (RS) depending on
factors such as processing, cooking, cooling, food storage, gelatinisation, and
cultivar(28; 29; 62; 72). Physiologically, RS resists hydrolysis by enzymatic digestion in
the small intestine(73) and enters the colon where it is partially or completely
fermented to produce beneficial short-chain fatty acids (SCFA)(74). Here, the RS can
act as a prebiotic(75; 76) by stimulating the proliferation of beneficial bacteria already
in residence in the gastrointestinal tract (GIT). To date these effects have not been
widely researched with respect to sorghum foods and sorghum-based diets.

Non-starch polysaccharides (NSPs) have been associated with lower blood plasma
cholesterol levels, reduced small intestine transit time, and improved bowel
function(77; 78). NSPs are the major component of dietary fibre in sorghum grain and
are mainly located in the pericarp and endosperm cell walls, constituting 2-7% of the
total weight of the grain depending upon cultivar(27;

79)

. Sorghum NSPs are both

cellulose and non-cellulosic consisting of arabinose, xylose, mannose, galactose,
glucose, and uronic acid monomers(37;

80)

. The non-cellulosic polysaccharides are

primarily water-insoluble glucuronoarabinoxylans (GAX) along with β-glucans(81),
although naturally occurring β-glucans in sorghum are lower than that of barley and
oats(29; 82). The GAX in sorghum are very abundant and are highly substituted with
glucoronic acid residues, and acetyl and feruloyl compounds. Sorghum contains
other non-carbohydrate cell-wall components that form part of the dietary fibre
fraction such as lignins, at levels up to 20% of the total cell wall contents by dry
weight(83). The total dietary fibre content of different sorghum cultivars ranges from
7.6% in low-tannin sorghums to 9.2% in high tannin varieties(27), and its level in

27

CHAPTER 2: Nutritional composition of sorghum and evidence of its effects on health

sorghum-based meals can be manipulated by cooking and fermentation(84). The effect
of consumption of sorghum NSPs has not been investigated in humans.

Proteins
Protein is the second largest constituent of sorghum grain (6-18%) after starch(42).
Sorghum endosperm proteins are found in both a matrix and as protein bodies that
are enveloped by the matrix. Sorghum proteins are classified as albumins, globulins,
kafirins, cross-linked kafirins and glutelins(85). Of these, kafirins are the main
protein(86), comprising 50-70% of total protein content(46). The kafirins are prolamin
storage proteins with limiting levels of some amino acids, in particular lysine(45), a
disadvantage not unique among cereal grains. The kafirins differ in structure from
the gliadin and glutenin storage proteins in wheat. They do not elicit damage to the
mucosa of the small intestine of people with coeliac disease(24), making sorghum a
viable ingredient for gluten-free foods such as bread. However, the inability of
sorghum kafirins to make elastic dough and the difficulty in making bread of high
consumer acceptability presents challenges and has driven research into the
manufacture of quality sorghum-based gluten-free food products(72; 87).

Sorghum kafirins are poorly digested due to the formation of cross-linking especially
when moist cooked, resulting in protease resistance(46). In vitro and animal studies
have also shown that sorghum protein digestibility may be reduced by other proteinprotein, protein-phenol and carbohydrate-phenol complexes that have been
identified(80; 88-90). Cornu and Delpeuch(91) reported that the nitrogen digestibility in
humans on a diet of 80% sorghum decreased from 65.4% to 60.5% when the
decorticated sorghum in the diet was replaced by whole grain sorghum, suggesting

28

CHAPTER 2: Nutritional composition of sorghum and evidence of its effects on health

that higher fibre sorghum varieties may have lower protein digestibility. Rather than
a fibre effect per se, this more likely relates to the higher polyphenol content that
naturally occurs in whole grain sorghum and the resultant binding of phenols to
dietary protein(80). In sorghum-consuming communities, where protein malnutrition
is an issue, efforts to increase protein digestibility are imperative and lactic acid
fermentation, decortication and extrusion have been shown to improve digestibility
and consequent amino acid availability(71; 90; 92).

Sorghum grain also contains a broad range of bioactive peptides, recently reviewed
by Lin et al.(93) These are of current interest to researchers due to their potential
biological role in human physiological processes including pathogenesis. The peptide
bioactivities include antioxidant, antihypertensive, anticancer, antimicrobial, and
opioid activities as well as immunomodulatory and cholesterol-lowering effects. The
specific bioactive peptides isolated in sorghum include but are not limited to:
amylase inhibitors(94), proteinase inhibitors(95), cationic peroxidase(96), 2-kDa antiviral
peptide(97) and xylanase inhibitors(93). To date, research linking cereal grains with
potential bioactive peptide activity has been limited, however there are more
sorghum studies appearing in the literature(93; 98). Overall, there is much to consider in
translating this knowledge to human clinical trials, in particular the study populations
of interest and the health/disease outcomes that might be researched.

Lipids
Sorghum grain contains approximately 3-4% lipids, the majority of which are
neutral triglycerides, rich in unsaturated fatty acids and mostly present in the
germ(30). The predominant fatty acids are oleic acid (31.1–48.9%), linoleic acids
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(27.6–50.7%), linolenic acid (1.7–3.9%), stearic acid (1.1–2.6%), palmitic acid
(11.7–20.2%) and palmitoleic acid (0.4–0.6%)(40; 99; 100). Two less common saturated
fatty acids, octanedioic (C8:0) and azelaic acid (C9:0), have been identified in some
sorghum varieties(99). This lipid composition has generated interest in sorghum as a
source of edible oil, representing a potentially valuable dietary source of
monounsaturated fatty acids (MUFA) and polyunsaturated fatty acids (PUFA), with
higher PUFA levels than MUFA(99). This desirable lipid composition is conducive to
mechanisms that lower lipid levels in humans and therefore to potentially lower risk
factors associated with heart disease.

Based on research in hamsters, Carr et al.(101) suggested that the primary cholesterollowering mechanism of sorghum lipid extracts appears to be a reduction in
cholesterol absorption with a concomitant increase in faecal sterol excretion.
Specifically, policosanols (a mixture of long-chained primary alcohols) in the
sorghum lipid extracts appear to inhibit endogenous cholesterol synthesis(84).
Sorghum also contains plant sterols that may reduce cholesterol absorption to
collectively lower plasma and liver cholesterol concentrations(101). These results were
recently supported by Lee et al.(102) in a hamster model of hypercholesterolemia,
investigating the effects of whole kernel grain sorghum oil (rich in plant sterols) and
wax (high in policosanols). The authors report that the sorghum oil played a more
significant role in modulating cholesterol, most likely by inhibiting absorption,
however subtle interactions by the wax may have contributed to the effect (102).

The policosanols in sorghum wax (found on the surface of the grain kernel) are
comprised of mainly docosanol (C22), tetracosanol (C24), hexacosanol (C26),
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octacosanol (C28), triacontanol (C30), and dotriacontanol (C32)(103). In sorghum,
C28 and C30 are the most abundant policosanols(31). A mixture of C28 and C30 from
sugar cane wax has been shown to improve blood lipid levels(104), however reports on
the human effects of sorghum-derived policosanols have not been published to date.

Martinez et al.(105) reported an alternative mechanism for the cholesterol lowering
effect of sorghum lipid extract from research done with hamsters. They reported that
sorghum lipid extract acts as a “prebiotic” to improve the host cholesterol
metabolism through effects on gut microbiota. Bifidobacteria significantly increased
in the hamsters fed grain sorghum lipid extract and was positively associated with
HDL plasma cholesterol levels(105). In humans, this shift in bifidobacteria is
associated with improved overall health, including reduced gut infections and
suppression of colon cancer initiation(106-108).

Finally, sorghum lipids may also possess antiproliferation properties. Zbasnik et
al.(109) extracted lipids from sorghum dry distiller's grain (a by-product of the ethanol
industry) and observed an anti-proliferative effect on human colon carcinoma cells.
They suggested that the effect may have been a result of synergistic interactions of
vitamin E (predominantly gamma-tocopherol), triacylglycerides, free fatty acids
(predominantly linoleic acid), policosanols, aldehydes, and sterols (predominantly
campesterol and stigmasterol) that were identified in the extracts(109). Although
sorghum dry distiller’s grain is primarily used for animal feed, it is chemically and
microbiologically safe as a human food ingredient, therefore further research in
humans is relevant.
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Phytochemicals
Most sorghum varieties, except white sorghums, have a high concentration of
phytochemicals (Figure 2.5), particularly phenolic compounds, which exhibit high
antioxidant activity and are linked to health benefits(23; 57; 110). In fact, bran of some
sorghum grain varieties reportedly has the highest antioxidant activity of all cereal
crop fractions, even higher than many fruits and vegetables(23). Specifically, sorghum
bran has up to two orders of magnitude higher antioxidant activity than oat bran and
wheat cereal, and an order of magnitude higher than rice bran although the precise
amount is highly dependent on the variety of sorghum (Figure 2.6).

Phenolic compounds
The phenolic compounds in some sorghum grain varieties are more abundant and
diverse than in any other cereal grain(57). Sorghum grain varieties that have a
pigmented testa and thick pericarps have the highest levels(111). The phenolic
compounds are concentrated in the bran component of the grain (in particular the
testa and pericarp) and can be categorised into three main groups; 1) phenolic acids
(hydrobenzoic acids and hydrocinnamic acids), 2) monomeric polyphenolic
flavonoids (flavanols, flavanones, flavones, flavan-4-ols and anthocyanins), and 3)
polymeric polyphenolic condensed tannins (also known as proanthocyanidins or
procyanidins). Refer to Figure 2.5.

The phenolic compounds in sorghum grain exhibit high antioxidant activity through
their ability to scavenge free radicals(57). The degree of antioxidant activity is
correlated to the content of phenolic compounds in a specific sorghum cultivar and

32

CHAPTER 2: Nutritional composition of sorghum and evidence of its effects on health

Figure 2.5 Classification of dietary phytochemicals (adapted from Liu, 2004)(121)
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Figure 2.6 Antioxidant activity in sorghum bran fractions (dry basis) relative to
other cereals and common fruits measured by Oxygen Radical Absorbance Capacity
(ORAC) and expressed as μmol Tocopherol Equivalents (TE)
(Compiled from previously reported data(23; 56))

this in turn is influenced by its genotype and growing environment(111). Levels of
phenolic compounds and the activity of enzymes, which synthesize or catabolize
phenols in sorghum grain, strongly influence food product properties such as flavor
and color, and are therefore important determinants of sorghum for food use(36). In
general, sorghum processing decreases antioxidant activity mainly as a result of
reducing levels of measurable phenolic compounds(112-114). This may be as a result of
thermal degradation or lowered extractability during the analytical procedures used
for their measurement(113). However, some processes including steeping,
germination, fermentation(115) and roasting of steamed grain(116) have been reported
to increase the level of polyphenolics. These may be related to improved
extractability through breakdown of the food matrix, which might also result in
higher bioavailability.
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It has been postulated that sorghum grain phytochemicals may provide overall
disease protection through not only antioxidative but also hypoglycaemic, and
hypolipidaemic mechanisms(117; 118). However, the extent of these health beneficial
effects is unclear since only limited clinical research has been reported. Reduction in
oxidative stress is implicated in these protective processes(119), therefore sorghum
polyphenolic compounds may be relevant in disrupting the cascade of
pathophysiological changes that lead to metabolic disease. In vitro, sorghum bran
extracts with a high phenolic content and thus high antioxidant properties were
shown to inhibit albumin glycation, whereas wheat, rice, oat and low-phenolic
sorghum bran extracts (such as white sorghum) did not(120). Albumin glycation is the
non-enzymatic process that results in formation of advanced glycation end-products
(AGEs). AGEs have been associated with metabolic diseases such as diabetes and
atherosclerosis. Human clinical investigations are warranted to further test these
effects, especially since sorghum bran extracts have been suggested for use in food
ingredients, food supplements or nutraceutical products.

Flavonoids
The anthocyanin flavonoids found in pigmented sorghums, but not in white
sorghums, are of particular interest to researchers since some are unique to sorghum
grain and they have potent antioxidant properties(122). The 3-deoxyanthocyanins (3DA and derivatives) are the major class of flavonoid and are located in the
pericarp(57; 58). 3-DAs lack the hydroxyl group in the 3-position of the C-ring and
include the apigenidin and luteolinidin that are largely responsible for the
pigmentation of certain sorghum grain varieties, namely red and black sorghums(123).
A recent in vitro analysis of red sorghum flour extracts showed strong free radical
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scavenging activity as measured by an oxygen radical absorbance capacity (ORAC)
assay and protection against LDL-oxidation, contributing to the evidence base for the
potential of red sorghum as a valuable health-promoting food grain(124). However,
understanding the bioavailability of sorghum anthocyanins for the putative healthpromoting effects in humans is a much-needed focus of future research.

In vitro research investigating effects of specific sorghum anthocyanins is emerging.
A study utilising the human epithelial larynx carcinoma cell line (Hep-2) by Devi et
al.(125) demonstrated that anthocyanins extracted from red sorghum bran, specifically
luteolinidin and apigenindin, induced significant anti-proliferative activity. Powerful
anti-proliferative effects were also observed against colon cancer cells when black,
red, and white sorghum extracts, rich in 3-DA were tested(126; 127). Yang et al.(128)
proposed that these protective effects result from estrogen-induced apoptosis of the
non-malignant colonocytes that were strongly influenced by the flavones, apigenin
and luteolin. In breast cancer cell lines, 3-DA isolated from red sorghum bran have
been shown to have strong anti-proliferative properties and to be cytotoxic(129).
Sorghum chloroform extracts have particularly strong anti-inflammatory effects in
vitro (in both cell-free and cell-mediated experimental systems) through almost
complete suppression of lipopolysaccharide-mediated production of nitric oxide,
tumor-necrosis factor-α, and interleukin-6. These effects are correlated to flavonoid
concentration in the extracts(130).

Tannins

Tannin sorghums contain high molecular weight condensed tannins that are
oligomers or polymers composed of flavan-3-ol nuclei, found in the pigmented testa
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of the sorghum grain(41). They are formed by B-type (dimeric) procyanidins
(3,5,7,’,4’-OH), namely procyanidin B-1 as represented in Figure 2.7. Condensed
tannins exhibit strong antioxidant activity in vitro via free radical scavenging
activity, chelation of transition metals and inhibition of pro-oxidative enzymes. The
antioxidant activity of sorghum tannins is higher than that of tannins extracted from
any other crop(122; 131; 132). In animal studies, sorghum tannins have been shown to be
15-30 fold more effective at quenching peroxyl radicals than simple phenolics(133).
OH
HO

O

OH
OH

OH
HO

OH

O

OH
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OH

Figure 2.7 Procyanidin B-1, a type of condensed tannin, isolated in sorghum
(Image source: ©Anita Stefoska-Needham, adapted from Koleckar et al.(134))

The presence of tannins in sorghum grain may reduce the nutritive value and lower
metabolisable energy of the grain. Several mechanisms have been proposed to
explain this “anti-nutritional” effect as reviewed by Awika and Rooney(23). These
include: binding of proteins and carbohydrates into insoluble complexes that resist
digestive enzyme breakdown(135-138); binding of digestive enzymes directly,
inhibiting their enzymatic activity(139; 140); and inhibition of intestinal brush border
bound amino acid transporters(141), particularly by tannin sorghums with higher
degrees of polymerization(142), resulting in reduced digestive enzyme activity. These
effects were also reflected in animal feeding trials that demonstrated the feeding
efficiency of tannin sorghums was 5 to 10% lower than non-tannin sorghums,
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depending on the animal species, the method of grain processing and diet type. In
general, animals consumed more feed yet experienced the same or slightly less
weight gain when tannin sorghum formed the basis of their diets(139; 140; 143). Such
effects in a Western diet, where food is ubiquitous, may be beneficial if these results
are to be translatable to humans.

Antioxidant tannins may be key protective components in sorghum foods for the
mitigation of oxidative stress-induced diseases, with anti-proliferative and antiinflammatory effects as their key mechanisms of action. For example, brans from
tannin sorghum varieties (naturally high in tannins, such as brown sorghum) and nontannin sorghum varieties (black, red and white-grained) have demonstrated significant
anti-inflammatory potential in vitro on the basis of strong inhibition of hyaluronidase
activity (enzymes involved in cancer metastasis, osteoarthritis and skin aging) (129).
The inhibition of the hyaluronidases correlated positively with total phenolic content
and antioxidant capacity of the extracts, with greater effects observed in sorghum
bran extracts than those of wheat and rice bran. In two experimental inflammatory
systems using blood cells and a mouse-model, Burdette et al.(144) also demonstrated
that the anti-inflammatory activity of ethanolic extracts of different sorghum brans
correlated with their phenolic content and antioxidant activity. At present, it is not
possible to extrapolate these in vitro effects to in vivo effects after realistic
consumption of sorghum by humans. However, the research provides mechanistic
models for further investigation.

Grimmer et al.(145) demonstrated the potent anti-mutagenic activity of higher
molecular weight compared to lower molecular weight tannins isolated in sorghum-
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derived polyphenol extracts. Gomez-Cordoves et al.(146) also demonstrated that
sorghum tannins induce anti-carcinogenic effects against human melanoma cells in
vitro through increased melanogenic activity (a protective effect against UV
irradiation damage to human skin) and therefore reduced formation of human
melanoma cells. Collectively, these cell line studies demonstrate the bioactive
potency of sorghum grain constituents, in particular the tannins, although in vivo
studies have not occurred.

2.2.6 Sorghum as a whole food: the case for “food synergy”
All of these components represent the lifecycle and survival of the sorghum plant,
and may in part explain the evolutionary success of sorghum, whose origins date
back to 8000 BCE(147). When the sorghum plant is eaten, as for all foods, there is an
impact on human biological systems, including processes that lead to chronic
disease. However, information about nutrients and bioactive components in isolation
is incomplete in explaining the health effects of sorghum foods because food is what
people eat, not individual constituents. Therefore, food is central to the relationship
between nutrition and health, underpinned by the food synergy concept, which views
food as a whole integrated system, and not merely as a collection of individual
nutrients and other bioactive substances(148). Hence, evidence from studies of whole
food sorghum foods will provide more useful information about the sorghum-diethealth relationship, examples of which are reviewed in the subsequent sections of
this review.
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2.2.7 Experimental research testing effects of sorghum consumption on human
health
There is extensive scientific literature identifying a diverse range of nutrients and
bioactive components in sorghum grain, with potential actions in numerous
biological systems in the human body. However, a key question remains: what
happens when people actually eat sorghum? To understand this, human studies are
needed, specifically designed to elucidate the effects of sorghum consumption on
protective health benefits. To date, these types of human investigations are severely
limited and there is an obvious paucity in the literature. Although numerous studies
have been conducted with human subjects (Table 2.4), the majority have addressed
micronutrient metabolism (such as interactions between leucine, molybdenum, and
niacin)(149), iron absorption from cereals(54), dietary fibre effects(150), protein
digestibility(151) and oral rehydration therapies(152). Overall, these studies contribute
to the knowledge base on sorghum, however they do not address the central question
associated with this thesis: what is sorghum’s potential to assist in chronic disease
prevention? The next section of this review therefore summarises the limited,
existing experimental evidence that suggests protective health effects of sorghum
consumption (for example, studies that investigate effects on energy balance,
glycaemic control, lipids, oxidative stress and cell-mediated responses).

Effects on energy balance
Energy balance is pivotal in body weight regulation. Changes in body weight are
associated with an imbalance between the energy content of food eaten and energy
expended by the body to maintain life and to perform physical work(153). Sorghum
may be a valuable lower-energy grain alternative in Western diets where overweight
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and obesity rates continue to rise and represent major public health burdens(35).
Sorghum’s energy value is approximately 1377 kJ/100 g however the available
energy for human metabolism may be lower than this estimate due to the described
low starch and protein digestibility rates. This postulation is partly based on evidence
from numerous feeding studies that show animals (from rodents to livestock species)
fed whole grain sorghum, in particular the slowly digested high tannin sorghum
varieties, have reduced weight gain(139; 140; 143; 154; 155).

In general, dietary fibre and whole grain intakes have been associated with reduced
risks of obesity, overweight and with lowered waist-to-hip ratio(156; 157). Effects of
dietary fibre on appetite and satiety have been proposed as major mechanisms for
these reductions. Whole grain sorghum, with high fibre and slowly digestible
starches, may increase satiety in humans due in part, to effects on GI of foods. It is
believed that many communities in Africa who prefer to eat foods made from tannin
sorghums do so because they impart stronger feelings of satiety and satiation
compared to other cereals(23). Sorghum’s satiety effects in humans have not yet been
investigated through controlled dietary trials.

Sorghum contains resistant starch (RS) and fermentation of RS in the colon is linked
to a number of positive effects including those on the gut microbiome(76; 158). Studies
specific to energy control with sorghum intake are limited however a recent study by
Shen et al.(159), evaluated the effects of sorghum RS on changes to body weight,
blood lipids and intestinal flora in 60 overweight and obese rats receiving treatment
for 8 weeks. Results demonstrated that overweight rats fed a high-fat diet containing
30% sorghum RS gained less weight than rats fed a comparator diet devoid of
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sorghum RS (p<0.05). However, there was no significant difference in weight
measures in the obese rats who were administered the same test diets. Thus sorghum
RS did not overcome weight gain caused by high fat diets, but it did have an
ameliorating effect. Statistically significant changes to the synthesis and secretion of
serum leptin and adiponectin, two adipose-derived hormones that are involved in the
regulation of food intake and body weight, were also reported in the sorghum RS
groups, as were improvements to the intestinal flora (as measured by increased
populations of Bifidobacterium and Lactobacillus and reduced populations of
Enterobacteriaceae). This is an important study that demonstrates mechanisms by
which sorghum RS may assist in the prevention and treatment of obesity. The study
also identified positive lipid changes. Triglycerides, total cholesterol and LDLcholesterol in both the overweight and obese rats consuming sorghum RS-enriched
diets were significantly lower than the control groups (p<0.05). HDL-cholesterol
levels were significantly higher in the sorghum RS groups (p<0.05).

It remains to

be seen whether these effects can be translated to the human condition. At this stage,
the human studies demonstrate only possible mechanisms but the positive results in
animal models identify that whole grain sorghum may be useful in managing energy
balance to assist with control of over-weight and obesity.

Effects on glycaemic control
Good glycaemic control is associated with reduced post-prandial glucose peaks and
is important in diabetes management(160). Sorghum foods have demonstrated slow
starch digestibility in vitro and in animal feeding trials, suggesting favorable effects
on post-prandial glycaemic and insilinaemic responses in humans. Numerous animal
feeding studies have shown that sorghum in the diet effectively improves glucose
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metabolism compared to sorghum-free diets(133; 161-163). A limitation in some of these
studies is that the specific type of sorghum extract is not defined, thus it cannot be
determined whether effects are linked to phenolic, fibre or macronutrient contents.
Furthermore, whether the concentrations of sorghum extracts are physiologically
relevant, that is, capable of eliciting these blood glucose attenuation effects in
humans after a realistic dose, is not yet clear.

A recent study by Cervantes-Pahm et al.(164) reported on the use of a pig model to
investigate the comparative nutrient and energy digestibility of a range of grains
widely used for human consumption, including whole grain sorghum. In this study,
the apparent ileal digestibility of sorghum starch was lower than for corn (164). The
authors attributed this to the high level of resistant starch in sorghum, which
appeared to be fully fermented in the pig hindgut since ~100% starch disappearance
was reported. The low apparent ileal digestibility of its starch in pigs suggests that
sorghum may be of value for reducing the GI of human foods(164). Caution in
extrapolating these pig trials to human health is needed, since in this study raw grains
were used, whereas in human food the grains are invariably cooked, changing the
structure and digestion properties of the starch.

Dixit et al.(165) have even gone as far as to specifically recommend sorghum grain is
regularly consumed in the modern Indian diet to assist in the reduction of Type 2
diabetes and cardiovascular disease in this population. Despite the positive
recommendation, only four in vivo human studies exploring these effects have been
reported in the literature, each with limitations and inconsistencies(166-169). The most
recent of these human studies investigated the effects of consuming muffins made
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from grain sorghum on plasma glucose and insulin levels(169). In a randomisedcrossover design, 10 male subjects consumed muffins containing 50 g of total starch
(TS) from either grain sorghum flour or whole wheat flour (although the available
carbohydrate was not reported), with all additional ingredients the same across both
treatments. Glucose and insulin levels were measured at baseline (15 minutes prior to
consumption), time-point 0 (onset of consumption) and 15, 30, 45, 60, 75, 90, 120,
and 180 minutes after consumption. Additionally, levels of rapidly digestible starch
(RDS), SDS, RS and TS in muffins were analyzed. Results indicated that RDS, SDS
and RS contents were significantly higher in sorghum muffins compared to wheat
muffins (p<0.05). Plasma glucose incremental area under the curve (iAUC) reduced
by ~26% and glucose measures at the 45 to 120 minute intervals were significantly
lower for the sorghum muffin (p<0.05). Also, plasma insulin iAUC reduced
significantly and insulin measures at the 15 to 90 minute intervals were significantly
lower for the sorghum muffins (p<0.05), reducing by ~55%. Lack of information on
the available carbohydrate in each test muffin is a limitation but this study shows the
potential of sorghum-based foods to attenuate blood glucose and insulin responses.

In a similar study, Lakshmi and Vimala(167) also demonstrated that the consumption
of whole grain sorghum meals compared with consumption of the same meals based
on dehulled sorghum and other recipes prepared with wheat and rice (as controls),
resulted in significantly lower glycaemic responses (P<0.05) in 6 subjects with Type
2 diabetes mellitus(167). These observations may have been in part due to the
difference in fibre content of the meals that ranged from 2.2 g to 4.8 g in whole grain
sorghum treatment meals and 1.8 g to 2.7 g in dehulled sorghum treatment meals.
Also, the different cooking methods utilised in the treatment meal recipes (pan-fried,
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boiled, fermented-steamed) may have had an effect on starch digestibility and
therefore carbohydrate metabolism.

Further glucose control studies by Mani et al.(166) evaluated the GI of six traditional
Indian meals, one of which was based on sorghum. The test meals were consumed as
baked bread (prepared from flours of sorghum or finger millet or pearl millet) or as
pressure-cooked meals (based on kodo millet, consumed as is or with added whole
mung beans or with added mung bean dal). No fats were added in the preparation of
the test meals. Testing was undertaken in 36 subjects with Type 2 diabetes mellitus.
Glucose responses were measured one and two hours after consumption of the test
foods (50 g available carbohydrate) and compared to a 50 g glucose load. The mean
GI of the sorghum bread was relatively high at 77% +/-8 (SE), but not as high as the
finger millett bread which had a GI of 104% +/-13 (SE), equivalent to the glucose
load . The pearl millet bread had the lowest GI of all six test meals, producing a GI
of 55% +/-13 (SE). No significant difference was observed in blood glucose level
after each of the test foods at the 1 hour and 2 hour time-points when compared with
the corresponding blood glucose response to the 50 g glucose load. The study
identifies sorghum’s digestibility in this meal format (baked bread) may not be as
slow as in vitro studies may suggest.

Abdelgadir et al.(168) investigated the influence of six traditional Sudanese
carbohydrate-rich meals (prepared from wheat, sorghum, millet and maize flours) on
glucose and insulin responses in a randomised crossover design with 10 subjects with
Type 2 diabetes mellitus (6 males and 4 females). Millet porridge had the most
favorable (lowest) post-prandial glucose and insulin responses followed by wheat
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pancakes, then sorghum porridge and sorghum flat bread, whereas maize porridge
induced higher glucose and insulin responses (as measured by mean iAUCs).
Consideration of the method and time of preparation, particularly the duration of
fermentation and the degree of milling, as well as the nature of starch and fibre
content is important when interpreting these findings. That is, inadequate reporting
of the precise physicochemical properties of the final products limits generalisability
in food studies. Overall, the glucose and insulin response studies using sorghum in
humans have used small sample sizes (with low statistical power), reducing the
likelihood that a statistically significant result reflects a true effect. Hence results are
ambiguous and the evidence base is inconclusive.

Effects on serum lipids
Measurement of a standard lipid profile (including total cholesterol, LDL (lowdensity lipoprotein) cholesterol, HDL (high-density lipoprotein) cholesterol, and
triglycerides) is recommended in the prediction of cardiovascular risk(170).
Mechanisms for the role of sorghum grain components in cardiovascular protection
have been investigated(23), however only one study has been conducted with human
subjects. In this study, using 10 males and 6 females, a significant reduction
(p<0.05) in total cholesterol, triglycerides and HDL cholesterol was observed after
daily consumption of 100 g of unrefined sorghum in the form of pancakes over 3
weeks(171). However, the content of subjects’ background diets was not adequately
reported, making assessment of dietary confounders difficult.

Most of the research identifying beneficial effects of sorghum consumption still lies
with animal models(133; 159;

172-174)

. Klopfenstein et al.(175) concluded that sorghum
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bran was effective in lowering serum and liver cholesterol levels in hamsters. This
effect was repeated in another hamster model of hypercholesterolemia, when grain
sorghum lipid extract included in the diet significantly reduced plasma non-HDL and
liver esterified cholesterol levels while increasing HDL levels(101). In all these
studies, total cholesterol levels were reduced in animals consuming sorghum-based
diets compared to sorghum-free control diets. In a single negative finding, Lee et
al.(176) found that while sorghum consumption increased HDL-cholesterol levels,
total cholesterol and LDL-cholesterol levels were increased in a rat model. However,
the lack of a control group in this research makes conclusions difficult.

Sorghum tannins have not been broadly investigated in relation to their effects on
cardiovascular disease risk factors, unlike tannins from some other foods and
beverages such as red wine and tea. There may be an anticoagulant effect of sorghum
tannins, yet to be tested in humans, as evidenced in cultured mullet fish that were fed
tannin-containing sorghum distillery residues(177). The sorghum residue significantly
improved blood thinning and erythrocyte membrane integrity of the fish blood cells
in cooler water temperatures over the winter months, enabling normal blood
viscosity and prevention of red blood cell hemolysis induced by typical oxidation
processes. The authors suggest that the antioxidant activity of the tannins and
polyphenols present in the sorghum residue contributed to the prevention of red
blood cell hemolysis. A translation to human studies has yet to be conducted but
overall the experimental evidence suggests that sorghum grain may induce beneficial
lipid-lowering effects.
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Effects on oxidative stress biomarkers and plasma antioxidant capacity
Oxidative stress is a condition in which an imbalance results between the production
and inactivation of reactive oxygen species (ROS) and reactive nitrogen species
(RNS) in the body that contributes to cellular dysfunction and pathogenesis of a
variety of human diseases (including atherosclerosis, diabetes, hypertension, aging,
Alzheimer's disease, kidney disease and cancer)(178). Oxidative stress is also linked to
metabolic syndrome (MetS)(179). A randomised, controlled, crossover human study,
involving 22 healthy adults, was conducted to assess the acute effects of consuming
pasta containing red or white whole grain sorghum flour (30% sorghum, 70%
semolina) on plasma total polyphenols, antioxidant capacity and oxidative stress
markers compared to a wheat control made from 100% semolina(180). Compared to
baseline, the 2 hour post-prandial levels of plasma polyphenols, antioxidant capacity
and superoxide dismutase (SOD) activity were significantly (P<0.001) higher
following the red sorghum pasta (RSP) meal while the protein carbonyl level was
significantly lower (P=0.035). Furthermore, net changes in polyphenols, antioxidant
capacity and SOD activity were significantly (P<0.001) higher while protein
carbonyls were significantly (P=0.035) lower following consumption of the RSP
meal than the control meal. Pasta containing red whole grain sorghum flour, but not
white sorghum flour, enhanced antioxidant status and improved markers of oxidative
stress in healthy subjects. The increase in plasma polyphenols by the RSP meal may
be attributed to its higher content of polyphenols. The potential limitations of this
study include the short duration and use of only one postprandial blood collection.
Furthermore, subjects in this study were healthy and their results may differ to
people with oxidative-stress induced disease such as diabetes and obesity. Studies in
subjects with mild to moderate oxidative-stress induced disease and who consume a
sorghum-enriched diet daily over an extended period of time are required to further
investigate potential effects on anti –oxidant processes from sorghum consumption.
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Effects on cell-mediated immune responses
Cell mediated immune responses have been linked to cancer development.
Epidemiological evidence dating back to the early 1980s has correlated consumption
of sorghum with reduced incidence of oesophageal cancer, warranting closer
attention to the potential chemopreventive properties of sorghum chemical
components. Data from various sorghum-consuming countries in Africa and Asia has
demonstrated lower esophageal cancer incidences compared to regions where wheat
and maize were the major cereals consumed(181-184). However, contamination of maize
in these communities by the Fusarium fungi, which convert nitrates to nitrites,
known carcinogens, has been identified as a more likely cause of increased rates with
maize consumption. Nevertheless, such epidemiological observations have driven
research efforts towards understanding potential cell-mediated chemopreventive
properties of sorghum grain components and their mechanisms of action not just against
esophageal cancer, but other cancers of the gastrointestinal tract and beyond.
Currently research is in its infancy, with growing numbers of cancer cell line studies
exploring anti-inflammatory, anti-mutagenic and anti-proliferative effects that are
important in prevention of carcinogenesis. Some animal studies have also shown that
phenolic extracts derived from sorghum, on the basis of high antioxidant activity
particularly from red, black and tannin sorghum varieties, have been able to
effectively induce cell arrest and suppress tumor growth in vivo(185). Many more in
vitro and animal studies are required before antioxidant effects of sorghum extract,
aimed at cancer prevention and treatment can be justified in clinical trials. The role
of sorghum consumption in cancer prevention is more likely to be examined in
epidemiological studies with mechanistic studies contributing to the discussion on
the plausibility of findings.

49

CHAPTER 2: Nutritional composition of sorghum and evidence of its effects on health

Table 2.4 Human studies incorporating sorghum-based test meals

Studies of vitamin metabolism
Lead Author/Year

Subjects/Experiment

Results

Role of amino acid imbalance
(relative excess of leucine) in the
pathogenesis of pellagra.
Sorghum molybdenum (Mo)
consumption effects on copper
(Cu) & uric acid excretion.
Vitamin B6, leucine absorption.

13 healthy & pellagrin subjects. 5g dietary leucine
administered daily & changes in urinary excretion of Nmethyl nicotinamide (NMN) measured.
4 adult males (age not specified). Low (0.21 μg/g) & high
(1.39 μg/g) Mo-containing grains were used in diets
controlled for calories, protein, minerals, sulfur.
6 healthy males (25-35 yrs). Metabolic interrelations between
excess dietary leucine & vitamin B6 studied.

Obizoba (1979)(188)

Mineral & vitamin metabolism.

Wang et al. (1991)(189)

Fibre effects on niacin status/
niacin utilisation.

Schmid et al. (2007)(149)

Dietary intake analysis of
mothers & their children in
South India.

5 healthy women (19-25 yrs). Fed 4 iso-nitrogeneous mixed
plant protein diets various blends based on whole wheat, navy
bean & 3 sorghum flour varieties (Purdue normal, high lysine
& Nigeria normal).
10 healthy adult subjects. 28 g per day of ready-to-eat cereal
(whole-ground sorghum flour) or cereal from decorticated
sorghum flour (bran removed, polished). Urine, stool &
fasting blood samples collected.
218 mothers (> 15 yrs) & their children (< 5 yrs) in South
India. Comparison of dietary intake of subjects with &
without intervention to manage malnutrition.

Leucine increased urinary excretion of NMN in all subjects. Isocaloric replacement
of rice by sorghum (jowar) resulted in increased urinary NMN excretion in all
patients.
Uric acid increased only in high Mo intakes (10-15 mg Mo/day). Urinary Cu
excretion was sig.ly increased with increasing levels of Mo. Faecal Cu excretion
was unchanged.
Vit. B6 counteracted effects of leucine on urinary quinolinic acid excretion, in vitro
nicotinamide nucleotide synthesis by erythrocytes; corrected abnormalities of 5hydroxytryptamine metabolism induced by excess leucine.
Various effects on measured Ca, Mg, Fe, Niacin, riboflavin, folic acid levels were
reported & related to the contents in the test diet.

Gopalan et al. (1960)(48)
Deosthale et al. (1974)(186)
Krishnaswamy et al.
(1976)(187)

Focus of investigations
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Whole grain sorghum cereal decreased fecal transit time, lowered urinary NMN
excretions, but raised blood serum levels of NMN & nicotinamide when compared
to polished grain sorghum cereal.
Mothers had sig. higher intakes of energy & protein in summer, & sig. higher
intakes of energy, protein & Fe in rainy season. No differences in children. In
mothers, sorghum contributed 29% energy, 33% protein, 53% iron.
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Table 2.4 Human studies incorporating sorghum-based test meals (continued…)

Studies of iron (Fe) status/absorption
Lead Author/Year

Focus of investigations

Derman et al. (1980)(190)

Fe absorption from maize &
sorghum.

Radhakrishnan et al.
(1980)(191)

Fe bioavailability.

Gillooly et al. (1984)(192)

Fe absorption.

Haidar et al. (1999)(193)

Fe deficiency anaemia (IDA)
status.
Fe absorption.

Hurrell et al. (2003)

(54)

Subjects/Experiment

Results

21 male & female South African subjects, healthy & Fedeficient. Ages not specified. Study compared thin gruel,
sorghum & wheat beers.
12 healthy & 13 anemic subjects. Ages not specified. Diets
based on high & low tannin sorghum.

Ten times as much Fe was absorbed from the traditional maize & sorghum beer as
from gruel made from the same ingredients.

53 Fe-deficient Indian females (age not specified). 6 different
experiments. Systematically examined effects on Fe
absorption of polyphenol & phytate in sorghum.
1449 pregnant & lactating subjects (15-49 yrs) in Ethiopia.
34 males & 44 females (21-38 yrs). Measured the influence of
phytic acid degradation on Fe absorption from cereal
porridges.

In 12 healthy subjects, Fe absorption from the low & high tannin varieties was
similar. In 6 anemic subjects, Fe absorption from low tannin sorghum was sig.
higher. In the other 7 anemic subjects, there was no difference observed.
When amounts of both compounds were reduced to low levels by pearling, there
was a sig. increase in Fe absorption.
Overall status of IDA determined by hemoglobin level was 18.4 % with higher rates
in maize, milk & sorghum staple areas.
Phytate degradation improves Fe absorption from cereal porridges prepared with
water but not with milk, except from high-tannin sorghum.

Cholesterol control
Suhasini et al. (1991) (171)
Cardiovascular effects

Effect of unrefined sorghum or
maize on serum lipids.

6 males & 10 females (23-26 yrs). Grp 1 ate 100g unrefined
sorghum. Grp 2 ate 50g of unrefined maize.
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Both diets showed sig. reduction in serum total cholesterol & triglyceride levels
with simultaneous increase in HDL cholesterol value over 3 weeks.
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Table 2.4 Human studies incorporating sorghum-based test meals (continued…)

Studies of diabetes/glycaemia/oxidative stress
Lead Author/Year

Focus of investigations

Mani et al. (1993)(166)

Determination of glycaemic
index of commonly consumed
foods in India.

Lakshmi et al. (1996) (167)

Glucose & insulin responses to
sorghum-based meals.

Abdelgadir et al. (2005) (168)

Glucose & insulin responses to 6
traditional Sudanese meals from
wheat, sorghum, millet & maize
flours.
Glucose & insulin responses to
sorghum-based meals.

Poquette et al. (2013)(169)
Khan et al. (2014)(180)

Plasma
total
polyphenols,
antioxidant capacity & oxidative
stress responses to sorghum
pasta meal.

Subjects/Experiment

Results

36 subjects (Type 2 DM). Glucose responses were measured 1 &
2 hrs after consumption of test foods (50g available carbohydrate)
& compared to a 50g glucose load. 6 foods tested, 1 based on
sorghum.
3 males & 3 females with Type 2 DM (45-60 yrs). Consumption
of whole grain sorghum meals compared with the same meals
based on dehulled sorghum & other recipes prepared with wheat
& rice.
Glucose & insulin responses in a randomised crossover design
with 10 subjects with Type 2 diabetes mellitus (6 males & 4
females).
Randomised-crossover design, 10 males consumed muffins
containing 50g of total starch from either grain sorghum flour or
whole wheat flour. Plasma glucose & insulin measured over 3 hrs.
Randomised-crossover design, 22 males and females consumed
pasta containing red or white whole grain sorghum flour (30%
sorghum, 70% semolina) or a wheat control made from 100%
semolina. One blood collection at 2 h time-point.
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The mean glycaemic index of the sorghum meal was 77% +/- 8 (SE), indicating
a relatively high glycaemic index. No sig. difference was observed in blood
glucose level at the 1 h & 2 h time-points when compared with the
corresponding reference.
The consumption of whole grain meals resulted in sig. lower glycaemic
responses (P<0.05) in 6 subjects, in part due to differences in fibre content &
cooking methods.
Millet porridge had the lowest post-prandial glucose & insulin responses
followed by wheat pancakes, sorghum porridge & sorghum flat bread. Maize
porridge induced higher glucose & insulin responses (as measured by mean
iAUC).
Plasma glucose & insulin iAUC reduced by ~26% & 55% respectively.
Glucose & insulin measures were sig.ly lower for the sorghum muffins
(p<0.05) at different time points.
Plasma polyphenols, antioxidant capacity and superoxide dismutase (SOD)
activity were significantly (P<0.001) higher following red sorghum pasta (RSP)
meal & protein carbonyl level was significantly lower (P=0.035) following
consumption of the RSP meal than the control meal (wheat).
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Table 2.4 Human studies incorporating sorghum-based test meals (continued…)

Fibre studies
Lead Author/Year

Focus of investigations

Cornu et al. (1981)(74)

Effect of fibre in sorghum on N
digestibility.

MacLean et al. (1983)(67)

Effect of decortication &
extrusion on the digestibility of
sorghum.
Effect of sorghum & wheat bran
on the colonic functions.

Fedail et al. (1984)(134)

Cornu et al. (1986)(174)

Effects of fibre on digestibility
of sorghum lipids.

Subjects/Experiment

Results

12 healthy Cameroonian adult males whose habitual diet is based
on a sorghum meal (2.4-4.2 g of crude fibre / 100 g DM). Subjects
received successive diets of 3.3, 4.8, 5.4 g of crude fibre / 100 g of
DM.
9 children (7-24 mo). Sorghum provided 8% protein & 62%
carbohydrate (kCal) in diet. Lysine was supplemented to 3% of
protein. Casein provided 6.4% protein (kCal) in the control diet.
10 males (22-24 yrs) healthy Sudanese subjects. Comparative
study of normal diet, diet of 20 g/day sorghum bran, & 20 g/day
wheat bran, for 3 wks. Wet stool wt, gut transit time, & freq. of
bowel evac. noted.
12 healthy Cameroonian adult males whose habitual diet is based
on a sorghum meal (2.4-4.2 g of crude fibre / 100 g DM). Subjects
received successive diets of 3.3 (A), 4.8 (B), 5.4 (C) g crude fibre
/ 100 g of DM.
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Increased fibre intake resulted in a sig. rise in quantity of fecal matter excreted
(N & formic insoluble substances), but a reduction in urinary N losses.
N absorption from sorghum & control not different but N retention lower than
control. Fecal weights & energy losses showed minor differences.
Decortication & extrusion improve protein quality & digestibility of sorghum.
The mean stool weight on normal diet was 136.6 ± 43.1 g/day, on sorghum
bran 173.3 ± 48.4 g/day, & on wheat bran 219.1 ± 98.3 g/day (p<0.001). Both
brans produced a similar number of bowel evacuations, stool weight & transit
time.
Reduced lipid digestibility occurred in all diets. No difference was observed
between A & B fibre diets but dropped with diet C. Lipid losses increased more
rapidly than N losses with increasing fibre content. No sig. changes in
concentrations of fecal fat.
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Table 2.4 Human studies incorporating sorghum-based test meals (continued…)

Protein digestibility studies
Lead Author/Year

Focus of investigations

Kurien et al. (1960)(194)

Metabolism of N, calcium &
phosphorus.

Nicol et al. (1978)(195)

Utilisation of protein in cassava,
rice & sorghum (Sativa) based
diets

MacLean et al. (1981)(151)

Protein quality & digestibility of
sorghum

Subjects/Experiment

Results

7 boys (10-11 yrs). Effect on metabolism of N, Ca & P of
replacing 25%, 50% or 100% of rice in a poor Indian diet by
Sorghum Vulgare was studied. Daily intake of N was constant in
all diets.
19 Nigerian men, 13 different feeding trials, each of 6 men. Net
protein utilisation (NPU) of diets based on rice, sorghum or
cassava, was compared to a minimal protein diet. Endogenous N
excretion measured.
13 children (6-30 mo). Protein quality & digestibility of 2 high
lysine (2.9-3.0 g/100 g protein) & 2 conventional varieties (lysine
content 2.1-2.2 g/100 g protein) of whole grain sorghum milled
were assessed.
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Protein digestibility coefficients of protein & mean daily N retention
diminished as sorghum increased. Sorghum led to: 1) higher Ca intake, but Ca
retention decreased 2) higher P intake, which resulted in higher P retention.
The NPU of a diet based on home-pounded, winnowed sorghum flour was
higher than that of a diet based on milled whole-meal sorghum due to the low
digestibility of the latter diet.
Weight loss or poor weight gain was reported. No difference by variety in N
absorption or retention. Stool weight & energy loss 2.5-3x control values. Total
conc. essential amino acids was low as were conc. Lys & Thr. Lys was the
limiting amino acid.
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Table 2.4 Human studies incorporating sorghum-based test meals (continued…)

Therapeutic food studies
Lead Author/Year

Focus of investigations

Subjects/Experiment

Results

Weaning foods
Dibari et al. (2013)(196)
Bisimwa et al. (2012)(197)

Acceptability/safety of new
ready-to-use therapeutic foods
(RUTF) before use.
Fortified
soybean-maizesorghum paste Vs fortified corn
soy
blend
porridge
in
underweight infants.

41 HIV/TB patients (>18 yrs) in Kenya. Cross-over RCT
comparing soy/maize/sorghum RUTF (SMS-RUTFh) to control 10 d measures of product intake.
6 mo Congolese infants randomly assigned to lipid-based readyto-use complementary foods (RUCF, n=691) or fortified corn soy
blend (UNIMIX, n=692) for 6 mo. Hemoglobin, triglyceride, &
cholesterol noted.

SMS-RUTFh is acceptable & can be safely clinically trialed, if close
monitoring of vomiting & nausea is included.

96 (children (6-40 mo) in Sudan. Comparative RCT (32 rice, 34
sorghum, 30 control). Safety & efficacy of rice or sorghum cerealbased oral rehydration solutions (ORS) relative to std. WHO ORS
formulation.
266 children (1-5 yrs), history of acute diarrhea for ≤ 48 h.
Digestibility of food-based ORS was assessed by stool pH,
glucose content before & after acid hydrolysis & osmolality.
64 Nigerian children (2.5 mo–5 yrs). Comparative RCT - subjects
consumed either the WHO recommended oral rehydration
solution (WHO-ORS) or a solution, containing 60 g/l sorghum
powder.

Cereal-based ORS shortened the duration of diarrhea, reduced stool vol. & the
freq. of diarrhoea & vomiting, & the mean total ORS intake. These effects were
more marked with the sorghum-based ORS than with the rice-based ORS.

No sig. differences in the concentrations of hemoglobin, serum triglyceride, &
serum cholesterol were found between the 2 grps.

Human oral rehydration solutions based on sorghum
Mustafa et al. (1995)(198)

Oral rehydration therapy for
acute diarrhea using cereal-based
solutions.

Molla et al. (1989)(152)

Food-based oral rehydration
solution (maize, millet, wheat,
sorghum, rice, potato).
Oral rehydration therapy for
acute diarrhea.

Pelleboer et al. (1990)(199)
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The mean stool output over the first 24 h in std ORT was sig. higher than foodbased ORT. Food-based ORT showed substantial reduction in stool output.
No sig. differences in amt. of fluid used, no. of stools & duration of diarrhea.
No sig. difference in weight gain. 7 children died, 2 (6%) in the sorghum-ORS
grp & 5 (17%) in the WHO-ORS grp. Sorghum-ORS was well accepted &
tolerated.
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Table 2.4 Human studies incorporating sorghum-based test meals (continued…)
Therapeutic food studies
Lead Author/Year

Focus of investigations

Subjects/Experiment

Results

Effects on immune status in people with HIV
Motswagole et al. (2013)(200)

Effects of a sorghum meal on the
immune status of adults with
HIV.

Ayuba et al. (2014)(201)

Effects of supplementation with
sorghum herbal preparation
(Jobelyn®) on immune status.

132 HIV+ adults. Double-blind randomised placebo-controlled
trial in Botswana. Micronutrient fortified sorghum meal including
Vit. A (n=67) or control (n=65). Serum retinol, Fe, Zn, albumin,
CD4 cell count & HIV viral load assessed over 12 mo.
61 HIV+ adults in Nigeria – 2 trials. 10 HIV+ patients not
receiving antiretroviral therapy (ARVT). Patients consumed 500
mg Jobelyn® daily for 8 wks. Control with 51 HIV+ patients
receiving ARVT.

Fortified sorghum meal did not influence serum retinol, CD4 cell count & HIV
viral load.

Consumption of Jobelyn® contributed to improved hemoglobin levels &
increased CD4 cell counts HIV+ patients.

Consumer/sensory studies
Kayitesi et al. (2010)(32)
Vazquez-Araujo (2012)(202)
Muhihi et al. (2013)(203)

Consumer opinions of marama
/sorghum composite porridge.
Consumer input for developing
human food products made with
sorghum.
Sensory study: sorghum ugali
(stiff porridge).

30 males & 22 females. Descriptive sensory analysis, consumer
testing, texture analysis, pasting & color.
Adults n=34 focus grps; n=1002 national survey; n=160 conjoint
analysis
Overweight & obese Tanzanian adults. Pre-& post-tasting
questionnaires were administered. A 10-point LIKERT scale used
to rate attributes of 3 test foods. Sorghum ugali was consumed by
23% of participants.
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The 100% sorghum porridge & the composite porridge with full-fat flour were
the most acceptable to consumers.
Heath aspects of grain products were the most appealing for consumers,
whereas conjoint analysis showed that sensory attributes were the principal
drivers for purchase intent.
All of the test foods were highly rated for smell, taste, color, appearance &
texture. Taste was rated highest for unrefined maize ugali. Whole grain
carbohydrates are highly acceptable.
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2.4 Conclusions
There is an emerging body of scientific literature on sorghum (Sorghum bicolor), an
underutilised cereal whole grain, that may provide health benefits and contribute to
the prevention of chronic lifestyle related diseases, particularly in regions where
associated morbidity and mortality rates are significant public health burdens(22). It
appears that sorghum grain components may have an impact on metabolic disease
processes through the delivery of slowly digestible starches, resistant starch, dietary
fibre, polyphenols (including phenolic acids, flavonoids and condensed tannins),
policosanols, unsaturated fatty acids and the food attribute of a high antioxidant
capacity. However, the vast majority of studies available for consideration utilised
extracts or purified compounds and were conducted in animal models. Few studies
in humans have been reported, and there is a need to study sorghum as a whole grain
in whole food formats, and in the context of a healthy diet. After all, food is
complex, comprised of a myriad of compounds that act synergistically to elicit food
effects(204), which are further impacted and altered by processing(205).

Substantiating potentially beneficial effects of sorghum foods on chronic lifestyle
related disease risk factors requires human studies whereby consistent results from
randomised controlled trials (RCTs) are reported, contributing to the highest level of
evidence for practice(185). To date there appears to be fewer than five RCTs
investigating sorghum metabolic disease-related effects in humans, and all
interventions are short-term and have some experimental design shortcomings.
Future RCTs should aim to directly examine a specific effect on chronic disease
biomarkers or health outcomes between a control and sorghum-intervention diet, for
a minimum of 3-6 months, enabling evidence for longer-term effects to emerge(186).
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Specifically, studies should investigate lipid profiles, longer-term markers of
glycaemic control, and body weight. While much of the research to date focuses on
extracts and components, the impact of the whole food reflecting the synergy
between the components needs to be considered (Chapter 3). It is also important to
study the content of the background diet in these RCTs as background diet can
confound results and may interfere with the ability to attribute effects to the dietary
variable of interest(206). In addition, for translation to practice, the impact of
sorghum-based foods on chronic lifestyle related disease must be seen in the context
of the whole diet, carefully monitored throughout trials (Chapter 3).

The evidence for a relationship between the antioxidant activity of sorghum and
health benefits of its consumption is of particular importance due to the role
oxidative stress plays in chronic disease development. To date, several in vitro and
animal model studies have highlighted the potential of sorghum grain components,
such as polyphenols, to scavenge free radicals(207-211). Unfortunately, these studies
are limited in their ability to attribute direct antioxidant effects of sorghum, as they
do not account for metabolic transformations and interactions that influence
bioavailability and biological activity of the polyphenols in the body after ingestion.
For example, it is unclear what transformations polyphenols undergo, from the oral
cavity, through the gastrointestinal tract and after absorption and metabolism(212).
Thus, test regimens from such in vitro and animal studies need to be repeated in
humans with mild to moderate oxidative-stress induced disease. Disease indicators,
such as oxidative stress and inflammatory markers, can be measured in subjects who
consume a sorghum-enriched diet daily over an extended period of time.
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Finally, while the development of an evidence base for a link between sorghum
consumption and chemoprevention is in its infancy, some evidence for strong
antioxidant and anti-inflammatory effects that may mitigate cell proliferation,
mutagenesis and carcinogenesis has been reported. Cell-line and animal studies
have demonstrated the potential for such cell-mediated effects, but require
substantiation in humans. Determining whether the concentration of sorghum grain
extracts used in these studies may be feasibly consumed through dietary intake of
sorghum-based foods is critical. Notwithstanding, the study of food effects on
cancer is highly complex and clinical trials are problematic for ethical reasons. Even
so, knowledge generated through various forms of experimental research adds to a
general understanding of how the sorghum food matrix may be beneficial.

Overall, the scientific literature exposes a range of health areas in which nutritional
effects of sorghum have been examined, such as energy balance, glycaemic control,
lipids, gut microbiota, and cell-mediated immune responses, including antioxidant
and anti-inflammatory effects. However, a paucity of human studies is evident.
Therefore, researching effects of sorghum consumption on indicators of metabolic
disease, such as weight, is warranted and elements of study designs from the reported
literature were incorporated into the experimental components of this thesis.
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3.1 Overview of methodological framework
This thesis provides a scientific framework to investigate the potential effects of
sorghum consumption on specific health outcomes in humans. Importantly, this is
food-based research that must be considered within the context of a whole diet and
hence “the assumption that in most cases the many substances in food have additive
or more than additive effects on health”(213). To take this further, this concept
suggests that food effects are the fundamental unit in nutrition, rather than their food
constituents(148). Within the framework of this thesis, sorghum as a whole grain
cereal food with inherent properties (nutrients, dietary fibre and other bioactive
components) is considered with the knowledge that these individual components
interact within the food matrix to demonstrate potential protective effects against
chronic diseases in humans (Figure 3.1).

This holistic approach results in nutrition science that focuses on the interdependency of nutrients/components and their food matrix within a whole diet and
the “additive” effects they have on health outcomes when consumed over longer
periods of time. Therefore, while observed effects within this thesis are reviewed in
the context of individual components to understand mechanisms of action, they must
be evaluated more broadly with outcomes assigned to the whole sorghum food rather
than isolated sorghum components. Specifically, research examining sorghum intake
and chronic disease requires clinical studies to elucidate the potential protective roles
of the sorghum grain as a constituent of foods within a whole diet. This thesis
reviews the potential active ingredients within the sorghum food products based on
existing literature identifying possible mechanisms associated with progression of
metabolic disease, especially weight control (for example, mechanisms involving
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slowly digestible starches and polyphenols). Body weight regulation and associated
inflammatory and oxidative changes are particularly relevant in chronic disease
prevention. Studies were therefore designed to examine potential mechanisms of
food intake regulation, acute oxidative changes, effects of chronic consumption on
markers of metabolic disease such as body weight, serum cholesterol and a range of
inflammatory markers (Figure 3.1).

Figure 3.1 Conceptualisation of thesis framework

Sorghum whole grain has slow in vitro starch digestibility and some varieties are
high in dietary fibre and rich in polyphenolic compounds that may contribute to
effects on body weight outcomes and other weight-related clinical indices when it is
consumed regularly as part of the human diet (Chapter 2). Food intake is a key
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regulator of body weight and so examination of satiety-enhancing mechanisms,
which may assist in reducing energy intake is an important component of
investigations related to weight control. This may include changes to glucose, insulin
and appetite-related gut hormone levels in response to altered intestinal changes that
may occur post-prandially. Initially, evaluating subjective measures (subjective
ratings of satiety sensations) together with food intake data, informed further studies
aiming to identify any positive outcomes from longer-term weight loss interventions,
such as body weight change. Collectively, the clinical investigations in this thesis
explored the acute- and longer-term effects of sorghum consumption, adding to the
proof of concept that eating foods made from whole grain sorghum may assist in the
prevention of chronic disease, in part due to mechanisms associated with positive
changes to body weight.

Well-designed clinical human trials, such as meal test studies (or mechanistic human
studies) and intervention trials (or randomised controlled trials - RCTs), are
important in scientific nutrition research. Mechanistic studies are highly controlled,
laboratory-based experimental investigations that aim to expose mechanisms of
action related to a specific component in food. On the other hand, RCTs involve
randomisation of the study sample to a treatment or a control group to measure the
effect of the treatment, thereby providing direct evidence of exposure to the dietary
factor of interest(194). The existing knowledge on sorghum whole grain was found to
be reasonably comprehensive and sorghum consumption appeared to have the
potential to assist in the prevention of chronic disease. This knowledge formed the
basis on which hypotheses for clinical investigations within the thesis could be
developed. Food product formulation and careful characterisation of the test
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foodstuff ensured that any effects associated with consumption of sorghum-based
foods would be carefully considered. An acute mechanistic meal test study provided
the basic understanding of the types of sorghum components that might be involved
in altering health outcomes, as well as their mechanisms of action. Finally, a RCT
provided direct evidence for the effects of chronic sorghum consumption on health
outcomes.

3.2 Key hypothesis and study aims
The central concept underpinning this thesis is –
“Sorghum is a viable alternative to more commonly consumed whole grain cereals in
the human diet and may have positive benefits on factors associated with metabolic
health including weight management.”

To test this hypothesis, research (Figure 3.1) was undertaken with the aims of:
1. Elucidating the functional components of sorghum reported in the scientific
literature with potential effects on human metabolic processes.
(Chapter 2: Nutritional composition of sorghum and evidence of its effects on
health)

2. Formulating an optimised sorghum-based test product that contains the
nutritional and chemical properties hypothesised to elicit clinical effects.
(Chapter 4: Formulation of a ready-to-eat sorghum flaked cereal food)
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3. Investigating effects on proposed mechanisms associated with weight control
and inflammation such as acute satiety, related hormonal responses and
antioxidant potential in an acute meal test study.
(Chapter 5: Acute meal test study testing short-term effects of sorghum
consumption, specifically targeting satiety mechanisms)

4. Testing for effects of functional components of sorghum foods within a
controlled clinical trial over a longer time-frame with body weight and
associated disease marker changes as outcomes.
(Chapter 6: Randomised controlled trial testing effects of chronic sorghum
consumption, specifically targeting body weight outcomes)

3.3 Measurement Issues
Measurement of outcomes from food consumption is pivotal in this thesis. This
considers how food “works” or impacts on both health and disease. Specifically, how
whole grain sorghum consumption might benefit health and assist in chronic disease
prevention is evaluated. To better understand the food/health/disease relationship it is
important to consider the key factors of the “spectrum of life” – beginning with
“healthy” and ending with “death”, intercepted by the appearance of disease risk
factors and the diagnosis of disease along that continuum. This thesis focuses
somewhere in the middle of the spectrum, to identify effects of sorghum food
consumption on disease risk factors in the aim of evaluating its potential to assist in
the prevention of chronic disease development in the longer term. To this end, the
measurement of key indicators of disease risk was necessary, including measurement
of body weight and body composition, as well as biochemical markers that expose
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the status of different systems or processes in the body, such as the cardiovascular
system (lipids), glycaemic regulation (glucose/insulin), inflammatory pathways and
oxidative stress. These are linked to the progression of disease if they are not
maintained within “healthy” reference ranges.

However, food consumption is intricately associated with human behaviour. There
are both biological cues (for example, appetite-regulating gut peptides) and nonbiological cues (environment, emotions, habits) that influence the food choices
people make. Since satiety may be a mechanism of action driving body weight
changes through altered energy intake, and since satiety encompasses both biological
and behavioural drivers of food intake, it logically follows that measurement of
specific satiety markers are also useful in studies measuring body weight outcomes.
Beginning with behavioural aspects of food intake, the satiety markers will be
discussed first in the next section, followed by a review of the major methodological
issues related to the measurement of food intake in clinical trials. Finally an
overview of the disease markers measured in this thesis will be presented.

3.3.1 Measuring Satiety, Satiation and Appetite
Satiety and satiation are processes that affect eating behaviour. Satiety is a
feeling/sensation that influences the interval between meals or episodes of eating(214).
Satiation occurs during the course of a meal and leads to a reduction or cessation of
eating, and determines meal size(215). Collectively, satiety and satiation processes
help to control the size of eating episodes and the frequency of eating. Investigating
foods that have the ability to accelerate satiation, suppress hunger, extend satiety and
reduce overall appetite are important for obesity/appetite researchers and for food
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manufacturers designing innovative products that may assist with dietary control and
weight management.

Studies assessing satiety, satiation and appetite commonly utilise a combination of
measures. More objective assessments include gut hormone concentrations, gastric
distention and emptying, brain activity and, potentially most related to outcomes,
food intake. Although more objective in nature, these assessments can only be
regarded as biomarkers or indicators, namely, because appetite cannot be directly
measured using a specific test and we may consume food independent of our level of
appetite. In particular, biomarkers for satiety measurement are of interest due to their
potential to expose putative mechanisms of action(216). On the other hand, the
subjective assessment of satiety (aiming to assess the desire-to-eat prior and in
response to meals) is generally measured by “the magnitude or duration of changes
in subjective ratings of appetite-related sensations”(217), often using Visual Analogue
Scales (VAS) (Section 3.3.1.3).

Generally, biochemical analyses of hormone concentrations plus subjective
measurements of appetite and food intake data are employed to evaluate satiety and
appetite in clinical trials, particularly in laboratory-based meal test studies. This
precise suite of assessments was selected to study sorghum’s potential satiety effects
in the clinical trials conducted within this thesis.

3.3.1.1 Biochemical Measurements of Satiety: Gut Hormones
Gut hormones, including ghrelin, leptin, cholecystokinin (CCK), peptide-tyrosinetyrosine (PYY), glucagon-like peptide-1 (GLP-1) and gastric inhibitory polypeptide
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(GIP), are postulated to be part of the hypothalamic-gut-axis (or gut-brain-axis) that
appears to be important in appetite and body weight regulation. The gut-brain-axis
modulates short-term satiety and hunger responses to regulate the delivery and transit
of nutrients through the gastrointestinal tract, enabling efficient digestion and storage
of energy(218). Furthermore, the axis plays a role in glucose regulation, adipocyte
function and energy expenditure, to ensure energy homeostasis after a meal(219). The
precise mechanisms by which this axis controls food intake and eating behaviour are
complex, and therefore beyond the scope of this review. However, evidence for the
effects of gut hormones on appetite sensations and food intake that were evaluated in
the meal test study conducted in this thesis, are reviewed here (namely, ghrelin,
PYY, GLP-1, GIP). Glucose and insulin are also commonly investigated in meal test
studies and their involvement in mechanisms that regulate appetite will also be
discussed. It should be noted that leptin and CCK were not evaluated in this thesis as
they are not the best fit for acute appetite investigations(220-223).

Ghrelin
Ghrelin, an acylated 28-amino-acid peptide, plays an important role in the regulation
of food intake. It is an endogenous ligand of the growth hormone secretagogue
receptor type 1a (GHS-R1a). Ghrelin is primarily secreted by the X/A-like cells of
the stomach(224), and is also produced in low levels by the hypothalamus and by most
peripheral tissues. As such, ghrelin may have both endocrine and paracrine effects.
Ghrelin exists as both acylated and desacylated forms, with acylated ghrelin being
more active. In this thesis, acylated ghrelin was assessed. The major biological
functions of ghrelin include the secretion of growth hormone, the stimulation of
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appetite and food intake, the modulation of gastric acid secretion and motility, and
the modulation of the endocrine and exocrine pancreatic secretions.

Ghrelin is the only circulating orexigenic peptide that stimulates hunger and food
intake in both animals and humans(221;

225-227)

. Both central and peripheral

administration of ghrelin in rats has been shown to induce food intake and reduce
energy expenditure accounting for body weight increases(221; 228; 229). In a study with
healthy humans, intravenous infusion of ghrelin led to a 30% increase in food
intake(221), however the dose was above physiological levels. Ghrelin is secreted in a
pulsatile manner with highest concentrations measured during the fasted state and
before the onset of meal consumption(227). After eating, ghrelin levels drop relative to
energy intake in people of normal weight(230), but not as much in obese
individuals(231). Concentrations remain low for approximately 1-1.5 hours,
particularly following a mixed-macronutrient meal(221; 232). This pulsatile secretion of
ghrelin suggests that it may act as a signal for meal initiation and termination and has
been directly correlated with hunger scores(233), but again not in every case(234).

The precise mechanisms underlying ghrelin’s effects on hunger are not completely
understood, however there is some evidence that ghrelin increases GI motility(235),
thereby increasing gastric emptying that consequently may reduce satiety. Further,
elevated ghrelin levels have been inversely correlated with insulin levels, adding
support to the association between high ghrelin levels and enhanced hunger(236).
However, ghrelin may be more important in long-term energy balance with reports
showing that ghrelin levels are inversely correlated with body weight and they rise
after weight loss(237; 238). For example, in obese individuals, ghrelin is chronically
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lowered compared to lean individuals(231), and rodents fed high fat diets have been
shown to develop ghrelin resistance(239). This suggests that ghrelin is down-regulated
in a state of excess energy, acting as a longer-term moderator of body weight
particularly through its interaction with leptin. In this light, ghrelin is less likely to
have a role in meal initiation in obese subjects(240).

The specific effects of ghrelin appear to be inconsistent and its underlying
mechanisms of action are not fully elucidated. However, it is clear that ghrelin plays
a role in meal initiation in lean individuals as well as longer-term weight
management, justifying its use in satiety research. Still, when interpreting
experimental study results, it is important to consider that the actual peaks of ghrelin
concentrations may be related to non-physiological functions such as meal patterns
and habitual diet, particularly in light of evidence showing that ghrelin levels may
rise in anticipation of eating rather than actual feeding or inter-relationships with
other hormone actions(241).

PYY
PYY is a 36 amino acid peptide that is produced and primarily released by the distal
L cells of the gut, in particular from the ileum, colon and rectum(242). It exists
predominantly as two bioactive forms: PYY3-36 and PYY1-36. PYY3-36 is the primary
circulating active form and is produced when PYY1-36 is cleaved by the enzyme
dipeptidyl peptidase-4 (DPP-IV). PYY3-36 levels are low in the fasting state and rise
after food intake, for several hours, in proportion to the amount of energy ingested
and especially after a protein-rich or high-fat meal(243). For the purposes of this
thesis, the generic term PYY will be used.
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PYY has been shown to have strong anorectic properties when it is peripherally
administered in both rodents and humans(244-247). In a seminal Nature paper,
Batterham and colleagues(248) demonstrated a reduction in food intake and weight
gain in rats when they received peripheral PYY injections. They also showed in
humans that the infusion of normal postprandial concentrations of PYY significantly
decreases appetite sensations (measured by VAS) and reduces food intake by 33%
over 24 hours.

The postprandial elevation of PYY and thus the inhibition of feeding have been
attributed to a gut–hypothalamic pathway. Specifically, altered neural activity
mediated through the hypothalamus and the vagus nerve may be responsible for
PYY’s anorectic effects(249). PYY may also promote satiety through activation of the
‘ileal brake reflex’ that occurs when dietary macronutrients, particularly fats and
carbohydrates, arrive in the ileum exposing it to an unusually high intraluminal
nutrient content(250). This reflex acts as a negative feedback mechanism inhibiting the
emptying of nutrients from the stomach, essentially slowing gastric emptying and
inhibiting transit of nutrients through the duodenum and jejunum, and as such
placing a “brake” on hunger and food intake(251). Furthermore, PYY may regulate
food intake through interactions with other hormones rather than acting alone, further
highlighting the complexity of this regulatory system. For example, in a crossover
study, participants ate 27% less at a buffet lunch after receiving an infusion of PYY336 plus

GLP-1, compared to infusions based on either PYY3-36 or GLP-1 alone, or a

saline control(252).
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There is a growing body of human studies that support PYY’s role in reducing
appetite and enhancing satiety. In both lean and obese subjects, blunted post-prandial
rises in PYY have been reported, resulting in the reduction of food intake by
approximately 25-30% at a subsequent buffet meal(248; 249). In fact, there may be a
dose-dependent decrease in food intake(230; 246). When Degen et al.(246) administered
varying doses of PYY to subjects, the highest dose resulted in a 35% reduction in the
amount of food eaten at a subsequent meal. However, the dose was not matched to
physiological concentrations and was associated with adverse effects such as nausea,
possibly confounding results. On the other hand, some research groups have not
found a corresponding decrease in energy intake with exogenous PYY infusions(247).

Obese individuals are more likely to have lower endogenous PYY levels, with
fasting PYY levels shown to inversely correlate with body mass index (BMI) (249); but
not in every case(253). Despite these inherently lower levels, obese subjects can still
be susceptible to the anorectic effects of PYY when it is administered intravenously,
in contrast to the reduction of leptin sensitivity that has been seen in obese
individuals(249). Furthermore, with sustained weight loss these levels may actually
increase in the circulation(254). Interestingly, exaggerated post-prandial PYY rises
occur following Roux-en-Y gastric bypass surgery(255), suggesting that this increased
response may have an important role in the initial weight loss noted by this surgical
treatment for obesity(256). These variations in post-prandial circulating PYY levels
and the associated anorectic effects, have stimulated strong research interest in the
development of PYY-based therapies for the treatment of obesity. From a therapeutic
food perspective, isolating ingredients/foods with the ability to continually stimulate
PYY release is particularly interesting given that repeated PYY infusions and
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injections have been shown to reduce food intake and body weight effectively in
rodent models(248; 257).

Although studies are not in complete agreement with regards to the precise effects of
food intake on post-prandial PYY concentrations and there is some variation in
reported levels, there is sufficient experimental evidence that demonstrates PYY’s
appetite-suppressing properties. This variation is more likely to again reflect the
complexity of gut hormone mechanisms and actions as they relate to appetite
regulation and food intake. Therefore, PYY remains an important hormone to study
in appetite research.

GLP-1 and GIP
GLP-1 and GIP belong to the incretin gut hormones that potentiate insulin secretion
after meal ingestion in a glucose-dependent manner. Overall, these peptides regulate
islet hormone secretion, glucose concentrations, lipid metabolism, gut motility,
appetite and body weight and immune function.

GLP-1 is formed from the cleavage of the preproglucagon precursor(258) and exists in
the circulation as two major bioactive forms GLP-17-26 and GLP-17-27. In this thesis,
the generic term GLP-1 will be used. GLP-1, like PYY, is secreted from the L-cells
of the gastrointestinal tract within minutes of food intake, in response to neural
stimulation (via the vagus nerve)(259) and in proportion to energy intake, especially
glucose ingestion(260). GLP-1 effects its actions through the GLP-1 receptor.
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The key incretin effects attributed to GLP-1 include increased insulin release, in a
glucose-dependent manner; decreased glucagon secretion and decreased gastric
emptying(261). As such, GLP-1 has an important role in attenuating post-prandial
glucose rises. GLP-1 is also involved in the “ileal break reflex” and has an anorectic
effect on appetite(262). Peripheral and central administration in animals has resulted in
reduced food intake(263). Similarly, in humans reduced food intake has been reported
when GLP-1 is peripherally administrated(264), both at high and normal physiological
levels(265). Therefore, GLP-1 is likely to play an important role in the regulation of
satiety.

In individuals with Type 2 diabetes, the incretin effect appears to be diminished,
namely through decreased postprandial GLP-1 secretion(266). Thus, the incretin
properties of GLP-1 have been of particular interest to researchers in the treatment of
Type 2 diabetes. Specifically, medications have been formulated as GLP-1 receptor
agonists to improve glycaemic control and promote weight loss, especially because
the glucoregulatory properties of GLP-1 remain functional in insulin resistant
individuals(267). A meta-analysis demonstrates that GLP-1 receptor agonists lead to
weight loss in obese patients with and without Type 2 diabetes(268). In this study,
improvements to blood pressure and total cholesterol were also reported, however it
is unclear whether these were related directly to weight loss effects rather than the
GLP-1 receptor agonists themselves. Astrup et al.(269) demonstrated sustained weight
loss and improved metabolic disease markers over a two-year period when
participants took a once-daily GLP-1 analogue called Liraglutide. On the other hand,
and as may be expected, antagonists to GLP-1 have been shown to increase food
intake and body weight(270).
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GIP is a 42 amino acid peptide that is produced predominantly in the duodenal K
cells in the proximal small intestine. GIP effects are actioned via the GIP receptor
(GIPR). GIP secretion, as for GLP-1, is stimulated by nutrient intake, with low
circulating GIP levels in the fasted state that rapidly rise within minutes after food
ingestion. The key physiological functions of GIP include: stimulation of intestinal
glucose transport; release of insulin from pancreatic beta cells in the presence of
glucose to facilitate nutrient storage(271); and uptake of glucose by adipocytes in an
insulin-mimetic fashion(272). Specifically, GIP promotes fat deposition through
increased lipogenesis (via stimulation of lipoprotein lipase activity), enhanced fatty
acid synthesis and incorporation into triglycerides, and down-regulation of glucagonstimulated lipolysis(272).

Although GLP-1 is decreased in individuals with Type 2 diabetes, GIP secretion
from entero-endocrine cells appears to be normal or slightly elevated. However,
impaired pancreatic β-cells appear to cause the insulinotropic effects of GIP and are
responsible for the reduced incretin effects in these individuals(273).

The dynamics of postprandial incretin secretion in diet-induced obesity are not
clearly defined. GIP secretion is either increased(274) or unaffected(275) and GLP-1
secretion appears to be decreased(274) or unchanged in obese, non-diabetic
individuals. Interestingly, it has been shown those mice lacking the GIPR are
resistant to diet-induced obesity(276), although it is unclear if incretin secretion is
affected by obesity per se or the high-energy diets that contribute to obesity.
Nevertheless, the incretins are important biomarkers to monitor in studies
investigating weight outcomes, including appetite research.
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Glucose and Insulin
Glucose is the body’s primary fuel source, exclusively for the brain, and insulin acts
to control blood glucose levels in response to food ingested, especially
carbohydrates. Both glucose and insulin appear to be involved in mechanisms of
energy homeostasis, however the role of postprandial blood glucose and insulin
levels in the regulation of short-term appetite in humans is less clear. Low blood
glucose levels prior to eating a meal have been postulated as a cue to meal initiation
but links to satiety remain weak(277). On the other hand, higher levels of blood
glucose have been associated with higher subjective satiety(278) and thus meals that
elicit a higher postprandial glycaemic response are expected to suppress short-term
appetite to a greater extent than those with a slower glycaemic response. This is
based on the glucostatic theory that links elevated blood glucose with fullness and
low blood glucose levels with hunger(279). Based on similar theories, higher insulin
levels have also been associated with increased feelings of satiety.

Conversely, the glycaemic index theory proposes that attenuated post-prandial blood
glucose and insulin levels are related to higher subjective satiety and feelings of
fullness, such that foods with a low glycaemic index (GI) are more effective at
alleviating hunger(280). The rationale for this can be explained by the notion that lowGI foods are characterised by a slower rate of digestion and absorption, which in turn
stimulate nutrient receptors in the gastrointestinal tract for a longer period of time,
resulting in prolonged feedback (through satiety signals) to the hunger/satiety centre
in the brain. However, neither the glucostatic nor the glycaemic index theories are
able to describe the interrelationships between glucose, insulin and satiety with
certainty, and there is even some suggestion that glucose and insulin may not be
directly involved in appetite regulation.
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A meta-analysis of meal test studies suggested that insulin, but not glucose, is
associated with short-term appetite regulation in healthy, normal weight participants,
but this relationship was not obvious in overweight and obese subjects(281). The
authors concluded that the postprandial insulin response may be an important satiety
signal, and that central nervous system insulin resistance in overweight might explain
the blunted effect on appetite. However, Holt et al.(282) found a significant negative
association between individual insulin and satiety AUC responses to four test foods
(containing 50 g of available carbohydrate as ordinary and quick-cooking rice and
high- and low-amylose puffed rice), suggesting that increased rate of starch digestion
and corresponding higher insulin responses are associated with lessened satiety, or
greater feelings of hunger.

Interestingly, Raben et al.(283) found that the consumption of a low GI raw potato
starch meal that was high in resistant starch resulted in lower reported satiety and
fullness compared with a highly digestible pre-gelatinised potato starch meal.
Furthermore, the lower levels of satiety after the low GI/high resistance starch meal
were concomitant with lower levels of GIP and GLP-1(283). A more recent
randomised crossover trial (involving 26 overweight or obese adults who received
four diets: high GI/high carbohydrate; high GI/low carbohydrate; low GI/high
carbohydrate; low GI/low carbohydrate at four different visits) showed that by
reducing the GI or carbohydrate content of mixed meals, postprandial glycaemia and
insulinaemia were also reduced over the course of a day(284). However, there was no
difference in subjective hunger and satiety ratings between the various diets,
regardless of GI or carbohydrate content.

77

CHAPTER 3: Methodology

Insulin is therefore more likely to be involved in longer-term regulation of body
weight, with fasting plasma concentrations and postprandial responses to a meal
being correlated with body adiposity (acting via a negative feedback signal to recent
energy intake and body fat)(285). Verdich et al.(275) and Flint et al.(281), propose that
insulin is more likely to be a mediator of satiety sensations in the postprandial
period, particularly decreasing ad libitum energy intake in normal weight individuals
but not in the overweight and obese. Despite the lack of a direct association between
insulin or glucose and satiety effects in humans, it is important to include
measurements of both in appetite research in view of their physiological responses to
the ingestion of food, their role in energy homeostasis and most importantly to help
monitor long-term changes to glycaemia and insulinaemia in chronic studies of
weight and disease risk.

3.3.1.2 Summary of gut hormone control in appetite regulation and some
limitations
The regulation of appetite by gut hormones is complex and influences dietary intake
through the “sum of many parts”. It is clear that ghrelin, PYY and the incretins
(GLP-1 and GIP) have a role to play in this intricate system and justifiably should
continue to be monitored in appetite studies. This review has highlighted the
variation in study results for the postprandial effects of the various gut hormones in
different types of studies - human, animal and cell-line. The reasons for these
variations are complex and may be partly due to the wide array of immunoassays and
test meals used in the studies. Furthermore, subjects’ background diet is often not
defined; therefore, it is difficult to determine if usual eating habits have any potential
effects on hormone secretion. Also, results from infusion studies need to be treated
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with care when translating them to food intake and appetite sensations in humans,
particularly where pharmacological and not physiological doses are used, as often
these may lead to adverse reactions that can alter desire to eat and impair dietary
intake. Furthermore, the effective translation of preclinical data into comparable
human observations is hampered by the predominant use of young mice and rats in
short-term preclinical studies; it is well established that there are clear differences in
biological responses between younger and older animals. More clinical dietary
studies that are designed to test hormonal responses after consumption of actual food
in humans are needed to build on the promising animal and infusion studies
conducted to date. Despite some controversy over their use as appropriate
biomarkers of appetite(286) in individuals and perhaps at a group level, the
measurement of glucose and gut hormones can be justified to examine mechanisms
and provide insight into potential functionality.

3.3.1.3 Subjective measurements of satiety: Visual Analogue Scales
Appetite sensations are used reliably to measure subjective desire-to-eat, prior to and
in response to meals(217). Visual Analogue Scales (VAS) are commonly used as a
methodological tool to quantify such feelings (Table 3.1), in a controlled
environment, immediately before and following an eating episode, and then
chronologically at regular time points(287). In general, the VAS consists of a 100 mm
horizontal line, anchored at each end with opposing extremes of a specific scale (for
example, "not at all hungry" and "never been more hungry"). Participants place a
vertical mark on the line to correspond with their appetite-related sensations. These
feelings are quantified by measuring the distance from the left end of the line to the
mark(216). Using the VAS tool in this manner results in an acceptable degree of
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validity and reliability(287). VAS have other advantages also; they are uncomplicated
and straight-forward to use, they are reproducible in repeated protocols where the
effect of different treatments are compared under similar conditions, and they exhibit
a good degree of within-subject reliability(217;

288)

. In most cases, subjects are

untrained. Vinoy(289) suggests that the use of untrained volunteers in studies using
VAS poses a number of issues. For example, the inter-individual differences in
gender, age, dietary restraint are likely to effect the experience of appetite and the
VAS ratings, making it difficult to obtain significant discrimination of satiety effects
using small samples(289). In addition, some individuals may have limited
introspection and poor awareness of their appetite sensations.

Table 3.1 Visual Analogue Scale Questions
Question

Extreme ends of the response

Factors of appetite tested

How hungry do you feel at this
moment?

I am not hungry at all

Hunger

I have never been more hungry
How satisfied do you feel at this
moment?

I am completely empty

Satisfaction

I cannot eat another thing
How full do you feel at this moment?

Not at all full

Fullness

Totally full
How much do you think you can eat
at this moment?

Nothing at all

Prospective food intake

A lot
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Other limitations of the VAS tool have been noted. For example, the satiety power of
different foods may depend on very small differences in composition, such as the
limited amounts of active ingredients found in cereal foods. Also, differences in both
experimental designs and in the sensitivities of study participants may make
between-study comparisons difficult.

3.3.2 Measurement of Dietary Intake
A key research benchmark in studies assessing appetite (satiation/satiety effects) is
the measurement of dietary intake. Dietary intake, in particular energy intake,
strongly influences body weight changes, and weight control is typically the longterm primary outcome measure of appetite research.

Thus, it is imperative to

quantify dietary intake in all appetite studies, both short-term and long-term,
especially to enable the connection between short-term satiation/satiety effects (most
likely observed in acute feeding trials) and longer-term weight control outcomes
(usually assessed through dietary intervention trials). After all, the main goal with
most appetite research is to reduce an individual’s dietary intake to, for example
control obesity. In the context of research investigating diet and chronic disease
specifically, healthy weight is a primary preventative measure, thus long-term studies
such as RCTs are the gold-standard to confirm that decreasing appetite will result in
decreased dietary intake and total energy that will subsequently lead to weight loss.
For this reason, an RCT was the obvious choice for testing longer-term effects of
sorghum consumption in this thesis. However, there are several limitations
associated with RCTs, some of which are relevant to this thesis and are briefly
summarised in Table 3.2.
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Table 3.2 Summary of some limitations associated with RCTs
Problems/Limitation

Steps taken in this thesis to overcome
problem

Difficulty in blinding researcher to intervention/control
treatments

Researcher not at subject interface at key
times during testing

Background diets confounding results

Diet histories of usual intake and 3-day
food records before testing starts

Control group also undergoes dietary intervention

Rigour in dietary recording, design and
analysis in order to interpret results
accurately

Dietary intake is measured by quantification of food consumed ad libitum. To assess
satiation, the intake of the test food (preload) alone or as part of a meal is measured,
whereas for satiety, energy intake at a test meal is quantified within a specified
amount of time following the consumption of the test food(216). Typically, the test
meal is offered in a buffet style or as a single meal, pre-selected by the participant
from a menu offered by the researcher(216). There are various methods for measuring
dietary intake in the research setting, depending on the study design, including: direct
weighing of food consumed before and after intake; dietary recall usually for the 24hour period preceding testing; diet history conducted by a trained professional or
weighed food records completed by the subject. In the case of laboratory-based meal
test studies, direct observation by the researcher is most commonly employed with
diet histories/records or recalls assessing the pre-test intake and subject-recorded
food records used to capture intake after testing. There are many obstacles and
limitations that relate to obtaining an accurate record of food intake from subjects in
dietary studies,

mostly involving under-reporting and

occasionally over-

reporting(290).
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The food composition database is an important scientific tool in dietary intake
measurement, however it presents with several limitations. Some obvious issues
relate to: variability in the composition of foods, partial or limited coverage of food
items and partial or limited coverage of nutrients. Currently, coverage of
polyphenolic compounds is grossly limited in many databases. In this thesis,
AUSNUT 2007 Database was utilised and like all food composition databases is not
immune to some of the problems just described. Hence, to maximise the integrity of
the research, it was an imperative that only qualified dietitians enter dietary
information into the database enabling informed decisions when data was missing.

It is clear that human appetite and eating behaviour are complex functions, with
many intervening variables (environmental, social and cognitive factors) that may
influence them and ultimately an individual’s intake. As described by Bornet et
al.(291), “appetite is dependent upon interactions between biology and the
environment. The environment contains extremely potent factors which for many
people can readily overcome biological processes operating to maintain body
weight”. Laboratory-based meal test studies are designed to tightly control for and
limit these intervening variables, and in doing so may actually make translatability to
the free-living condition somewhat less realistic.

The Stunkard and Messick

questionnaire (also referred to as the three-factor eating questionnaire or TFEQ) has
been designed to measure dietary restraint, disinhibition and hunger(292). It is used in
dietary studies to limit confounding factors relating to emotional or cognitive
restraint or overeating. It is used in the screening phase to help recruit a similar study
population whereby such emotional/cognitive drivers of food intake are reduced.
Another point to consider in satiety studies is the fact that effects of a single eating
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episode on satiety and energy intake may not be sustainable as repeated consumption
could lead to either habituation and waning of the effect over time or to
strengthening the effect due to learning(216). This further indicates the importance of
longer-term intervention trials whereby subjects are eating the test food in their
usual, natural environment, which was the aim of the RCT described in Chapter 6.
Though meal test studies do not usually necessitate dietary standardisation prior to
testing(217), in the acute meal test study described in this thesis, the evening meal
prior to each visit was standardised. Importantly though, it was stratified to usual
energy intake to ensure that subjects did not feel greater than “usual hunger”, or vice
versa. The main reason for standardisation was to limit the variability in baseline
plasma total antioxidant capacity (affected by polyphenolic content of foods)
between testing days.

Clinical

studies evaluating

acute

appetite effects post consumption of a test

food often use buffet-style meals to assess energy intake at a subsequent mealtime.
The amount of food offered in the buffet-style meal is deliberately in excess of
participants’ usual intake and consists of a variety of food items, varying in
macronutrient composition. However, this introduces a potential confounder in that
more food may be eaten in this setting than in free-living conditions as the food is
prepared for the subjects, is in abundance (higher quantity and greater choice) and is
free. Thus it is difficult to distinguish whether energy intake is influenced more
strongly by individuals’ food selections rather than the actual satiety-related effects
of the test food.
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In summary, understanding the limitations of different methodologies is essential to
enable the design of rigorous clinical dietary trials and to maximise the opportunity
to observe minimally confounded outcomes.

3.3.3 Measurement of Relevant Markers of Health/Disease Risk
Metabolic Syndrome (MetS) is defined by a cluster of associated metabolic
abnormalities,

including

central

obesity,

dyslipidaemia,

hypertension,

hyperglycaemia, and insulin resistance. These metabolic disorders present significant
risk factors for chronic disease development, including cardiovascular disease and
diabetes. Dietary interventions and therapies specifically aim to prevent the
development or advancement of such diseases, hence it is important to monitor the
progression to MetS and its individual components when evaluating the diet-health
relationship, or specifically in this thesis, the relationship between a sorghumenhanced diet and health.

Traditional markers of metabolic disease relate to body measurements (such as
weight, body mass index (BMI), and waist-to-hip ratio) and serve as indicators of
obesity and risk of chronic metabolic disorders. In addition, biomarkers (also known
as biological indicators) are used to monitor and predict the health of a population, to
identify individuals with particular susceptibility or resistance to health problems,
and to evaluate therapeutic or clinical interventions. Human dietary trials
investigating effects on health outcomes require the measurement of such
biomarkers, of which there are many, and each reflecting activity in at least one
biological system such as the cardiovascular, metabolic or immune system. Selection
of appropriate biomarkers to capture changes to clinical outcomes affected by dietary
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intake is imperative. Blood pressure, heart rate, and pulse are commonly measured to
indicate cardiovascular functioning. Serum cholesterol and triglyceride levels
provide information on metabolic processes and have been used to evaluate the risk
of coronary heart disease. Glucose and insulin are common indicators of glycaemic
regulation and insulin resistance, providing useful information on the future risk of
developing diabetes mellitus. Examining biomarkers of oxidative stress and
inflammation is also essential, especially because oxidative stress is a key mediator
of increased cytokine concentrations and low-grade systemic inflammation,
precursors in the pathophysiology of chronic diseases. Therefore, measurement of
cytokines (interleukins, tumor necrosis factor alpha, c-reactive protein) as well as the
overall antioxidant potential of plasma itself (total antioxidant capacity) may be
useful indicators of health/disease risk status.

A summary of the specific disease markers evaluated in the experimental studies in
this thesis is provided in Table 3.3. Normal references ranges have been provided for
all weight-related measures (BMI, waist circumference, percentage body fat) (Table
3.3a) and biochemical indices such as lipids, glucose and insulin levels (Table 3.3b).
However, benchmarks for some of the inflammatory biomarkers are not yet available
in the literature or accepted by pathology laboratories that may conduct such
analyses. In these cases, the desired outcome would be to observe a decline in levels
over time, especially after a beneficial weight-loss inducing dietary intervention
(Chapter 6).
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Table 3.3 (a) Summary of disease markers evaluated in the experimental studies in this thesis
Indication

Marker/

Normal

In which study was

Primary (1O) or

Measurement

reference range

marker evaluated?

Secondary (2O) Outcome

RCT

1O

18.50-24.99 kg/m2

RCT

1O

Body fat

Females

Males

RCT

2O

20-39 years

21-33%

8-20%

40-59 years

23-34%

11-22%

60-79 years

24-36%

13-25%

< 80 cm (Females)

RCT

2O

< 94 cm (Males)

RCT

2O

Obesity
Body Weight

Weight
BMI

Adiposity

Waist circumference

Cardiovascular system
Blood Pressure

Diastolic blood pressure

<80 mmHg

Acute Meal Test & RCT

2O & 2O

Systolic blood pressure

<120 mmHg

Acute Meal Test & RCT

2O & 2O
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Table 3.3 (b) Summary of disease markers evaluated in the experimental studies in this thesis
Indication

Marker/

Normal

In which study was

Primary (1O) or

Measurement

reference range

marker evaluated?

Secondary (2O) Outcome

Total cholesterol

3.6 - 5.2 mmol/L

RCT

2O

LDL cholesterol

< 2.59 mmol/L

RCT

2O

HDL cholesterol

0.9 - 2.0 mmol/L

RCT

2O

Triacylglycerides

< 1.70 mmol/L

RCT

2O

Glucose

3.6 - 5.5 mmol/L

Acute Meal Test & RCT

2O & 2O

Glycoslyated

4-6%

RCT

2O

2.6 - 10 mIU/L

Acute Meal Test & RCT

2O & 2O

Metabolism
Lipid metabolism

Glucose metabolism

haemoglobin
Insulin regulation
Insulin
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Table 3.3 (c) Summary of disease markers evaluated in the experimental studies in this thesis
Indication

Marker/

Normal reference

In which study was

Primary (1O) or

Measurement

range

marker evaluated?

Secondary (2O) Outcome

Interleukin 6 IL-6

Not defined

RCT

2O

Interleukin 8 IL-8

Not defined

RCT

2O

Interleukin-IB

Not defined

RCT

2O

Tumour Necrosis Factor-α

Not defined

RCT

2O

c-Reactive Protein

0-5 mg/L

RCT

2O

Hydroperoxide

0-2.3 mmol/L H2O2

RCT

2O

Total antioxidant capacity

1.07-1.53 mmol/L

Acute Meal Test & RCT

2O & 2O

Inflammation/ Oxidative Stress Status
Cytokines

Antioxidant
potential

Trolox
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3.3.3.1 Biomarkers of Inflammation and Oxidative Stress: A brief overview
Indications of the extent of inflammation and oxidative stress caused by ROS and
RNS are very important in the assessment of health and/or disease status. Clinical
trials aiming to measure the outcomes of food consumption on different human
biological systems therefore require measurement of specific oxidative stress and
inflammation biomarkers. A “panel” of disease markers, including cytokines, creactive protein and hydroperoxide, was selected to monitor changes to inflammation
and oxidative stress status in the RCT described in this thesis, with the aim of
enhancing the overall evaluation of the effectiveness of the intervention (Table 3.3
(c)).

Cytokines
Cytokines are important regulators of adipose tissue metabolism. Adipocytes (fat
cells) within the adipose tissue synthesise a range of cytokines including tumour
necrosis factor alpha (TNF-α) and several interleukins (IL), notably IL-1beta (IL-1β),
IL-6 and IL-8(293). In MetS, adipocyte dysfunction is frequently present and is
associated with an increase in M1 macrophage population within the adipose tissue.
The M1 macrophages secrete these pro-inflammatory cytokines, which in turn act
through a number of cell signaling pathways to induce insulin resistance and
abnormal glucose metabolism(294). Through their inflammatory properties, these
cytokines have been implicated in endothelial cell damage within blood vessels that
leads to vascular dysfunction and atherosclerosis. Studies have shown that elevated
levels of TNFα, IL-6, IL-8 and IL-1β are associated with MetS and increasing levels
are associated with more severe MetS (also assessed by hypertriglyceridemia,
hypertension, and fasting glucose levels)(295; 296). Cytokines can therefore serve as
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potential biomarkers of inflammation and progression to MetS, and in the longerterm, progression to more serious chronic disease. In the context of this thesis,
TNFα, IL-6, IL-8 and IL-1β were selected as biomarkers of disease-risk status after a
3 month dietary intervention (Chapter 6), specifically monitoring the impact of
dietary modifications and weight loss on these markers.

C-reactive protein
C-reactive protein (CRP) is an acute-phase protein produced by the liver in response
to inflammation. The cytokines TNFα, IL-6 and IL-1β are widely reported to induce
synthesis of CRP by hepatocytes (liver cells)(297). In relation to metabolic disease,
CRP is secreted in the presence of atherosclerotic inflammation and is perhaps the
most well-known cardiovascular biomarker. In fact, CRP is commonly measured in
health screening assessments in clinical practice(298). Moreover from a nutrition
perspective, a recent meta-analysis of 17 studies found evidence that consumption of
a healthy dietary pattern was associated with significant reductions in CRP (weighted
mean differences:-0.75 (−1.16, −0.35), p=0.0003))(299). CRP, specifically high
sensitivity CRP (hs-CRP), was measured in this thesis based on its widespread use
and effectiveness as a predictor of disease progression or health status in previous
clinical studies and in practice.

Hydroperoxide
Lipid peroxidation, mediated by free radical activity, has been implicated in several
disease states including cancer and rheumatoid arthritis, as well as in the
degenerative processes associated with ageing(299). There is also evidence that
circulating lipid hydroperoxides (HPX) play a pivotal role in atherogenesis (300) and
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thus coronary heart disease, the leading cause of death in Western societies such as
Australia(301). Lipid peroxidation initiates a cascade of events that lead to enhanced
uptake of low-density lipoproteins by macrophages and formation of lipid-laden
foam cells, one of the earliest indicators of atherosclerosis. Given the study cohort in
the RCT (Chapter 6) was overweight and mildly obese, and presumably under
greater oxidative stress, plasma HPX was also measured as a biomarker. It was
anticipated that HPX would provide insights into the effectiveness of the dietary
intervention (and more specifically its constituent antioxidant food components) to
reduce the extent of lipid peroxidation and more broadly alleviate overall oxidative
stress.

Total Antioxidant Capacity
The concept of “total antioxidant capacity” (TAC) originated in chemistry but in
recent times it has been applied to medicine, biology and nutrition as an indicator of
antioxidant status both in vitro and in vivo. Researchers in the food and nutritional
sciences have been interested in evaluating TAC of foods (such as fruits, vegetables,
grains and wine)(302), as well as measuring the TAC of plasma in human studies as an
indicator of antioxidant status(180). Plasma TAC considers the cumulative action of all
the antioxidants present in plasma, thus providing an integrated parameter rather than
the simple sum of measurable antioxidants(303). Hence, the capacity of known and
unknown antioxidants and their synergistic interaction is assessed. Studies have
explored acute effects of eating foods with high TAC on plasma TAC, such as high
tomato consumption(304), while other studies have evaluated nutritional interventions
containing foods with a high TAC on disease risk and prevention(305). For example,
Pitsavos et al.(305) demonstrated that adherence to Mediterranean dietary practices
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was positively associated with plasma TAC levels and negatively associated with
oxidation of the atherogenic LDL-cholesterol. In the present thesis, TAC of the test
foods was measured, as was plasma TAC in both the acute meal test study and the
longer-term RCT (measured at baseline and after 3 months). However, there is some
criticism that the TAC assay excludes enzymatic activity from the total measure of
antioxidant activity, precluding meaningful application to in vivo conditions(302).

3.4 Overview of thesis research design
In view of the opportunities to develop new sorghum products for human
consumption, this thesis begins by asking the questions: what are the nutritional
properties of sorghum and what do we know about the effects of consumption on
humans? The first part of the thesis involved review of the literature to describe
sorghum grain structure and the specific chemical, nutritional and functional
attributes that relate to mechanisms by which sorghum grain components may
influence weight management and chronic disease risk. In addition, the evidence
reported in the scientific literature on effects of sorghum consumption on health
outcomes related to chronic disease prevention. Next, a sorghum based food product
was developed with a food manufacturer and two experimental studies were
conducted to examine effects of consumption on relevant chronic disease indicators.
Overall, these thesis components integrate to arrive at a position on sorghum’s
potential as an underutilised whole grain cereal to assist in chronic disease
prevention in humans.
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CHAPTER 4:
Formulation of Ready-To-Eat
Sorghum Flaked Breakfast Biscuits

A component of this chapter is published in the article:
Stefoska-Needham, A., Beck, E.J., Johnson, S.K., Chu, J., Tapsell, L.C. (2015) Flaked sorghum
biscuits increase post-prandial GLP-1 and GIP levels and extend subjective satiety in healthy subjects.
Molecular Nutrition and Food Research. 60:1118-1128.

A component of this chapter is published in the article:
Stefoska-Needham, A., Beck, E.J., Tapsell, L.C. (2015) Perspective: The path to confirming and
exploiting potential satiety-enhancing effects of sorghum-based foods for human diets. Quality
Assurance and Safety of Crops & Foods. (DOI: 10.3920/QAS2015.0695).

The experimental work in this chapter was undertaken in collaboration with Sanitarium (the Industry
Partner of the ARC Linkage Grant LP100200125) and the use of their pilot processing facility to
formulate the biscuits. All biscuit analyses were completed at the Department of Food Science and
Technology, Curtin University, Western Australia, and were led by Associate Professor Stuart
Johnson. The candidate attended Curtin University in 2012 and was trained in analysis techniques
detailed in this Chapter and engaged in all decisions around methods and foods/ingredients requiring
testing. Scanning Electron Microscopy and interpretation of micrographs was performed by the
candidate at the University of Wollongong.
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4.1 Introduction
Healthy dietary patterns are positively associated with indicators of health and
wellbeing(17) and contain specific foods and food components to which potent
positive effects on disease markers may be attributed. Though food has been used
historically to improve the health of people, modern food and nutrition research has
focused on improving and innovating food itself, through a greater understanding of
the links between food components, the whole diet and health. This approach has
facilitated improvements in the quality (or functionality) of food products, enhancing
their potential to benefit health and reduce the risk of disease when they are
consumed regularly. Today such foods are commonly referred to as “functional
foods”.

Global food mega-trends, particularly in the developed countries, indicate a strong
and growing consumer interest in “naturally functional” food products, including
those that promote greater feelings of fullness and satiety(11; 306). Food companies
have responded by investing in innovative product development and reformulations
that have resulted in novel satiety-enhancing food products. Diets containing foods
with optimised satiety attributes could be beneficial for appetite regulation and
longer-term weight management(306) and may have the potential to assist in the
prevention of obesity-related chronic diseases. It has been shown that plant-based
diets rich in whole grains, with naturally higher fibre content and lower energy value,
promote satiety(307). This thesis focuses on sorghum as a specific example of foods
that may assist in driving satiety or decreasing energy intake, and may be particularly
beneficial in populations where excess weight is a key driver of metabolic disease.
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4.2 The opportunity for sorghum-based foods with satiety attributes
Food choice at breakfast represents an important opportunity to increase satiety in
the morning and reduce energy intake at lunch and during the rest of the day(308).
Consequently, developing breakfast products from whole grain cereals with inherent
satiety-enhancing functional properties is a growing area of interest for researchers
and food companies alike. Sorghum, with its reputation for being satiating(23), may
be a viable high-value ingredient for such food applications. Food manufacturers are
also interested in sorghum for its gluten-free attribute. Traditionally, sorghum has
been used in a variety of foods particularly in Africa, India and Central America,
including breads, porridges, steamed and boiled products, beverages and snack foods
(such as popped sorghum)(60; 309).

In more recent years in Western cultures, sorghum’s light color (characteristic of
some cultivars), neutral flavour and pleasing texture has made it suitable for use in
non-traditional food products including breakfast cereals, baking mixes for bread,
gluten-free bread, cakes/brownies, pancakes, bars and gluten-free beer(310). A US
consumer survey(202) identified several drivers for purchase intent of sorghum grain
products including: local origin (domestically-grown grain), inherent health benefits
(for example, antioxidants), and appealing sensory characteristics (such as crunchy
texture in breakfast cereals). To date, most of the sorghum-based products that have
been launched are marketed for their gluten-free attribute rather than the more
broadly applicable health effects of sorghum grain.
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4.3 Developing an optimised sorghum-based breakfast cereal
In this thesis, a ready-to-eat (RTE) sorghum-based breakfast cereal was formulated
as whole grain flaked cereal biscuits, mainly because this food format is well
accepted by consumers as a breakfast cereal option based on sales data of an
equivalent wheat-based product already on the market. A gluten-free alternative to
traditional wheat flaked biscuits has been long sought after, particularly by
individuals with a wheat or gluten intolerance such as coeliac disease. Of additional
value to sorghum’s inherent gluten-free attribute would be any potential appetite and
weight regulating functionality. Before testing for these potential effects in humans,
it is important to confirm that the sorghum flaked cereal biscuits actually contain the
implicated chemical and nutritional components and that processing has not
negatively altered their physicochemical properties.

For the meal test study (Chapter 5), the flaked cereal biscuits were derived from
three different sorghum cultivars (red-, white- and brown-grained sorghums) and a
single wheat control biscuit (Figure 4.1). Wheat was chosen as the suitable food
control because it has a different polyphenolic profile to red sorghum but has similar
nutritional attributes and, from a behavioural perspective, wheat cereal products are
readily interchangeable with sorghum breakfast cereal products. For the RCT
(Chapter 6), the same red sorghum and wheat control biscuits were tested. Great
effort was made to formulate a similar control biscuit (not disparate in appearance
and taste) in order to minimise confounding effects that might emerge if the control
was markedly different to the other treatment biscuits.
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Figure 4.1 (a) Red sorghum flaked breakfast biscuits

Figure 4.1 (b) Brown sorghum flaked breakfast biscuits
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Figure 4.1 (c) White sorghum flaked breakfast biscuits

Figure 4.1 (d) Wheat (control) flaked breakfast biscuits
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4.3.1 Processing Methods
White sorghum grain (variety Liberty - a commercial hybrid) and red sorghum grain
(variety Alpha - an in-bred line), were grown and supplied by Lochabar Enterprises
Pty Ltd (Tara, QLD, Australia) using organic conditions specifically for human food
use. Brown sorghum grain, variety IS8237C (an in-bred line), was supplied by the
Queensland Government Department of Agriculture, Fisheries and Forestry and
grown at the Hermitage Research Station (Warwick, QLD, Australia). Non cultivarspecific Australian Prime White (APW) hard wheat, grown in central New South
Wales, Australia and siloed at ambient temperature was supplied by Sanitarium
Health and Wellbeing (Cooranbong, NSW, Australia). The bleach test of Waniska,
Hugo and Rooney(311) was used to determine the presence or absence of tannins in
the grains of different sorghum varieties used for the manufacture of the breakfast
cereals.

The white and red sorghum gave no blackened grains, indicating the

absence of tannins. However blackened grains were observed for the brown sorghum
indicating the presence of tannins in this variety.

The test biscuits were prepared according to the following recipe: 2.5 L of water was
added to 25 kg of whole sorghum grains and the mixture steamed for 30 minutes in a
rotating pressure vessel. A small amount of malt extract was added (precise
quantities not available due to a confidential formula). The cooked grains were then
air dried to approximately 24% moisture before being passed through a flaking mill,
reducing their thickness to approximately 0.1 mm. This differs from the “shredded
wheat” process, in that the flakes were not cut into strips at any stage. These moist
flakes were then pressed into a biscuit shape by hand and baked for 25 minutes at
130 °C, drying the biscuits to approximately 7% moisture (weight basis). Prepared
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biscuits were labeled in non-descript packaging with coding such that both the
researcher at the participant interface and the subjects were blinded to the test foods.

4.3.2 Analyses of biscuit contents
To enable proximate and dietary fibre analysis, the test biscuits were ground to a fine
particle size using a Grindomix GM200 mill (Retsch, Haan, Germany). All analyses
were done in duplicate using standard methods (AOAC, 2008) and expressed as
g/100g as is. Moisture content was determined by loss of mass on drying by AC
945.15. Protein content was determined by Kjeldahl nitrogen determination (nitrogen
conversion = 6.25) by AOAC 991.20. Fat content was determined by Soxhlet
extraction according to AOAC 2003.05. Ash content was determined after
combustions at 550 °C as described in AOAC 923.03. Total dietary fibre was
determined by enzymatic-gravimetric analysis according to AOAC 991.43. The
available carbohydrate of the samples was calculated by difference and the energy
content calculated using Atwater factors according to the Australian Food Standards
Code(312).

To determine polyphenolic content and antioxidant capacity, the flaked breakfast
biscuits were ground in a bench-top blender to pass 100% though a 500 µm sieve.
Free and bound phenolic extraction was performed in duplicate, as described by
Adom and Liu(117). Extraction of free phenolic compounds was performed by shaking
1g of ground sample with 2 mL of 75% acetone for 10 minutes and centrifuging at
20 °C for 10 minutes at 4000 x g to recover the supernatant. The pellet was reextracted twice more in the same manner and the supernatants pooled and made up to
a final volume of 10 mL with 75% acetone. The extracts were stored at -20 °C in the
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dark until analysis. Bound phenolic compounds were extracted from the residue after
the extraction of free phenolics. Twenty-five millilitres of 2M sodium hydroxide was
added to each residue and digestion was performed for 1h at room temperature under
nitrogen gas whilst shaking. Concentrated HCl was used to lower the pH to 2 and
then the mixture was extracted twice with 10 mL hexane for 10 minutes with
shaking, followed by centrifugation for 10 minutes at 4000 x g at 20 °C. After each
extraction the hexane upper layer was discarded. The lower aqueous phase was
extracted five times with 15mL ethyl acetate by shaking for 10 minutes, followed by
centrifugation for 10 minutes at 4000 x g and 20 °C. The pooled ethyl acetate
fractions were evaporated to dryness at 30 °C using vacuum rotary evaporation. The
phenolic residue was re-dissolved in 10 mL of 75% acetone and stored at -20 °C in
the dark until analysis.

The phenolic content of extracts was measured using a method by Singleton and
Rossi(313) (adapted from Adom and Liu(117)). Duplicate 50µL samples of the extracts
of free or bound phenolics were diluted with 650 µL ultrapure water. Fifty
microliters of Folin-Ciocalteu reagent was then added followed by 500µL of 7%
solution sodium carbonate in water. The sample was mixed by vortex and incubated
at room temperature for 90 min. The sample absorbance was measured at 750 nm
against a 75% acetone blank. Known amounts of gallic acid (0 – 250 µg/mL) were
used to prepare a calibration curve. The phenolic content was expressed as gallic acid
equivalents (mg of GAE/g as is).
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In associated investigations (to be reported elsewhere)1, liquid chromatography-mass
spectrometry (LC-MS) was used in the identification and characterisation of the
different phenolic compounds of both the unprocessed whole grains and the final
flaked breakfast cereals.

Determination of antioxidant capacity was based on the method reported by Awika et
al.(314), whereby duplicate 150 µL samples of the extracts of free and bound
phenolics and standards of 0 – 150 µg/L Trolox in absolute ethanol were reacted
with 2850µL of 60 mM 2,2-diphenyl-1-picrylhydrazyl (DPPH) solution in methanol
for 8 h at room temperature in the dark whilst shaking. The absorbance at 515nm was
measured against a blank (150µL absolute ethanol +2850 µL of DPPH solution). A
Trolox standard curve was generated to calculate the antioxidant capacity of the
samples expressed as Trolox equivalents (µmol TE/g as is).

An enzymatic colorimetric method (K-TSTA 04/2009 kit; Megazyme International
Ireland Ltd, Wicklow, Ireland) was used to determine total starch content (in
duplicate) of the flaked breakfast cereals as g/100g as is. In vitro starch digestibility
was determined by a method using rapid glucometry(315) after manual grinding
through a 1mm sieve. At time intervals of 0, 10, 20, 45, 60, 90 and 120 minutes from
addition of pancreatin mixture in the in vitro simulation of digestion, duplicate
glucose readings were made using an AccuCheck® Performa® glucometer (Roche
Diagnostics Aust. Pty. Ltd, Castle Hill, Australia) and corrected against a reagent
blank.

Price, W., Kang, J., Fang, Z., Stefoska-Needham, A., Tapsell, L.C., Johnson, S.K. Nutritional and phytochemical properties
of flaked sorghum breakfast cereals. Food Research International (In draft).
1
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Equation (1) was used to calculate digested starch D (g per 100g dry starch) at each
time point.

(1)

Where GG is glucometer reading (mM/L), V is volume of digesta (mL), MG is
molecular weight of glucose (MG=180), W is weight of sample (g), S is starch content
of sample (g per 100g dry starch), M is moisture content of sample (g per 100 g
sample), and c is stoichiometric constant for starch from glucose contents (c=0.9).
Rapidly digestible starch RDS (g/100g dry starch) was calculated as GG = G20 G0. Slowly digested starch SDS (g/100g dry starch) was calculated as GG = G120 G20 and resistant starch RS (g/100g dry starch) was calculated as GG = 100 - RDS
(g/100g dry starch) – SDS (g/100g dry starch).

Additional physicochemical profiling was enabled with scanning electron
microscopy (SEM), particularly showing characteristics of the starch granules in the
different biscuits.

4.4 Results and Discussion
Optimised flaked breakfast biscuits were successfully formulated by Sanitarium
Health and Wellbeing on a pilot line in their manufacturing plant at Cooranbong,
NSW, Australia. Analyses of proximate and dietary fibre composition and energy
content (on as is basis per 100g) identified modest differences between the control
and different sorghum varieties (Table 4.1). The wheat control had the lowest levels
of total energy, fat and available carbohydrate compared to the sorghum biscuits.
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Total dietary fibre content of the wheat biscuit was similar to the brown sorghum
biscuit but significantly higher than the red and white sorghum biscuits (p<0.05).

Table 4.1 Proximate and dietary fibre composition and energy content of flaked
1,2,3
breakfast cereals
Flaked cereal
biscuit type

Moisture

Protein

Fat

Ash

Total

Total

Energy

(g/100g as

(g/100g as is)

(g/100g as is)

(g/100g as is)3

dietary

available

content

fibre

carbohydrates

(kJ/100g as is)

is)

(g/100g as is)

(g/100g as is)

Wheat control

6.6±0.0

13.7±0.2d

1.7±0.0a

1.6±0.0

9.6±0.1b

66.9±0.1a

1508±1a

White sorghum

6.6±0.0

10.7±0.0b

2.9±0.0b

1.6±0.0

7.3±0.4a

71.0±0.4b

1553±4c

Red sorghum

6.6±0.0

9.4±0.1a

2.9±0.1b

1.6±0.0

7.7±0.0a

71.9±0.1b

1550±0c

Brown

6.1±0.0

11.7±0.1c

2.9±0.1b

2.1±0.0

9.9±0.2b

67.4±0.3a

1530±1b

sorghum
1

Means (n=2) ± standard deviation
Values within a column with the same superscript letter denotes no significant difference (p>0.05)
3
Statistcal comparison not possible as some replicates identical
2

The wheat biscuit also contained the highest level of protein compared to all three
sorghum biscuits (P<0.05). Free and bound polyphenolic (PP) content (mg GAE/g as
is) and antioxidant capacities (µmol TE/g as is) of the test foods were also
determined (Table 4.2). As expected, red and brown sorghum biscuits had the
highest PP levels, on account of the high anthocyanin and tannin contents previously
reported for these varieties(23), and lower levels of total PP were reported for white
sorghum and wheat biscuits.

Preliminary results from the LC-MS analyses

(unpublished data) identified different types and amounts of free, bound and total
phenolic compounds in both the unprocessed whole grains and the flaked sorghum
biscuits. The types of phenolics acids identified were: protocatechuic acid, caffeic
acid and ferulic acid. The flavonoids eridictyol, quercetin, luteolin, naringenin and
apigenin, were also identified in the samples, as were luteolinidin and apigeninidin,
two types of 3-deoxyanthocyanidins unique to sorghum.
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Table 4.2 Free, bound and total phenolic content and antioxidant capacity of flaked
1,2
breakfast cereals
Flaked cereal

Free PP

Bound PP

Total PP

Free AC

Bound AC

Total AC

biscuit type

(mg GAE/g as is)

(mg GAE/g as is)

(mg GAE/g as is)

(µmolTE/g as is)

(µmolTE/g as is)

(µmolTE/g as is)

Wheat control

0.71±0.01a

0.67±0.22a

1.37±0.21a

2.64±0.01a

2.67±0.01a

5.31±0.01a

White

0.65±0.04a

0.82±0.04a

1.46±0.07a

3.39±0.18a

2.08±0.01a

5.46±0.20a

1.27±0.01b

1.00±0.11ab

2.27±0.12b

11.25±0.57b

9.16±0.62b

20.40±1.18b

c

b

c

c

sorghum
Red sorghum
Brown

1.46±0.04

1.51±0.06

2.99±0.01

16.36±0.23

14.69±0.55

c

31.05±0.79c

sorghum
1

Means (n=2) ± standard deviation
Values within a column with the same superscript letter denotes no significant difference (p>0.05)
PP, polyphenolic; AC, antioxidant capacity; GAE, gallic acid equivalents; TE, Trolox equivalents
2

Data for the in vitro starch characterisation of the biscuits only showed significant
differences in RS, with higher levels occurring in brown sorghum biscuits compared
to the wheat control (p=0.044) (Table 4.3). Levels of SDS and RDS did not differ
between biscuits.

Table 4.3 Starch properties of flaked breakfast cereals1,2
Flaked cereal
biscuit type

Rapidly digested
starch
(g/100g dry starch)

Slowly
digested
starch

Resistant
starch
(g/100g dry starch)

(g/100g dry starch)

Wheat

31.9±1.6a

47.9±4.2a

20.2±3.9a

White

a

30.2±1.6

a

46.5±3.2

23.3±3.5ab

31.9±4.2a

46.9±7.7a

21.2±3.6ab

a

a

27.6±2.6b

sorghum
Red sorghum
Brown

29.3±3.2

43.2±1.6

sorghum
1

Means (n=2) ± standard deviation
Values within a column with the same superscript letter denotes no significant difference (p>0.05)

2

SEM show a consistent degree of starch gelatinisation within all breakfast biscuits
(Figure 4.2), further supporting the results of the starch profiling studies which
identified minimal differences in starch properties between biscuits (Table 4.3).
Minimal differences in the degree of gelatinised starch between biscuits are a
positive result since this has implications for the post-prandial clinical effects and
may have confounded results if significant differences existed.
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(a)

(b)

(c)
Figure 4.2 Scanning electron micrographs (15kV) of (a) white sorghum flaked
biscuit (b) red sorghum flaked biscuit (c) brown sorghum flaked biscuit depicting
gelatinised starch granules.

4.5 Conclusions
This study confirmed that the flaked cereal biscuits retained the chemical and
nutritional properties inherent to native sorghum whole grains, particularly with
respect to polyphenolic content (key differences emerging between cultivars, as
expected) and similar levels of SDS. These results validate the utilisation of the
formulated sorghum breakfast biscuits as suitable test foods in the clinical dietary
trials described in this thesis. They also support the use of this breakfast cereal
format for the formulation of novel sorghum-based cereal foods. Consideration of the
effects of processing on the biscuits’ functional, nutritional and chemical attributes
was imperative to enable more rigorous interpretation of clinical results from the
dietary trials conducted in this thesis and represents a key strength of the overall
research strategy.

107

CHAPTER 5: Acute meal test study investigating satiety-related effects of flakes sorghum biscuit intake

CHAPTER 5:
Acute meal test study investigating satiety-related effects of
flaked sorghum biscuit intake

The majority of this chapter is the substantive content of the published article:
Stefoska-Needham, A., Beck, E.J., Johnson, S.K., Chu, J., Tapsell, L.C. (2015) Flaked sorghum
biscuits increase post-prandial GLP-1 and GIP levels and extend subjective satiety in healthy subjects.
Molecular Nutrition and Food Research, 60:1118-1128.

Discussion regarding the use of a standardised of dinner meal in this study design:
Needham, A., Beck, E., Tapsell, L. (2014) Does a standardised dinner meal consumed the evening
prior to testing add methodological integrity to an acute meal test study design? Nutrition and
Dietetics, 71 (Suppl. S1), 26. (Oral presentation at DAA Conference, 2014, Brisbane, Australia).
Discussion relating to meal test study design exploring sorghum’s potential satiety-enhancing effects:
Stefoska-Needham, A., Beck, E., Tapsell, L. (2014) Acute effects of consuming sorghum-based
breakfast meals on objective and subjective measures of satiety. Cereal Foods World. 59, No.6
(Suppl):A29, 2014. (Oral presentation at AACCI Annual Meeting 2014, Rhode Island, U.S.).
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5.1 Introduction
Whole grain consumption is postulated to decrease chronic disease risk, largely due
to beneficial effects on body weight regulation(316). Studies of whole grain
constituents, including slowly digestible starches (SDS), dietary fibre and
phytochemicals, implicate their effects on energy balance, glycaemic control, lipids
and inflammation. Sorghum grain constituents have also been shown to produce such
effects (Chapter 2).

Recent studies demonstrate that sorghum foods can be formulated and processed to
deliver SDS(72). Sorghum foods with both higher levels of SDS and dietary fibre
content have the greatest potential to assist in improving blood glucose control and
possibly to influence appetite-related gut hormones such as ghrelin, GLP-1, GIP and
PYY. Influences on gut hormone profiles may be a key mechanism of satietyenhancing action. GLP-1 and GIP are incretin gut hormones that potentiate insulin
secretion after meal ingestion in a glucose-dependent manner. They are secreted
within minutes of food intake and are associated with increased satiety(317). PYY has
been shown to have strong anorectic properties in both lean and obese subjects(245),
reducing appetite and food intake by approximately 25-30% at a subsequent
meal(248). Ghrelin, an orexigenic hormone, decreases immediately after ingestion of
food and stimulates hunger and food intake(221). Understanding how sorghum grain
intake acts acutely, for example affecting these key satiety hormones, may help to
justify and formulate hypotheses for the effects of chronic sorghum consumption in
longer-term weight reduction intervention trials. In addition, consideration can be
given to any observed effects in relation to known effects of individual components
within sorghum, such as polyphenols, starches and fibre.
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5.2 Study Aims and Hypothesis
The aim of this double-blinded, randomised, crossover feeding study was to test the
effects of eating three different RTE whole grain sorghum flaked breakfast biscuits
on appetite responses in healthy subjects. The biscuits were derived from white, red
or brown whole grain sorghum, or wheat (control), all high in SDS levels but
differing in polyphenolic content and dietary fibre levels (Chapter 4). It was
hypothesised that the consumption of sorghum-based breakfast cereal foods would
reduce appetite compared to a wheat control. Specifically, sorghum-based products
would: (1) increase acute subjective satiety; (2) alter responses of appetite-regulating
hormones (plasma ghrelin, GIP, GLP-1, PYY and insulin) and plasma glucose; and
(3) reduce food intake at a subsequent meal and during the remainder of the test day.
It was postulated that mechanisms involving polyphenolic, starch and dietary fibre
components will synergistically drive satiety changes. A secondary aim was to
review any differences in satiety outcomes between the sorghum varieties to better
inform which components may drive any benefits of sorghum consumption when
consumed as whole cereal foods.

5.3 Materials and Methods
5.3.1 Subjects
Healthy subjects, 20 males and 20 females, aged 18-50 years (BMI range from 20–
31 kg/m2) were sought within the local community through paid media
advertisements and institutional emails. Subjects with serious illness including
diabetes, with known food allergies, restrictive eaters (identified using the TFEQ
described in Chapter 3) and those who were smokers, were excluded. Pregnant,
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breastfeeding and post-menopausal participants were also excluded. Height, weight,
waist circumference and percentage body fat (Tanita Scales Model no.TBF-662)
were recorded. A diet history (DH) and three-day weighed food records were
collected from subjects prior to the start of the testing phase in order to design an adlibitum meal within the subjects’ taste preferences and based on familiar foods.
Twenty-four hour dietary recalls were collected for the day prior to each study visit
(Figure 5.1).

Participant calls
Dietary Hotline to
register interest
TESTING VISIT at
clinical trials unit

Evening prior to
first testing visit:
standardised dinner
meal consumed then
12h fast

3-day weighed food
record completed prior to
first visit

Call back from Researcher –
telephone screening

Attend screening interview
(includes DH, 3FEQ,
baseline anthropometry)

Recruit into study,
randomise

Figure 5.1 Participant engagement before randomisation into study and prior to first
testing visit

5.3.2 Test Protocols
Subjects consumed four different breakfast cereal meals on four separate occasions
after a 12-hour overnight fast with a minimum of three days between visits. Subjects
consumed a standardised frozen meal for dinner the evening before testing, stratified
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to subjects’ usual energy intake. Subjects were advised to refrain from vigorous
physical activity and alcohol consumption in the 24-hour period prior to testing.
Female subjects were tested within the same phase of their menstrual cycle(318). The
study was approved by the University of Wollongong Human Research Ethics
Committee (application number HE12/410) and was prospectively registered with
the Australian New Zealand Clinical Trials Registry (ACTRN12614000640606). See
Figure 5.2.

5.3.3 Test Foods
The flaked whole grain biscuits were made from three different sorghum cultivars
(red, white and brown grained) and a single wheat control, as per the protocol
discussed in Chapter 4. Each test breakfast meal consisted of 3 biscuits (50 g total)
served with 200 mL water. An additional 400 ml water was provided to participants
during the course of the four-hour testing period. Analyses of proximate, dietary
fibre, energy and polyphenolic contents of the test biscuits were completed in
accordance with methods detailed in Chapter 4. Results of these analyses are also
reported in Chapter 4, together with scanning electron microscopy studies.

At each study visit, participants were also instructed to complete a product
evaluation form shortly after eating the test biscuits (Appendix 2). This comprised
both open-ended questions and also 100mm VAS lines. Specifically, questions
related to organoleptic properties of the biscuits and asked about subjects’
perceptions of taste, texture, and crunch.
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Figure 5.2 Overview of protocol for acute meal test study
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5.3.4 Appetite Markers and Measures
On arrival to the clinical trials unit, subjects had anthropometric measurements and
baseline blood pressure measured. A cannula was inserted and initial fasting blood
samples were collected. The subject then ate one of the four test breakfast meals
within a 10-min period. Fifteen minutes from commencement of the test breakfast
meal, the next blood sample was taken. Further samples were then collected at 30,
60, 90, 120, 180 and 240 min. All biochemical analyses were performed by an
accredited Pathology Laboratory, according to standard protocols for the respective
assays. Glucose analysis was performed by the glucose hexokinase method (Roche
Diagnostics, Australia). Analyses of insulin, active ghrelin, PYY and GIP were
performed using a multiplexed Merck Millipore Human Metabolic Hormone Panel.
Active GLP-1 was assayed using an Epitope Diagnostic Elisa kit. Plasma total
antioxidant capacity (TAC) was measured using a method adapted for a Cobas Mira
(Roche Diagnostics, Australia). Plasma was incubated with met-myoglobin and 2,2'azino-bis (3-ethylbenzothiazoline-6-sulphonic acid). After incubation, hydrogen
peroxide was added and the sample incubated again. Absorbance was measured
spectrophotometrically to determine TAC.

At each of the eight time-points for blood collection, subjects completed a fourquestion visual analogue scale (VAS) related to appetite(217). The questions were:
How hungry do you feel at this moment? How satisfied do you feel at this moment?
How full do you feel at this moment? How much do you think you can eat at this
moment? The VAS consisted of a 100 mm horizontal line, anchored at each end with
opposing extremes of the scale (for example, "not at all hungry" and "never been
more hungry"). The study participants were instructed to place a vertical mark on the
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line to correspond with their feelings. The subjective sensation was quantified by
measuring the distance in millimetres from the left end of the line to the mark. Four
hours after completion of the breakfast, a buffet lunch was served, consisting of a
variety of sandwiches (cut into bite-size pieces), a cold pasta salad, dried fruit,
yoghurt and water (totaling approximately 7500 kJ and containing 50%
carbohydrate, 20% protein and 30% fat) (Figure 5.3). All the foods were made to
standardised recipes and were weighed before the meal was consumed and at
completion to enable calculation of the amount of food eaten.

Figure 5.3 Buffet (ad-libitum) lunch

5.3.5 Statistical Analysis
Sample size was calculated based on previous appetite studies measuring satietyrelated biochemical markers and VAS scores. Flint et al.(217) suggested that 18
subjects should identify statistically significant changes using a paired design and a
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study power of 0.8 if VAS ratings vary by at least 5 mm. However, Beck et al.(308)
concluded that a sample size of 37 would be required for results to reach statistical
significance in a paired design with a power of 0.8 (alpha 0.05). Specifically for
detection of biochemical differences, a sample size of 14, with seven subjects of each
gender, was suggested as being sufficient to see significant results(220). In
consideration of these studies and the fact that sorghum has not been previously
tested, a target sample size of 36-40 subjects of equal genders was set to undergo
subjective satiety assessment through VAS, and a subset of 18-20 subjects to
undergo biochemical analysis. Results for VAS scores, biochemical analyses and
second-meal dietary intake were entered into SPSS for windows, Version 21.0 (SPSS
Inc., Chicago, IL, USA). Differences in VAS responses between the breakfasts were
identified using repeated measures analysis of variance (RMANOVA) with post-hoc
Bonferroni adjustments. The area under the curve was assessed using trapezoidal
methods for all biochemical data with values corrected for baseline and inclusive of
all incremental area below the curve, as well as the area below the fasting
concentration (net incremental AUC or net iAUC as previously described(319).
Differences in net iAUC for glucose, insulin, ghrelin, GLP-1, GIP and PYY between
the breakfasts were identified using RMANOVA with post-hoc Bonferroni
adjustments. For meal intake values, RMANOVA of kilojoules consumed was
performed. Data was analysed for individual and combined sexes as past studies
have identified some gender-related differences in satiety markers(220). Regression
analysis relationships were explored between biochemical, subjective and meal
intake data and 24 h dietary recalls. A p<0.05 was considered statistically significant.
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5.4 Results
5.4.1 Subjects
A total of 81 potential subjects expressed interest in the study, of which 65 were
contacted to undergo further preliminary screening via telephone. From this group,
43 people were eligible for further assessment and attended an interview to
determine final eligibility. A total of 40 subjects were then randomised into the
study. All subjects attended the required four study visits, resulting in a 100%
participant retention rate. Twenty male and twenty female subjects were aged 21-50
years (average ages were 27.7 and 31 years, respectively). Further subject
characteristics are summarised in Table 5.1.

Table 5.1 Subject characteristics at baseline (mean ± standard deviation)
Age (years)

Male (n=20)
27.7 (±6.921)

Female (n=20)
31.0 (±8.891)

Age range (years)

21-43

21-50

Weight (kg)

80.50 (±8.094)

63.84 (±7.814)

Height (m)

1.84 (±0.073)

1.67 (±0.053)

BMI (kg/m )

23.78 (±2.025)

22.94 (±3.00)

Waist circumference (cm)

83.05 (±5.196)

75.85 (±8.53)

Body fat (%)

16.81 (±3.15)

28.35 (±5.287)

Blood glucose (mmol/L)

4.71 (±0.303)

4.80 (±0.371)

Blood insulin (mmol/L)

254.60 (±47.350)

289.50 (±89.022)

2

5.4.2 Test Food Analysis
Test foods in the form of flaked cereal biscuits were consumed by subjects with no
adverse reactions. Responses to the product evaluation questionnaire did not identify
differences in subjects’ perceptions about taste, texture and crunch between the
different sorghum biscuits and the wheat control (data not presented), suggesting that
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they were equally acceptable to the study sample. Analyses of proximate and dietary
fibre composition and energy content, as well as the free and bound polyphenolic
(PP) content (mg GAE/g as is) and antioxidant capacities (µmolTE/g as is) of the
test foods, were reported in Chapter 4, and confirm that the formulated RTE biscuits
were suitable test foods for this trial. Specifically, analyses of proximate and dietary
fibre composition and energy content (on as is basis per 100g) identified modest
differences between the control and different sorghum varieties (Table 4.1), with the
wheat control containing the highest soluble fibre levels (4%), followed by brown
sorghum (2.3%), red sorghum (1.5%) and finally white sorghum (1.2%). Free and
bound polyphenolic (PP) content (mg GAE/g as is) and antioxidant capacities
(µmolTE/g as is) of the test foods were also determined (Table 4.2). As expected, red
and brown sorghum biscuits had the highest PP levels, due to the high anthocyanin
and tannin contents previously reported for these varieties(23), and lower levels of
total PP were reported for white sorghum and wheat biscuits. Assessment of starch
properties showed no difference in the amount of total starch, RDS and SDS between
biscuits (Table 4.3). RS was highest in the brown sorghum biscuit compared to all
other biscuits (p<0.05).

5.4.3 Baseline Measurements
Dietary recalls for the 24-hour period prior to each visit averaged 8867 kJ (4871 kJ –
15 780 kJ). Average intake for females was 7587 kJ and for males 9949 kJ. As
expected, regression analysis indicated some contribution of total energy intake
consumed in the previous 24 h to the prediction of total lunch time ad-libitum intake
(R2 = 0.281, p<0.001), as well as intake during the remainder of the day (R2 = 0.153,
p<0.001). No relationship was identified between the 24 h recalls and baseline
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measurements of individual VAS questions, fasting glucose, insulin, ghrelin, GIP,
GLP-1, PYY and TAC levels. There was some correlation between polyphenolic
content of the standardised dinner meal consumed the evening prior to testing and
baseline plasma TAC levels, adding support to the decision to standardise this meal
in this study design (Table 5.2).

Table 5.2 Correlation between polyphenol content of standardised dinner meal and
baseline plasma TAC
Correlations

Male (n=8)

Female (n=8)

Pearson Correlation (r)

0.863

0.451

Significance (2-tailed)

0.006

0.088

Effect size (Cohen’s*)

Large

Medium

*Due to the small sample size, Cohen’s values were applied to determine effect size.

5.4.4 Subjective Satiety
The measurement of appetite sensations using VAS showed the treatment effect was
significant in all four questions (p<0.001, RMANOVA of means for all questions)
(Table 5.3).

Pairwise comparisons using Bonferroni adjustments indicated

differences primarily between the control (wheat biscuit) and all three sorghum
biscuits (red, brown and white) for all four questions (p<0.05 for all three
comparisons in each question). No differences between sorghum biscuits were
identified using Bonferroni adjustments for multiple comparisons. Overall, means of
VAS responses showed significantly greater hunger and lower satiety ratings after
consumption of wheat biscuits compared to all three sorghum treatments over the 4 h
testing period (also shown in Figure 5.4).
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Table 5.3 Mean VAS ratings (mm) for all 4 questions after intake of different
breakfast cereal biscuits1
Flaked cereal
biscuit type

Q1

Q2

Q3

Q4

Hunger

Satisfaction

Fullness

Desire to eat

Wheat control

58.9 ± 24.9a

36.6 ± 24.3a

35.8 ± 24.5a

65.4 ± 22.9a

White sorghum

54.4 ± 26.7b

41.9 ± 26.6b

39.8 ± 27.2b

61.7 ± 25.9b

Red sorghum

52.8 ± 26.4b

43.9 ± 26.6b

42.9 ± 27.7b

60.4 ± 26.1b

Brown sorghum

53.9 ± 27.1b

41.4 ± 27.6b

41.1 ± 27.6b

60.2 ± 26.9b

1

Values within a column with different superscript letters denotes significant differences (p<0.001).
Values with the same superscript letter denote no significant difference (p>0.05).
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Figure 5.4 RMANOVA of mean satiety ratings(mm) for all 4 questions
(Q1, Q2, Q3, Q4) after intake of different breakfast cereal biscuits
at different time points over 4h1,2
1

Q1, Q4: Increasing values on y-axis associated with greater hunger/lower satiety sensations
Q2, Q3: Increasing values on y-axis associated with greater satiety/lower hunger sensations

2
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5.4.5 Biochemical Indices
Between meal differences in iAUC postprandial responses of glucose, insulin and
various gut hormones are shown in Table 5.4. RMANOVA of insulin iAUC data
(corrected for baseline) indicated a significant difference between responses over the
4 h testing period (p=0.016). Post-hoc comparisons using Bonferroni adjustments
showed differences of statistical significance between the red sorghum biscuit and
the wheat control (p=0.032), with a greater insulin response after the red biscuit
treatment.

Similar analysis of iAUC responses for the incretin gut hormones, GIP and GLP-1,
also showed significant differences over 4 h (p=0.031 and p=0.018 respectively),
identified using RMANOVA. Post-hoc comparisons using Bonferroni adjustments
showed significant differences in GIP responses for the overall 4 h period only
between red sorghum and the wheat control (p=0.028) (Figure 5.5d).

Although overall, between-treatment variations in GLP-1 responses were statistically
different (p=0.018), Bonferroni post hoc comparisons only showed a trend towards a
higher response after red sorghum biscuit intake compared to control (p=0.127), with
no differences between the control and the other two sorghum varieties (p>0.05)
(Figure 5.5c).

Overall, differences in PYY iAUC responses between treatments during the 4 h
testing period did not reach statistical significance (p=0.197), although the greatest
release of PYY was after the consumption of red sorghum biscuit (Figure 5.5e).
When gender-specific data was reviewed using Bonferroni adjustments, the PYY
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concentrations were significantly higher in males after red sorghum intake compared
to wheat (p=0.036). No significant between-treatment differences were found in
glucose and ghrelin responses during the testing period (Figure 5.5a and 5.5f).
RMANOVA of TAC iAUC did not identify differences between treatments (data not
presented). No significant correlations between biochemical indices and flaked
biscuit properties were identified (data not presented).

5.4.6 Energy intake at ad-libitum lunch meal and for the rest of the day
No significant differences in lunch energy intakes were detected (p=0.955) for the
group or individual genders between test diets (data not presented). Similarly, when
analysing total energy content from the rest of the day, or that intake combined with
the ad-libitum buffet lunch, no significant differences were detected (data not
presented).
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Table 5.4 Postprandial responses of glucose, insulin and various gut hormones over 4h (expressed as mean net iAUC ± standard deviation)

Wheat control

White sorghum

Red sorghum

Brown sorghum

p-value
(RMANOVA)

Glucose

Δmmol/L.min

Insulin

67.03 ± 84.03

47.17 ± 85.94

55.30 ± 90.28

47.68 ± 85.94

0.841

Δ pg/ml.min

53524.93 ± 31550.26

52787.32 ± 29370.34

69282.49 ± 40375.97

64218.02 ± 35412.16

0.016*

Ghrelin

Δ pg/ml.min

2229.28 ± 4861.99

4690.35 ± 5561.33

4224.62 ± 4504.79

846.86 ± 7357.46

0.361

GIP

Δ pg/ml.min

7200.08 ± 3891.26

7892.01 ± 3796.86

10155.30 ± 3860.78

8853.11 ± 3722.51

0.031*

GLP-1

Δ pM.min

-30.69 ± 211.62

82.57 ± 124.70

104.19 ± 107.98

72.71 ± 113.74

0.018*

PYY

Δ pg/ml.min

1025.66 ± 4035.30

2489.46 ± 5093.02

3610.03 ± 2739.10

2387.58 ± 3043.18

0.197
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Figure 5.5 Changes in mean plasma concentrations of
(a) glucose, (b) insulin, (c) GLP-1 over time
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Figure 5.5 Changes in mean plasma concentrations of
(d) GIP, (e) PYY and (f) ghrelin over time
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5.5 Discussion
The VAS ratings for subjective appetite/hunger showed that sorghum flaked
breakfast biscuits significantly decreased hunger and increased satiety sensations
compared to wheat, and in particular the red sorghum showed variations in appetite
hormones associated with satiety. Although this did not translate to differences in
intake at the subsequent ad-libitum meal, the presence of wide standard deviations in
the food intake data indicated there may have been a lack of power to detect
differences at this level. Nevertheless, the subjective satiety results align with
traditional experiences of some African communities who report feelings of satiety
after eating sorghum foods(23).

Enhanced satiety has been attributed to SDS in sorghum grain and their role in
lowering glycaemic index (GI) of sorghum foods(169), particularly those made from
polyphenol-rich sorghum varieties(62). In our study, it seems SDS in isolation did not
play a role in satiety-enhancing mechanisms between treatments, because SDS levels
were high in all the flaked biscuits (Chapter 4)(320). RS has been shown to increase
satiety(73), however in the present study the higher RS levels in the brown sorghum
biscuits compared to wheat did not coincide with greater satiety responses postprandially. Hence, we must turn to other non-starch components present within the
food matrix of the sorghum biscuits, such as dietary fibre and polyphenolic
compounds concentrated in the bran component of the grain, to explain the observed
differences in satiety effects in this study.

In general, foods rich in fibre may promote satiety due to bulking(283), relatively low
energy density(321) and increased viscosity of intestinal contents, delaying gastric
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emptying and slowing absorption of macronutrients(322). Fibre may also affect
secretion of gut peptides, independent of glycaemic responses, which may act as
satiety-enhancing factors(321). The total dietary fibre in the sorghum biscuits was
relatively high, ranging from 7.3-9.9%, and similar to the control food, wheat (9.2%).
The soluble fibre, often associated with acute satiety, was highest in the wheat so it is
also difficult to specifically ascribe effects on satiety from sorghum to the fibre in
these food products. The absolute differences in total and soluble fibre between the
wheat biscuit and the red biscuit, for example, was modest at 0.95 g and 0.14 g per
serve, respectively. These doses of fibre are possibly too small to drive
experimentally discernable differences in satiety outcomes. Future dose response
studies, with specific manipulation of the fibre types (soluble and insoluble) found in
sorghum, would be useful to more precisely investigate the role of fibre in satietyenhancing mechanisms of sorghum-based foods.

Dietary polyphenols have also been implicated in appetite regulation mechanisms,
mainly through the inhibition of α-amylase and α-glucosidase, the key enzymes
responsible for digestion of dietary carbohydrates to glucose(66). The sorghum
biscuits were confirmed to have higher levels of total and free polyphenolic
components compared to the wheat biscuit, however no correlations between
polyphenolic contents and clinical measures were identified. It is interesting that the
red sorghum showed the greatest alteration in appetite hormones, but this did not
translate to differences in the subjective appetite responses in comparison to the other
sorghums, only to the wheat control. This indicates that the specific combination of
components in the red sorghum biscuit requires further investigation. Mechanisms
invoked by polyphenolic components and dietary fibre, for example, may not be
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discernable in appetitive and digestive responses over four hours(323). Hence, review
of hormones over greater periods of time in a study with chronic ingestion, and with
different sorghums varieties, would be useful. This would also help to identify
potential differences in hormone release for acute versus chronic sorghum
consumption.

Of note, plasma glucose responses were not altered. Despite similar glucose
responses, satiety ratings differed significantly between sorghum and wheat biscuits,
supporting the case for insulin (and not glucose) being a more likely mediator of
satiety sensations in the postprandial period in normal weight individuals(275;

281)

.

Flint et al.(281) showed in a meta-analysis that insulin response was significantly and
inversely related to post-prandial hunger in normal-weight subjects, particularly
decreasing ad libitum energy intake at a second meal. In the present study,
consumption of red sorghum biscuits produced the highest insulin response, as well
as the lowest ratings of hunger. Interestingly though, insulin was lower after the
white sorghum biscuit compared to the red sorghum biscuit but resulted in the same
subjective satiety ratings, so this again does not explain the entire mechanism.

Postprandial GLP-1 and GIP responses were also higher for all sorghum biscuits
compared to the wheat. GLP-1 in particular has an important role in attenuating postprandial glucose rises and is involved in the ileal break reflex, having an anorectic
effect on appetite(262), with some studies showing reduced food intake when it is
peripherally administrated(264). However, positive changes in GLP-1 and GIP in both
sexes, and PYY levels in men, did not translate to decreased food intake at a second
meal in the present study.
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The key limitation in interpreting results from the present study was the inability to
detect significant differences in food intake data at the ad libitum meal and for the
rest of day. A larger sample size may have enabled these differences to emerge and
to corroborate the significant subjective satiety ratings (VAS scores) and also the
biochemical indices (insulin, GIP, GLP-1, PYY). Importantly, such a small breakfast
as the test meal, followed by 4 hours of fasting, may have increased hunger to an
extent that blunted any subtle differences in food intake. Factors that relate to nonbiological drivers of appetite and food intake such as environment, social and
cognitive influences are also relevant to consider in the present study. For example,
the amount of food offered in the ad-libitum lunch was deliberately in excess of
participants’ usual intake and consisted of a variety of appealing food items that may
have led to more food being eaten simply because the food was in abundance and
pre-prepared. Differences in fibre content between biscuits, although modest, limited
the ability of researchers to confidently ascribe effects to specific grain components
such as polyphenolics. While controlling for fibre content may more clearly elucidate
mechanisms in future work, the present study defined results within a standard serve
size, relevant to consumers.

5.6 Conclusions
In conclusion, exploration of the use of sorghum whole grain as an ingredient in the
formulation of foods targeted for weight control through appetite regulation is
justified in future research. In the present study, whole grain sorghum-based flaked
cereal biscuits (red-, white- and brown- grained) were formulated and were shown to
increase short-term subjective satiety ratings compared to a wheat biscuit control.
Differences in polyphenolic contents between the red, white and brown sorghum
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flaked biscuits appear to play a role in satiety-enhancing mechanisms, although their
precise actions are not clear. Actions of SDS and dietary fibre may contribute to
these effects, reflecting the benefits of the whole cereal food delivering synergistic
effects of individual grain components into the body. Additional mechanisms
involving interactions between insulin and the incretin hormones, GLP-1 and GIP, as
well as PYY, may be contributory factors to enhanced satiety effects of sorghum
flaked biscuits. Choice of a test food based on red sorghum is justifiable in
randomised controlled trials that aim to directly examine effects of sorghum intake
on chronic disease biomarkers or health outcomes. Chapter 6 describes a 3-month
intervention trial examining these outcomes.
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CHAPTER 6:
Examining the longer-term effects of chronic sorghum
consumption: a randomised controlled trial

The majority of this chapter is the substantive content of the article:
Stefoska-Needham, A., Beck, E.J., Johnson, S.K., Batterham, M., Grant, R., Ashton, R., Tapsell, L.C.
(2016) A diet enriched with red sorghum flaked biscuits, compared to a diet containing white wheat
flaked biscuits, does not enhance the effectiveness of an energy-restricted meal plan in overweight
and mildly obese adults. Journal of the American College of Nutrition. (Accepted for publication)

131

CHAPTER 6: Examining the longer-term effects of chronic sorghum consumption: a RCT

6.1 Introduction
The acute satiety study described in Chapter 5 showed that flaked biscuits made from
red sorghum grain, a variety rich in anthocyanin flavonoids, elicited the greatest
overall acute satiety-enhancing responses. Neither the dietary fibre nor the starch
contents of the biscuits could explain the responses, but overall differences in
polyphenol contents, or a synergy between polyphenols, dietary fibre and SDS, may
have played a role. While these initial acute satiety results were promising, longerterm effects on chronic disease biomarkers or health outcomes from a sorghumenriched diet required investigation using a “gold-standard” RCT design. To
maintain the integrity of the methodological framework used to explore the key
hypothesis, the equivalent flaked breakfast biscuits were used in this RCT, with the
obvious choice of red sorghum as the treatment on account of its superior acute
satiety effects. The RCT results are important to provide the level of evidence
necessary to guide clinical practice, inform science-based food messages (such as
those found in Dietary Guidelines and health claims) and to support commercial
investments by food industry and hence product development.

6.2 Study Aims and Hypothesis
This study was a 3 month randomised controlled dietary intervention trial, aiming to
test effects of whole grain red sorghum included in an energy-restricted meal plan.
The primary outcome was difference in weight loss between the control and
intervention groups. Secondary outcomes included a variety of biochemical measures
linked with change in body weight and disease markers, such as glucose, insulin,
cholesterol and various anti-inflammatory/oxidative stress markers, as well as
subjective

satiety measures.

Overall,

overweight

individuals

following a
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nutritionally-balanced, energy-restricted diet including sorghum whole grain foods
would be expected to lose more weight than if they followed the same diet without
sorghum-based foods, driven by reduced energy intake as a result of satiety actions
of sorghum grain. Specifically, it was hypothesised that: (1) subjects receiving foods
made from whole grain sorghum would lose more weight than the subjects receiving
control foods (wheat-based); (2) weight loss would be accompanied by changes in
metabolic disease risk factors, which may be anticipated given the higher
polyphenolic content of sorghum.

6.3 Materials and Methods
6.3.1 Subjects and Recruitment
This study was a 3 month, double-blinded, parallel, randomised controlled trial with
a total of 60 subjects, 46 females and 14 males. There were two arms to the study:
sorghum intervention and wheat control, with both groups receiving advice on an
energy-restricted diet from an Accredited Practising Dietitian. All subjects were
provided with cereal products, in the form of flaked breakfast biscuits, to include in
their diets (Figure 6.1). The target sample size of 30 subjects per group was based on
previous human intervention studies incorporating cereal/high fibre foods into hypocaloric diets(324-326). Difference in weight loss between groups was used as the
primary outcome measure to establish power for the study. To observe a twokilogram weight difference between groups, at a power of 80% and to be
significantly different at level of α 0.05, 26 subjects would be required per group.
Therefore, setting the recruitment target at 30 subjects per group would account for
an approximate dropout rate of 15%.
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Figure 6.1 Overview of protocol for RCT
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Eligible subjects (aged 18–65 years, BMI range from 25–35 kg/m2) were sought
through paid media advertisements and institutional emails. Subjects with serious
illness including diabetes, with known food allergies, and those taking appetitealtering medications were excluded from the study. Restrictive eaters (identified
using the TFEQ described in Chapter 3) and subjects who were smokers, were
pregnant, breastfeeding and post-menopausal were also excluded. All procedures
were approved by the University of Wollongong, Human Research Ethics
Committee (approval number HE14/100). The trial was also prospectively registered
with the Australian New Zealand Clinical Trials Registry (#12614000640606).
Figure 6.1 provides an overview of the study protocol.

A total of 115 potential subjects expressed interest in the study of which 103 were
contacted to undergo further preliminary screening via telephone (Figure 6.2). From
this group, 80 people were eligible for further assessment in the form of a detailed
screening questionnaire. This led to sixty-one people attending an interview to
determine final eligibility with sixty subjects randomised into the two study groups
by a researcher independent of the subject interface, stratified by sex, block
randomised using STATA Version 12 and using the RALLOC command (StataCorp,
2011, College Station, Texas, USA). The researcher/dietitian (myself) and all
subjects at the subject interface were blinded to the randomisation. The subjects
attended the clinical research trials unit (CRTU) at the University of Wollongong,
Australia, on five occasions. The first visit included collection of background dietary
data using a validated diet history interview(327) and instruction on the completion of
a 3-day weighed food record. The subsequent visit included collection of fasting
blood samples (baseline) and dietary education. Two follow-up dietary visits
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occurred at the 1-month and 2-month time-points, with collection of fasting blood
samples at 3 months (final visit). All the subjects had their height, weight, percentage
body fat (Tanita Scales Model no.TBF-662) and waist circumference recorded at
each visit to the CRTU. Visual analogue scales (VAS) related to appetite(215) and
food records were all completed at baseline, half-way through the study (at the 6week point) and within the final week of the study. The Baecke Physical Activity
Questionnaire(328) was completed at baseline and at the completion of the study.

Figure 6.2 Flow of participants through the trial
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For the appetite VAS, the subjects recorded their appetite responses on individual
forms at six different time- points throughout the day: immediately before each of
the three main meals and 2 h after each of these meals but before their subsequent
snack. The VAS consisted of a 100 mm horizontal line, anchored at each end with
opposing responses (for example, "not at all hungry" and "never been more hungry").
The study participants were instructed to place a vertical mark on the line to
correspond with their feelings and the subjective sensation was quantified by
measuring the distance in millimeters from the left end of the line to the mark. All
nutritional analysis was performed using FoodWorks 2007, version 5 (Xyris
Software, Brisbane, QLD, Australia) with nutrient contents of study foods added as
required.

6.3.2 Dietary Intervention
For each subject, a basal metabolic energy requirement was calculated using the
Mifflin-St Jeor equation where a BMI equal to 25 kg/m2 was included(329). A low
activity factor (1.3) was chosen to estimate energy requirements (given the
overweight sample with limited usual physical activity) and then this level was
reduced by 20% to drive weight loss. Intervention diets were designed to control for
all macronutrients with the only variation being the trial cereal products given, as
described in Table 6.1. The sorghum intervention group received sorghum-based
cereal biscuits and the wheat control group received wheat-based cereal biscuits,
matched by serve size (3 biscuits) and therefore overall mass (45 g per day).

137

CHAPTER 6: Examining the longer-term effects of chronic sorghum consumption: a RCT

Table 6.1 Dietary prescription (totaling 5, 500kJ) for a typical participant
Food Group

Portion or serve size

Number of serves / day

Control or intervention products

1 flaked cereal biscuit equivalent to 15g

3 (2 biscuits at breakfast and 1 at afternoon tea)

Breads/cereal/starchy vegetables

1 slice bread or 1/2 cup cooked pasta or 1/3 cup
cooked rice or 1 small potato

4

Other vegetables

1/2 cup cooked or 1 cup raw

2.5 cooked or 5 raw

Fruit

1 piece fresh or 3/4 cup canned and drained

2

Milk / alternatives

2-3
150ml light or 200ml skim, 100g low-fat yoghurt

Meat / alternatives

30g meat or 50g fish or 20g low fat cheese

3-4

Fats

1 tsp oil or margarine or 1 tbsp avocado

3-4
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6.3.3 Test food products
Test foods were manufactured in the form of RTE flaked cereal biscuits, as for the
acute test study (method detailed in Chapter 4). The sorghum flaked cereal biscuits
were processed from the same red sorghum grain, variety Alpha, grown and supplied
by Lochabar Enterprises Pty Ltd (Tara, QLD, Australia). The wheat flaked cereal
biscuits were made from non-cultivar-specific Australian Prime White (APW) wheat
(grown in central New South Wales, Australia) and was again supplied by
Sanitarium Health and Wellbeing (Cooranbong, NSW, Australia). The subjects were
instructed to eat two cereal biscuits (30g) at breakfast and one biscuit (15g) at
afternoon tea daily. The proximate, dietary fibre and energy content (on as is basis
per 100g) (Table 6.2), polyphenolic (PP) content (mg GAE/g as is) (Table 6.3) and
starch properties (per 100g as is) (Table 6.4) between the sorghum and wheat
biscuits were reported and were analysed according to the methods described in
Chapter 4.

Analyses identified modest differences between the control and red sorghum biscuits
with respect to energy, macronutrients and dietary fibre (Table 6.2). Notably, both
total and soluble fibre levels were higher in the wheat control compared to the
sorghum biscuits, however the actual difference between biscuits was modest at 0.86
g and 0.13 g per 45 g test serve, respectively. Individual macronutrient levels were
not controlled for because this study was designed to test whole foods as consumed
in real-life settings, hence the serve size rather than specific components were
matched. As expected, red sorghum biscuits had higher PP levels compared to the
control (Table 6.3), most likely due to high anthocyanin contents characteristic of
this sorghum variety(330). Assessment of starch properties showed no difference in the
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amount of total starch, rapidly digestible starch (RDS) and slowly SDS between
biscuits, and in particular the levels of SDS in each serve classified as high (Table
6.4).

Table 6.2 Proximate and dietary fibre composition and energy content of flaked
breakfast cereals1,2,3,4,5
Flaked
breakfast
cereal type

Moisture

Protein

Fat

Ash3

(g/100g as

(g/100g as

(g/100g as is)

(g/100g as

is)

is)

is)

Total

Soluble

Total available

4

dietary

Fibre

carbohydrates

fibre

(g/100g as is)

(g/100g as is)

Energy

5

content
(kJ/100g

(g/100g as is)

as is)

Wheat

6.6±0.0

13.7±0.2b

1.7±0.0a

1.6±0.0

9.6±0.1b

4,0

66.9±0.1a

1508±1a

6.6±0.0

9.4±0.1a

2.9±0.1b

1.6±0.0

7.7±0.0a

1.5

71.9±0.1b

1550±0b

(control)
Sorghum
(red)
1

Means (n=2) ± standard deviation
Values within a column with the same superscript letter denotes no significant difference (p>0.05)
3
Statistical comparison not possible as some replicates identical
4Analysis provided by manufacturer – standard deviations not available and statistical comparison not possible
5
Available carbohydrate calculated by difference
2

Table 6.3 Free, bound and total phenolic content and antioxidant capacity of flaked
breakfast cereals1,2
Flaked
breakfast

Free PP

Bound PP

Total PP

Free AC

Bound AC

Total

(mg GAE/g as is)

(mg GAE/g as is)

(mg GAE/g as is)

(µmolTE/g as is)

(µmolTE/g as is)

antioxidant

cereal type

capacity
(µmolTE/g as is)

Wheat

0.71±0.01a

0.67±0.22a

1.37±0.21a

2.64±0.01a

2.67±0.01a

5.31±0.01a

1.27±0.01b

1.00±0.11a

2.27±0.12b

11.25±0.57b

9.16±0.62b

20.40±1.18b

(control)
Sorghum (red)
1

Means (n=2) ± standard deviation
Values within a column with the same superscript letter denotes no significant difference (p>0.05)
PP, polyphenolic; AC, antioxidant capacity; GAE, gallic acid equivalents; TE, Trolox equivalents
2
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Table 6.4 Starch properties of flaked breakfast cereals1,2,3
Total starch3

Rapidly digested starch

Slowly digested starch

Resistant starch

cereal type

(g/100g as is)

(g/100g dry starch)

(g/100g dry starch)

(g/100g dry starch)

Wheat control

54.2 ± 0.2a

Sorghum (red)

57.7 ± 2.3a

Flaked breakfast

a

31.9±1.6

a

47.9±4.2

20.2±3.9a

31.9±4.2a

46.9±7.7a

21.2±3.6a

1

Means (n=2) ± standard deviation
Values within a column with the same superscript letter denotes no significant difference (p>0.05)
3
Total starch was determined using a Megazyme K-TSTA 09/14 Total Starch Kit (Bray, Ireland) which excludes low molecular
weight starch hydrolysis/breakdown products that may have resulted during the manufacturing process
2

6.3.4 Clinical Indices
Fasting blood samples were collected at 0 and 3 months into clot gel tubes,
centrifuged and stored at -80° Celsius until analysis could be completed according to
standard protocols for glucose, insulin, total cholesterol, high-density lipoprotein
(HDL-c), low-density lipoprotein (LDL-c), triacylglycerides (TAG) and highsensitivity c-reactive peptide (hsCRP) at Sydney Adventist Hospital Pathology
(Wahroonga, NSW, Australia). Glycosylated haemoglobin (HbA1c) was performed
by Southern Pathology (Wollongong, NSW, Australia) after samples were collected
into tubes containing potassium EDTA and stored at 4° Celsius until analysis was
conducted. Additional markers for inflammation and oxidative stress, Interleukin 1
(IL1), Interleukin 6 (IL-6), Interleukin 8 (IL-8), hydroperoxide (HPX), tumour
necrosis factor alpha (TNFα) and total antioxidant capacity (TAC) were performed
by the Australasian Research Institute, (Sydney Adventist Hospital, Wahroonga,
NSW, Australia) according to established protocols.

6.3.5 Statistical Analysis
Data for all anthropometry, blood analysis, VAS measurements and dietary intake
were entered into SPSS for windows, version 21.0 (IBM SPSS 21.0, IBM
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Corporation, Armonk, NY, USA). Repeated measures ANOVA (RMANOVA) using
the general linear model with group (control, sorghum) as the between subjects
factor, was used to identify primary changes in each parameter over time and also
differences between the groups. Post hoc analysis using Bonferroni adjustments was
reviewed to detect specific differences between the control and intervention groups.
Regression analysis was used to identify correlations between group anthropometric
and biochemical indices.

6.6 Results
6.6.1 Baseline Data
There were twenty-six subjects in the sorghum intervention group (after four subjects
withdrew) and thirty subjects in the control group. Reasons provided for their
withdrawal were: relocation, commencement of a contraindicated medication and the
lack of motivation to adhere to an energy-restricted meal plan. For the final analysis,
fifty-six subjects were included, although numbers in each calculation varied because
some subjects did not complete all forms (food records or VAS). There were no
significant differences between group anthropometric, dietary and metabolic
measures at baseline (Table 6.5), except for a slightly lower protein intake in the
sorghum group. Baseline energy intakes seemed low, suggesting under-reporting by
some subjects. Consequently at subsequent study visits, dietitians specifically
addressed potential under-reporting with subjects when reviewing their individual
food records. The subjects were mildly obese but overall they did not exhibit
impaired

glucose

tolerance

or

insulin

resistance(15),

nor

were

they

hyperlipidaemic(331) or hypertensive(332).
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Table 6.5 Baseline characteristics of study subjects (means and standard deviations)
CONTROL
VARIABLE

SORGHUM

DIFFERENCE

Mean

SD

Mean

SD

p-value

Age (years)

48.6

11.4

48.1

10.3

0.859

Weight (kg)

86.1

9.8

87.1

12.9

0.732

BMI (kg/m2)
Waist (cm)

31.6
105.3

2.8
9.5

31.2
102.5

3.5
12.0

0.632
0.311

Fat (%)

40.3

5.8

38.7

6.3

0.309

Fasting Blood glucose (mmol/L)

5.2

0.4

5.3

0.6

0.297

Fasting Insulin (mIU/L)

12.5

5.7

12.3

6.9

0.893

HbA1c (%)

5.3

0.3

5.2

0.4

0.554

Total Cholesterol (mmol/L)

5.6

1.0

5.3

1.0

0.173

LDL-c (mmol/L)

3.5

0.9

3.2

0.8

0.193

HDL-c (mmol/L)

1.4

0.4

1.5

0.3

0.533

TAG (mmol/L)

1.6

0.8

1.3

0.7

0.155

IL1 (pg/ml)

0.9

1.0

0.9

0.9

0.841

Il-6 (pg/ml)

1.5

1.6

0.8

0.7

0.052

Il-8 (pg/ml)

6.2

2.8

5.2

1.8

0.096

TNFα (pg/ml)

2.9

1.3

3.2

1.2

0.483

hsCRP (mg/L)

2.7

2.6

2.4

2.1

0.662

TAC (mmol/L Trolox)

1.2

0.2

1.3

0.2

0.476

HPX (mmol/L H2O2)

2.5

0.5

2.4

0.6

0.495

Diastolic BP (mm Hg)

82.3

9.6

80.4

7.4

0.407

Systolic BP (mm Hg)

126.2

16.9

122.3

14.4

0.349

6.6.2 Dietary Intervention
The flaked cereal biscuits were consumed by subjects with no adverse reactions and
dietary compliance was relatively high at approximately 85%, as determined by a
manual count of uneaten biscuits upon study completion. Food record analysis
indicated no significant difference between the groups for protein, carbohydrate and
fat intakes at any of the time-points once the study commenced. Review of the
overall dietary composition of baseline diets compared with the 3 month end-point
showed a significant decrease in percentage energy from fat (p<0.001), as well as
saturated fat (p<0.001). Percentage energy from protein and carbohydrate was not
altered over time (Table 6.6).
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Compliance with a weight reduction meal plan was identified by overall weight loss
and energy reduction reported in the food records. Total energy intake was
significantly lower at the mid-point (mean 7136kJ (SD 2164 kJ)) and the end-point
(mean 6880 (SD 1815) kJ) (p<0.001) of the trial compared with the baseline (mean
8742 (SD 2656) kJ), using RMANOVA with treatment as the between-group effect
and time as the within-subject variant. The lack of an interaction effect over time
(p=0.671) suggests that there were no differences between groups in energy intake
over time. There were no significant differences in activity scores between the
groups at any time-point, indicating that changes in physical activity were not a
factor in influencing overall results.

6.6.3 Clinical Indices
The majority of the anthropometric and biochemical indices changed over 3 months;
however, there were no significant differences between the groups for any of the
measured clinical parameters over this time (Table 6.7). The average weight loss for
the study sample was significant at 5.3 kg (p<0·001) (or 6.1% of baseline body
weight) over the 3 month intervention. The mean weight changes ranged from a 2.1
kg gain to a 14.7 kg loss, however weight loss was not significantly different
between the groups (p=0·369). Waist measurements and percentage body fat
decreased significantly compared to baseline (p<0.001). Regression analysis
indicated that weight loss significantly predicted waist change (p<0·001) and
percentage body fat (p<0·001). As expected, these predictions were strong (R2 0.389
and R2 0.615). Fasting blood glucose (p<0·001) and fasting insulin levels decreased
over 3 months (p<0·001) but HbA1c did not change. No between group differences
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Table 6.6 Energy and macronutrient intakes reported by subjects at baseline, mid-point and 3 months, with p-values for repeated measures
ANOVA between control and sorghum groups (mean values and standard deviations)
BASELINE
CONTROL

MID-POINT

SORGHUM

CONTROL

3 MONTHS

SORGHUM

CONTROL

P-VALUES
SORGHUM

VARIABLE

Mean

SD

Mean

SD

Mean

SD

Mean

SD

Mean

SD

Mean

SD

Energy (kJ)

9274.0

2696.2

7897.3

2429.8

6993.0

2244.8

7363.9

2076.2

6752.8

2090.6

7082.0

Protein (g)

106.6

33.2

89.5

30.8

88.9

35.0

95.4

32.6

81.7

26.2

89.6

% E Protein

20.0

5.2

19.5

4.1

22.4

6.5

21.9

4.0

20.7

3.4

CHO (g)

234.6

84.5

190.6

60.7

187.8

74.4

181.4

43.5

177.9

Group

Time

Interaction

1297.1

0.110

<0.001*

0.671

24.7

0.049*

0.008*

0.909

21.5

4.1

0.56

0.059

56.8

183.2

40.9

0.144

0.040*

% E CHO

39.9

5.1

39.1

7.09

42.6

8.3

40.0

5.2

42.6

6.3

41.5

6.0

0.811

0.161

Total Fat (g)

85.1

25.7

77.2

31.5

54.9

23.5

61.9

26.0

57.1

23.8

57.6

15.3

<0.001*

0.381

% E Total Fat

34.0

5.2

35.5

5.3

28.5

5.4

30.4

4.9

30.8

7.0

30.1

5.2

0.435

<0.001*

SFA (g)

34.3

12.4

29.8

14.3

18.4

7.4

22.9

10.9

20.3

8.6

20.4

5.8

0.161

<0.001*

% E SFA

13.7

3.2

13.6

3.3

9.7

2.0

11.3

2.8

11.0

3.0

10.7

2.2

0.090

<0.001*

PUFA (g)

12.7

5.3

12.9

6.6

9.7

5.8

9.3

5.0

9.1

4.7

9.5

4.2

0.829

0.003*

% E PUFA

5.1

1.7

6.1

2.8

4.9

2.0

4.5

1.5

4.9

1.9

4.9

1.6

0.234

0.081

MUFA (g)

31.6

10.8

28.8

14.2

20.3

10.5

23.0

11.0

21.3

6.5

21.5

6.5

0.486

<0.001*

% E MUFA

12.6

2.8

13.1

3.2

10.4

3.2

11.2

2.6

11.3

4.0

11.3

2.8

0.789

0.005*

Total Fibre (g)

26.3

9.0

25.6

9.5

24.4

9.1

24.9

7.2

24.1

9.2

27.2

10.2

0.432

0.626

E – energy; CHO – carbohydrate.
* Significant values (p<0.05) were measured using repeated measures ANOVA.
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Table 6.7 Changes in anthropometric and biochemical indices over time between control and sorghum groups (means and standard deviations)
ALL GROUPS

SORGHUM

CONTROL

P-VALUES
CLINICAL
INDICES

Baseline data

Mean change

Baseline data

Mean change

Baseline data

Mean change

Mean

SD

Mean

SD

Mean

SD

Mean

SD

Mean

SD

Mean

SD

Group

Time

Interaction

Weight (kg)

86.6

11.6

-5.3

3.7

86.1

9.8

-5.4

3.6

87.1

13.6

-5.2

4.0

0.369

<0.001*

0.772

2

BMI (kg/m )

31.3

3.1

-1.9

1.4

31.6

2.6

-1.9

1.3

31.1

3.4

-1.9

1.4

0.754

<0.001*

0.601

Waist (cm)

104.2

10.9

-10.9

5.4

105.3

9.5

-11.8

5.6

102.9

12.5

-9.9

5.2

0.209

<0.001*

0.594

Body fat (%)

39.4

6.0

-2.1

2.3

40.3

5.8

-2.1

2.3

38.3

6.9

-2.3

2.5

0.876

<0.001*

0.194

Glucose (mmol/L)

5.26

0.50

-0.13

0.4

5.18

0.36

-0.11

0.3

5.35

0.62

-0.15

0.4

0.705

0.009*

0.162

Insulin (mIU/L)

12.32

5.78

-2.86

3.3

12.55

5.8

-3.17

3.0

12.06

5.86

-2.53

3.7

0.481

0.000*

0.905

HbA1c (mmol/L)

33.95

4.2

0.10

3.1

33.97

3.89

0.20

3.2

33.92

4.60

0.00

2.9

0.843

0.843

0.896

HbA1c (%)

5.26

0.37

0.00

0.3

5.26

0.34

0.00

0.3

5.25

0.41

0.00

0.2

0.926

0.926

0.912

Total cholesterol
(mmol/L)

5.47

0.99

-0.40

0.7

5.64

0.98

-0.50

0.7

5.28

0.99

-0.30

0.6

0.139

<0.001*

0.384

HDL-c (mmol/L)

1.42

0.38

-0.07

0.2

1.40

0.40

-0.10

0.2

1.45

0.37

-0.10

0.2

0.674

0.008*

0.454

LDL-c (mmol/L)

3.39

0.85

-0.15

0.5

3.52

0.90

-0.20

0.6

3.24

0.79

-0.10

0.4

0.225

0.05

0.379

TAG (mmol/L)

1.46

0.76

-0.40

0.6

1.59

0.81

-0.50

0.7

1.30

0.67

-0.30

0.5

0.393

<0.001*

0.174

IL1β(pg/ml)

0.93

0.97

-0.15

0.4

0.92

1.03

-0.10

0.4

0.94

0.92

-0.20

0.3

0.565

0.004*

0.943

Il-6 (pg/ml)

1.19

1.29

-0.22

0.3

1.48

1.59

-0.20

0.4

0.86

0.73

-0.20

0.3

0.752

<0.001*

0.071

IL-8 (pg/ml)

5.73

2.46

-0.49

1.1

6.20

2.84

-0.40

1.2

5.19

1.86

-0.60

0.9

0.621

0.001*

0.075

hsCRP (mg/L)

2.52

2.41

-0.28

1.8

2.65

2.64

-0.30

2.1

2.37

2.15

-0.20

1.3

0.059

0.207

0.728

TNFα (pg/ml)

3.06

1.23

-0.76

0.8

2.95

1.27

-0.60

0.7

3.19

1.18

-0.90

0.8

0.110

<0.001*

0.748

HPX (mmol/L H2O2)

86.6

11.6

-5.3

3.7

86.1

9.8

-5.4

3.6

87.1

13.6

-5.2

4.0

0.296

0.174

0.150

TAC (mmol/L Trolox)

1.26

0.18

-0.06

0.1

1.24

0.15

-0.10

0.1

1.29

0.20

-0.10

0.1

0.759

<0.001*

0.247

c – cholesterol; TAG – triacylglycerides; HbA1c – glycosylated haemoglobin; IL1 – Interleukin 1; Il-6 – Interleukin 6; IL-8 – Interleukin 8; hsCRP – high sensitivity c-reactive protein; TNFα – tumour necrosis
factor alpha; TAC – total antioxidant capacity.
* Significant values were measured using repeated measures ANOVA
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were identified for any of these clinical indices (Table 6.7). The inflammatory
cytokines IL1β, Il-6 and Il-8, decreased significantly compared to baseline
(p<0.001), as did TNFα (p<0·001). TAC levels also decreased significantly
compared to baseline (p<0.001). There were no significant changes over time in
hsCRP and HPX levels. The reduction in total cholesterol was not significantly
different between the groups, with mean decreases of 0.3 mmol/L (SD 0.6 mmol/L)
for the sorghum group and 0.5 mmol/L (SD 0.7 mmol/L) for the control. There was a
significant decrease in total cholesterol over 3 months for all subjects (p<0.001), as
well as significant decreases in HDL-c (p<0.001), LDL-c (p<0.05) and TAG
(p<0.001) levels over this time.

6.6.4 Subjective Satiety
VAS results were reviewed for the six daily time-points at 0, 6 and 12 weeks to
compare any differences that may have existed between the control and test groups
(RMANOVA). No significant differences were identified, demonstrating that all
individuals reported similar feelings of hunger/fullness at the same test points (data
not shown).

6.7 Discussion
As a consequence of this dietary intervention, a reduction in energy intake was
achieved in the overweight study sample. The reduced energy intake in both groups
was an effective driver of weight loss over the 3 month period. Regardless of the diet
subjects followed, they lost weight and experienced beneficial changes in waist
circumference, fasting glucose, fasting insulin, lipids and inflammatory markers. If
maintained over time, the mean weight loss of 6.1% and reduced waist
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circumference (10.9 cm (SD 5.4 cm)) for the study sample, could decrease risk of
insulin resistance, impaired glucose tolerance and dyslipidaemias(333), as well as
lower the incidence of developing type 2 diabetes(334).

The present study failed to confirm differentiating effects of sorghum grain
consumption on weight loss in an energy-restricted diet over 12 weeks where only
the test foods were different. This design is necessary, however, for rigorous testing
of individual foods where other dietary confounders are cancelled out. Despite the
previous acute satiety study showing promising results (Chapter 5) (335), the present
study showed that differences in meal satiety do not necessarily translate to weight
reduction differences in the long term. Bearing in mind that the energy restriction of
the total diet was the same for both groups, subjects receiving foods made from
sorghum included in the dietary advice, did not lose more weight than the subjects
receiving control foods and similar overall dietary advice. Thus, the meal-based
satiety mechanisms postulated to involve sorghum polyphenols did not have an
enhancing effect on body weight changes over 3 months, nor on overall reduction in
metabolic disease risk factors.

Previous research conducted by our group has also shown that where both the
control and intervention diets focus on healthy eating patterns and control for energy
intakes, a difference in weight loss is not seen(315). Ostensibly this is because weight
loss is dependent on control of energy intake and hence the percentage energy
reduction in both arms was matched. Typically also, no differences are seen when
structured dietary advice to both the control and intervention groups is provided(336;
337)

, as was the case in the present study. However, differences in other risk factor
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variables (affected by dietary attributes other than total energy, such as dietary
fat(338;

339)

) have been observed. Given our assumption that a higher polyphenol

intake from sorghum may have had similar effects, the study design was appropriate,
but we may now need to look to other potential synergistic components of the diet,
or a higher dose to pursue our hypothesis further.

The lack of differences between groups in changes in lipid levels was not consistent
with another study investigating the effects of consuming sorghum foods on serum
lipid levels(171). In this study, a significant reduction (p<0.05) in total cholesterol,
TAG and HDL-c was observed in 10 males and 6 females after daily consumption of
100 g of unrefined sorghum in the form of pancakes over 3 weeks. However, this
study used a small sample size (with low statistical power), reducing the likelihood
that a statistically significant result reflects a true effect. Further, the content of
subjects’ background diets was not adequately reported, making assessment of
dietary confounders and final conclusions difficult. Overall, these results are
ambiguous hence more human evidence for lipid effects in relation to sorghum
consumption is warranted, and may be more relevant where weight loss inducing
diets are not prescribed so as to discern lipid lowering effects independent of weight
loss.

A further strength of the present study was that the polyphenolic composition of the
test foods was profiled. From a physiological perspective, consideration was given to
the results of a recent randomised, controlled, crossover human study, involving 22
healthy adults, assessing the acute effects of consuming pasta containing red or white
whole grain sorghum flour (30% sorghum, 70% semolina) on plasma total
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polyphenols, TAC and oxidative stress markers compared to a wheat control made
from 100% semolina(180). Pasta containing red whole grain sorghum flour (RSP), but
not white sorghum flour, enhanced antioxidant status and improved markers of
oxidative stress in healthy subjects (p<0.001). The increase in plasma polyphenols by
the RSP meal was attributed to its higher content of polyphenols. In the present
study, despite significant differences in the levels of polyphenols and TAC between
the test food products, differences in the levels of inflammatory biomarkers and
plasma TAC between the sorghum intervention and wheat control groups were not
detectable (Table 6.3). The reasons are not clear as to why the TAC levels
unexpectedly decreased over time even though the inflammatory markers showed
significant improvement. While standard protocols were followed and precautions
taken, possible oxidation of blood samples during preparation or storage, cannot be
ruled out(302). Furthermore it may be that the effects of ingesting sorghum grain
components are short-lived and subtle, hence the positive outcomes observed in
acute studies may not translate to whole of diet studies conducted over a number of
months.

The lack of differences in subjective satiety scores was perhaps expected. VAS are
validated for use in highly controlled situations(217), such as acute meal test studies.
The inclusion of satiety-related VAS was justified to enable a possible link between
reported ratings in this study and those of the previous acute satiety study(335)
(Chapter 5), though realistically, the small differences from month to month in the
present study were unlikely to be captured accurately by the subjects using the VAS
tool. An alternative appetite questionnaire, validated for use in free-living
conditions(340), may have been more informative.
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Separating out the effects of individual components within a food, in this case the
flaked cereal biscuit matrix, is difficult within a human intervention trial. To this end,
a key strength of the present study is the comprehensive characterisation of the
physicochemical properties of the test foods used in the intervention diets, enabling
the link between clinical effects and components within the food. In the previous
acute study(335), determination of polyphenolic compounds, dietary fibre, profiling of
starch contents and proximate analyses of the RTE sorghum flaked biscuits, guided
the hypothesis that the polyphenolic compounds in particular played a role in
observed acute satiety effects that would drive weight loss in the present RCT.
Overall, the lack of positive results should not infer that sorghum is not a beneficial
ingredient in cereal foods, as subjects consumed the foods successfully, lost weight,
decreased their serum cholesterol and showed other positive outcomes related to
metabolic health. The whole grain sorghum product was as effective as the whole
grain wheat product in the present study. Sorghum, like other whole grain cereals,
delivers beneficial, health-promoting components and properties (such as
antioxidants, dietary fibre, SDS and valuable energy) when it is consumed as part of
a healthy food within a healthy diet.

As with most human dietary intervention trials, there are a number of confounding
variables in the present study that require some consideration. Firstly, the trial was
only a 3 month intervention and this period of time may not be long enough to detect
differences between the subjects’ compliance with an energy restricted diet and the
actual effects of the dietary intervention. It has been shown that subjects who
reported greater compliance with a weight loss protocol lost more weight regardless
of the dietary intervention(341), suggesting that strategies to increase adherence may

151

CHAPTER 6: Examining the longer-term effects of chronic sorghum consumption: a RCT

be more important than the actual composition of the diet. Validated “measures of
adherence” to enhance compliance to dietary advice in the context of clinical
interventions would therefore be useful in future studies(342).

Secondly, the present study included similar test food products for both the
intervention group and the control group, which only varied in the source of grain
(sorghum versus wheat). The effect of individual grain components within the cereal
biscuits, even if positive, are likely to be relatively small and hence showing a
statistical difference between the groups would be difficult, especially over 3
months. Significant differences between the treatment and control groups may have
been detected if the whole wheat control biscuits were lower in dietary fibre and
higher in RDS compared to the sorghum biscuits. Further, instructing subjects to eat
food products at both breakfast and at afternoon tea as part of the compliance criteria
for the dietary intervention protocols, may have actually increased overall energy
consumption at times when the subjects might otherwise have chosen not to eat or to
eat less in either arm of the study.

Thirdly, it is difficult to control the dietary intake of human subjects. Although food
records and discussions with subjects during study interviews indicated high
compliance with consumption of test products, the subjects were less compliant with
the energy restriction as evidenced by the lower-than-predicted weight loss. All four
subjects that withdrew from the study were from the intervention group, which could
infer the greatest difficulty with compliance, but this is less likely given the reasons
provided for their withdrawal. Lastly, large standard deviations existed within all the
analysed datasets, limiting the ability to detect significant results. The large standard
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deviations indicated that individual fluctuations are more varied than any overall
effect of sorghum intake.

6.8 Conclusions
In summary, although the groups experienced significant weight loss and general
improvement in all clinical measures such as fasting glucose, insulin, cholesterol and
key inflammatory biomarkers, no effects appeared specifically related to sorghum
consumption. Overall, there were no discernable differences between an energyrestricted diet containing a wheat-based cereal food and that containing a sorghumbased cereal food. With a longer intervention and greater exposure to the test foods,
some differences might have been detected, as subtle effects of components in the
cereal foods would become more prominent. Nevertheless, the consumption of
sorghum flaked breakfast cereal biscuits in the context of an energy-restricted diet is
not deleterious in overweight and mildly obese individuals, and in fact represents a
viable gluten-free alternative to wheat in food products.
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CHAPTER 7:
Conclusions and Recommendations

A component of this chapter is contained within the article:
Stefoska-Needham, A. (2016) Progressing the position of sorghum, a potentially sustainable cereal
crop, through the food product innovation pipeline: an Australian perspective. Agroecology and
Sustainable Food Systems. (Under Review)
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7.1 Summary of Findings

“Food is not just food. Food is a many splendoured thing”
Anita Stefoska-Needham…Inspired by Kaisa Poutanen (Dietary Fiber Conference, Paris, 2015)

Food represents a complex set of compounds. In nature these compounds act
synergistically and serve a biological purpose in the original organism (plant or
animal)(63). Even more complex, is the understanding of a food’s capacity to
contribute to beneficial effects in the human body. The complexity of dealing with
food was demonstrated in this thesis, which presented a case study of the effects of a
novel food on health. This case study investigated the potential of whole grain
sorghum as an ingredient in whole foods to assist in the prevention of chronic
disease, particularly by examining hypotheses relating to body weight regulation as a
key strategy for management of metabolic disease. Specifically, it was hypothesised
that sorghum was a viable alternative to existing whole grain cereals and may have
positive benefits on markers of metabolic health including weight management. In a
broad sense, by focusing on a single food ingredient – the sorghum grain – this thesis
asks whether sorghum might have a more significant place in the diets of
Australians.

The research undertaken for this thesis could be seen as a particular form of case
study on how research on new foods for human consumption might take place. After
positioning sorghum as a nutritious food, the research focused on the effects of a
novel food product developed in partnership with a food manufacturer (Sanitarium
Health and Wellbeing) and facilitated through the Australian Research Council
Industry Linkages program. The examination of sorghum’s potential to assist in the
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prevention of chronic disease exposed a number of the complexities which scientific
research needs to address in dealing with food effects on health. Findings from this
thesis add to the knowledge base for sorghum as a viable human food, particularly
within the Australian context where interest from food companies, researchers,
farmers and consumers is just beginning to grow. The thesis considers an important,
albeit gradual, transition for sorghum as a low-value livestock feed to a value-adding
human food ingredient. With the backdrop of a changing Australian economy (where
the agricultural sector is becoming a more significant economic stimulator), and a
growing priority for sustainable agriculture in the face of climate change(5), sorghum
appears as an appealing and appropriate choice of crop. After all, sorghum is
relatively cheap to produce, with remarkable adaptability, enabling it to survive in
harsh climates common to many regions of Australia.

An examination of the existing scientific research on sorghum provided a picture of
the state of the evidence base for sorghum consumption assisting in the prevention of
chronic disease. It also exposed a myriad of nutrients and bioactive compounds in
sorghum grain with potential actions in metabolic processes. The sorghum grain
components included slowly digestible starches, non-starch polysaccharides,
proteins, fats and a vast array of phytochemical compounds, including phenolic acids
and flavonoids. Studies of these components implicated effects on energy balance,
glycaemic control, lipids, gut microbiota, and cell-mediated immune responses,
including antioxidant and anti-inflammatory processes. Put together, it also appeared
likely that, as a result of food synergy, the whole food is likely to be more potent
than its individual components(148). For this reason, whole sorghum-based foods were
used to test the effects of sorghum intake. The critique of effects of bioactive
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components within sorghum gained from the literature review guided the direction
and formulation of valid hypotheses for subsequent human studies reported in the
thesis, and informed the development of an optimised sorghum-based food product
for testing. This was a necessary and innovative step in the thesis, and reflected the
absence of existing sorghum-based foods in the Australian diet.

The food product innovation transformed sorghum from its raw grains into a whole
food product (flaked cereal breakfast biscuits), appealing to the Australian palate. To
link the potential actions of food components within the sorghum flaked biscuits with
effects, it was necessary to comprehensively characterise the physicochemical
properties of the test foods and this was a major strength of this thesis. Aside from
typical

analyses

such

as

proximate

determinations,

evaluation

of

polyphenolic/antioxidant compounds and starch properties was also made. Full
details on the processing of the sorghum grain were considered including unique
information from scanning electron microscopy, which intimated details on the status
of starch granules in the final test foods (mainly with respect to gelatinisation).
Collectively, this data assisted with ascribing clinical effects to particular
components within the sorghum food matrix. This information also guided specific
recommendations made to the food manufacturer around future formulations of
flaked sorghum biscuits. In particular, consideration was given to lowering the input
and final moisture levels in order to minimise starch gelatinisation, to further
increase the content of slowly digestible starches and to potentially lower the
glycaemic index of the final product. Importantly, this information also provided
evidence for potential mechanisms of action that may contribute to outcomes in the
subsequent trial testing the longer-term effects of chronic sorghum consumption.
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This thesis contributed to the evidence that whole grain sorghum enhances acute
satiety and is likely to be equivalent to wheat when consumed as an ingredient in
whole foods. Meal test results showed an increase in anorexigenic hormones (GLP-1
and GIP in both sexes and PYY in males) over four hours after sorghum whole grain
was ingested in the form of flaked breakfast biscuits, especially after red sorghum
intake. Likewise, subjective satiety was increased acutely after sorghum biscuits
were consumed compared to wheat biscuits. Interactions between polyphenols,
dietary fibre and SDS within the food matrix may have contributed to the observed
elevated satiety effects of sorghum flaked biscuit consumption (compared to wheat),
although the involvement of other nutrients and bioactive components may also be
relevant. These may include additional effects from gut hormone stimulation. While
differences in polyphenol content may be relevant, no individual component was
definitively implicated in the mechanistic pathways, supporting the food synergy
concept whereby “many substances in food have additive or more than additive
effects” on health outcomes(343).

As part of an energy-reduced diet, sorghum produced significant weight loss and the
majority of clinical measures (fasting glucose, insulin, serum cholesterol and key
inflammatory biomarkers) improved over 3 months during the dietary intervention
trial. However, these effects were not significantly different to an energy-reduced
wheat control diet. Overall, it was not possible to conclude that whole grain sorghum
assisted specifically with weight management, or was superior to wheat (another
whole grain product). However, the lack of differentiating results between chronic
consumption of sorghum and wheat should not infer that sorghum is an inferior
ingredient in cereal food products, especially since subjects consumed the sorghum-
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based foods successfully and experienced beneficial effects. What is evident from
this research is that a whole grain sorghum product appears as effective as a whole
grain wheat product in the context of an energy-restricted diet.

Sorghum, like other whole grain cereals, delivers beneficial, health-promoting
components and properties when it is consumed as part of a healthy food within a
healthy diet, and it represents an excellent gluten-free whole grain alternative to
wheat. This knowledge assists with future marketing of sorghum as a food with
potential health benefits, to consumers. Today more people are motivated by the idea
that healthy eating encompasses wholesome foods and drinks, which are minimally
processed, to fuel the body and provide long-lasting energy(11). Weight management
is often an underlying driver for consumer food choice, particularly in Western
societies where rates of overweight and obesity are prevalent. Foods that are able to
assist in appetite control are of particular interest to both consumers and food
companies alike. Equally appealing is the use of alternative and/or novel ingredients
that are naturally functional, the so-called “ancient grains” being a good example(11).
Market researchers predict that the “healthy living” movement will continue(11),
resulting in more consumers prioritising their personal health and demanding
naturally healthy, minimally processed whole food product innovations, which could
include products from sorghum.

Following this demand will be interest from the food industry to make health claims
about these novel “healthy” food innovations, and thereby an increased demand for
science to substantiate these claims is expected. For now, specific health claims
about weight regulation, appetite and satiation/satiety enhancement are not permitted
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in Australia under the FSANZ regulations(12), though this may change with more
scientific evidence demonstrating appetite-regulating effects of different foods. This
would firstly require the development of guidance documents on satiety-related
health claims, similar to those produced by Health Canada(216). Should this become
available, the results from the research in this thesis would make a contribution to the
required evidence base.

7.2 Limitations and considerations for further research
As with all research, the major limitations of this thesis relates to the breadth and
depth of analysis that is made available through the study designs. Nevertheless, the
choices made were consistent with convention. Food-based research has historically
used mechanistic studies to explain health effects of food consumption, though this
has often proven futile for supporting claims on health outcomes mainly because the
human body is complex and the pathways that lead to improved health or disease
development are multifaceted. Adding to this intricacy is the complexity of food
itself and the myriad of interactions between food components and body processes.
A good example of this complexity comes from the acute study in this thesis,
whereby insulin response was lower after the white sorghum biscuit compared to the
red sorghum biscuit but resulted in the same subjective satiety ratings. If greater
insulin responses are indeed associated with enhanced acute satiety effects(281), then
why did the subjects not perceive greater feelings of satiety? Similarly, although the
satiety related hormones GLP-1 and GIP were elevated after red sorghum
consumption, the release of the hunger hormone ghrelin was not different between
treatments despite differences in subjective satiety sensations. There is no clear
answer to fully explain these results, although human behaviour may be the most
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powerful determinant of people’s food choices. We all experience eating food in
response to non-biological cues such as emotions, hedonic hunger (eating to obtain
pleasure in the absence of an energy deficit), environmental influences, and habits.
For example, if satiating/satiety effects could override other factors on eating, then
the sorghum group may have eaten less, but this was not the case. More
consideration should therefore be given to assessing human behaviour in these types
of studies.

Given the complex nature of food effects, translating scientific research into practical
food and nutrition advice on disease prevention is difficult. Nevertheless,
mechanistic studies of food components add to our knowledge about nutrition and
contribute to inferences about important causal pathways. In this vein, the acute meal
test study in this thesis identified important satiety-enhancing actions occurring
within the sorghum grain (ascribed potentially to SDS, polyphenols, dietary fibre), as
well as highlighted potential physiological processes involving gut hormones. The
subsequent trial then served as a platform to test whether these effects could be seen
over a longer time frame and within the context of a whole diet, which after all, more
closely resembles the natural context of human eating behaviour. However these
studies were conducted with a single food – and while well-characterised to define
the ingredient, it is difficult to ascertain how an ingredient will translate into another
food.

The RCT design (Chapter 6) was the necessary choice for conducting this
“translational” nutrition research because its internal validity for comparing an
intervention to a control is considered to be the “gold standard” and results from

161

CHAPTER 7: Conclusions and Recommendations

RCTs are usually reliable for causal inferences. However, where both the control and
intervention diets focus on healthy eating patterns and control for energy intakes, as
was the case in the RCT in this thesis, it seems that a difference in weight loss is not
likely to be seen(336). This is because weight loss is dependent on control of energy
intake and the percentage energy reduction was matched in both arms in the present
RCT. Usually though, differences in other risk factor variables (not affected by total
energy) can be observed, as seen in other studies of similar design(339). It was
postulated that a difference in serum cholesterol, glucose, insulin and inflammatory
markers may be detected between groups (partly due to differences in bioactive
components such as polyphenolic compounds), but this was not the case. Possibly,
the amount of sorghum grain in the serve size of the test cereal food products was
inadequate to elicit differences in satiety and metabolic markers over 3 months.
Although it is not novel to consider that serve size/dose is important in food studies,
it is an important factor especially in cereal food studies because clinical effects may
be dependent on small components within the food matrix.

The RCT results raise the important question about whether the strategy to match the
percentage energy restriction in both the control and intervention arms is actually a
limitation. An alternative option is to design studies with additional study arms,
whereby subjects consume their usual diet without energy restriction and eat the test
foods of interest daily. To demonstrate this using the RCT in this thesis as an
example, there would be four study groups: 1) usual diet + sorghum; 2) usual diet +
wheat; 3) energy-restricted diet + sorghum; 4) energy-restricted diet + wheat.
Effectively, this suggests two controls and two intervention groups; a control for
overall dietary composition (including total energy) and eating behaviour and a
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control for the test food being studied (cereal). It should be acknowledged that this
might be prohibitive from a practical point of view as costs are increased with more
subjects and subject recruitment becomes a challenge when volunteers are not
promised a weight loss intervention. Nevertheless, an alternative strategy such as this
may be worthwhile to increase opportunities of detecting differences in weight loss
or biomarkers between groups. Greater study power achieved through a larger
sample size and/or conducted for a longer time-frame may have allowed differences
between groups to emerge, though this presents with other challenges typical of
RCTs including confounding and compliance issues (Chapter 6).

Although energy restriction is pivotal to weight loss, and weight loss is a key
preventative strategy for disease prevention, it does not reflect the overall quality of
an individual’s dietary intake. In fact, energy restriction could compromise nutrient
intake and lead to an unbalanced diet. Aside from the energy-restricted dietary
prescription provided to subjects in the RCT (based on the Dietary Guidelines of
Australia), diet quality was not formally monitored. Grafenaeur et al.(344) state that
the emphasis on diet quality in a weight-loss context recognises the interrelationships
between foods and food components, and considers the relationship between the
dietary pattern and overall health. Upon reflection, this is a key component of the
research framework of this thesis and to this end, a formal assessment of diet quality
using a validated tool, for example the Food Choices Score (FCS)(344), would have
provided useful information about the types of food choices individuals made and
how those selections influenced their eating behaviour, rather than using adherence
to total energy reduction as the sole gauge of dietary intake and in the end, body
weight outcomes.
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7.3 Key recommendations for future studies
Specifically in relation to sorghum, ongoing investigation is warranted on the use of
sorghum whole grain as an ingredient in the formulation of foods targeted for weight
control through appetite regulation, in both a research and commercial context. The
outcomes of this thesis identify the following key points and raise important
recommendations and questions for prospective studies using sorghum foods.

1. Part of the effects of sorghum consumption on acute satiety appears to relate
to stimulation of gut hormones such as GLP-1, GIP and PYY. These effects
were demonstrated over 4 hours, hence future research should use this time
frame as the minimum testing period. However, review of hormones over
greater periods of time in a study with chronic ingestion, and with different
sorghums varieties, would be useful, especially since mechanisms involving
polyphenolic components and dietary fibre appear to be quite subtle. These
hormones would be best reviewed during meal test studies pre- and postlong-term interventions, given that a single fasting level taken at a particular
point in time over 3 months is not likely to be representative. Although,
plasma glucose responses were not altered in the acute study (probably due to
similar starch properties between treatment foods), specific testing of the
flaked biscuits’ GI and insulin index would have provided additional
mechanistic information. This may have also helped to better understand the
increased insulin response observed after red sorghum biscuit intake.
Numerous studies suggest that insulin plays a greater role in acute satiety
than glucose(281), however ideally reduced insulin responses may be more
valuable in diabetes prevention. Controlling for fibre content may more
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clearly elucidate mechanisms and future dose response studies with
manipulation of the sorghum fibre types would be useful to more precisely
investigate the role of fibre in satiety-enhancing mechanisms of sorghumbased foods.

2. Studies should aim to determine whether differences in satiety would persist
with chronic sorghum intake – and in turn whether these differences would
influence long-term food intake and thence weight management. Specifically,
evidence from future RCTs (aiming to directly examine effects on health
outcomes between a control and sorghum-intervention diet) are needed to
better understand the health-promoting potential of sorghum consumption –
as this remains ambiguous in this thesis. However, food-based RCTs present
with substantial design challenges, particularly when examining weight loss
outcomes. Developing research strategies to test weight loss outcomes in
free-living individuals where energy intake is not controlled but scientific
rigour is preserved, should be a key focus in this endeavor. Additionally, a
focus on diet quality in a weight-loss intervention trial and more broadly in
research aiming to link food and health (such as sorghum consumption and
health), would be advantageous as improved diet quality exposes individuals
to health promoting food components such as dietary fibre and antioxidant
compounds and these factors can be better evaluated and considered in the
overall study outcomes.

3. More-commonly consumed food formats should be tested in future studies of
sorghum grain consumption, including bread, pasta, porridge and other
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breakfast cereal options. Invariably, foods are processed from cereals using
different methods that impact on both sensory and nutritional aspects of the
food. The acute satiety study in this thesis may have been improved with at
least an additional test food included in the crossover design, one based on an
alternative food format such as porridge. This would have assisted with
evaluating the influence of processing on the sorghum grain and subsequently
the impact on biomarkers. Various chemical and physical reactions are
initiated during food processing that may alter the properties of the sorghum
grain and food matrix, impacting on the fate of the food once ingested. It is
imperative in future sorghum-based studies to broadly define the postprocessing physicochemical properties of the test foods in order to make
plausible links between observed clinical effects and potential mechanisms of
action at the food level.

7.4 Concluding Remarks
Sorghum is an excellent crop suitable for sustainable agriculture, particularly in
Australia which is experiencing negative impacts of climate change and global
warming(5). This research suggests that commercial investment in sorghum food
product development is warranted. Further, with consumer trends indicating a
growing demand for naturally functional, minimally processed and satiety-enhancing
foods(11), whole grain sorghum represents a novel ingredient in food formulations,
especially those targeted for appetite control. ‘Value-adders’ would benefit not only
from sorghum’s gluten-free attribute, but its source of nutrients, slowly digestible
starches, dietary fibre, antioxidant compounds, and its application (especially red
sorghum) as a natural food colour. Not only do the findings from this thesis provide
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new knowledge that may improve health outcomes for consumers of sorghum-based
products in the longer term, but they also contribute to developing and growing the
sorghum industry globally. Multinational corporations and smaller entrepeneurial
food companies now need to invest in launching sorghum-based product formats that
have the potential to become popular within these markets.

7.5 Post-Script
By the completion of this PhD thesis, a sorghum-based food product was launched
successfully in the market by the food manufacturer associated with this research; a
business decision that was supported by scientific developments from this body of
work. This joint innovation project reflects the value of collaboration between food
industry and academic research to explore a food’s potential through rigorous
science.
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APPENDIX 1
Appetite-Related Visual Analogue Scales (VAS)
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QUESTIONS ON APPETITE AND DESIRE FOR FOOD

Make a vertical mark

INSTRUCTIONS:
on each line that best matches how you are feeling at this moment.
For Example:

I am not
hungry at all

________________________________________________ I have never been
more hungry

How hungry do you feel at this moment?

I am not
hungry at all

________________________________________________ I have never been
more hungry

How satisfied do you feel at this moment?

I am completely
empty

________________________________________________

I cannot eat
another bite

How full do you feel at this moment?

Not at all full

________________________________________________

Totally full

How much do you think you can eat at this moment?

Nothing at all

________________________________________________

A lot
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APPENDIX 2
Product Evaluation Questionnaire: Flaked Cereal Biscuits
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ABOUT YOUR BREAKFAST CEREAL
Instructions
For questions that appear like this, draw a vertical mark (|) on each line that
best matches how you feel about the breakfast cereal you have eaten
Dislike very much ________________________________________________ Like very much

1. How much did you like or dislike the taste of the breakfast cereal?
I disliked the
taste a lot

________________________________________________

I liked the
taste a lot

2. How would you describe the taste of the breakfast cereal you have eaten?
(please tick the boxes which correspond to your selection)
Sour
Bitter
Sweet
Salty
Other (please specify):

3. How much did you like or dislike the texture of the breakfast cereal?
I disliked the
texture a lot

________________________________________________

I liked the
texture a lot

4. How much did you like or dislike the crunchiness of the breakfast cereal?
I disliked the
________________________________________________
crunchiness a lot

I liked the
crunchiness a lot
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5. How satisfying/filling was the breakfast cereal after you had eaten it?
Not very filling

________________________________________________ Very filling

6. Do you usually add any additional food items such as fruit, sugar, yoghurt
or honey (apart from milk) to your breakfast cereal?
__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________
__________________________________________________________________________________________

7. If you were allowed to add additional food items such as fruit, sugar,
yoghurt or honey to the breakfast cereal you have eaten, how likely would
you be to eat this cereal (please circle one):
Be more likely to eat the cereal
Be equally likely to eat the cereal
Be less likely to eat the cereal

8. If you were able to buy this breakfast cereal from a grocery shop and it was
priced similarly to other breakfast cereals, how likely would you be to buy
it? (Please tick one)
Definitely Would Buy
Probably Would Buy
Unsure
Probably Wouldn’t Buy
Definitely Wouldn’t Buy
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